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Abstract 
 
Chlamydia trachomatis is an obligate intracellular bacterium, responsible for the most 
prevalent bacterial sexually transmitted infection and is the leading cause of acquired 
blindness worldwide. Chlamydiae survive and replicate within a specialised intracellular 
membrane-bound compartment known as the inclusion. Inclusion biogenesis requires 
manipulation of host processes by translocated bacterial effectors. Despite Chlamydia 
targeting at least one effector into the nucleus, surprisingly little is known about how and why 
the bacteria interact with this major organelle. The aim of the work presented in this thesis 
was to examine the consequences of Chlamydia infection on nuclear architecture, organisation 
and function.  
 
Structurally, nuclei of cells infected with C. trachomatis become highly lobulated, reminiscent 
of both laminopathy and transformed cells. Analysis of the nuclear lamina (NL) demonstrated 
that lamin A/C is enriched at the inclusion-proximal face of the nuclear envelope (NE) and 
depleted elsewhere around the nuclear periphery. Lamin B is reduced and nuclear pore 
complexes (NPCs) are depleted in the inclusion-proximal lamin A/C-enriched region. Other NL 
scaffolding proteins including SUN proteins and emerin are unaffected. Transmission electron 
microscopy revealed a minimal distance of ~100 nm is maintained between the NE and 
inclusion membrane (IM), showing a classical membrane contact site does not form. Lamin A/C 
enrichment and NPC depletion occur independently of existing cellular NPC-free islands 
present in the NE, and are specific to C. trachomatis rather than C. muridarum. 
 
Functionally, these infection-associated NE alterations are promoted by bacterial factors and 
can recover following induced bacterial killing or inclusion clearance. Host nuclear protein 
transport ceases in the NPC-depleted region, whereas host nuclear mRNA distribution is 
unaffected. Associated local changes in host chromatin architecture occur, since 
heterochromatin accumulates at the inclusion-proximal face of the nuclear periphery at NPC-
depleted and lamin A/C-enriched zones. Lamin A/C changes are the driving force behind the 
NE modifications, as the NPC-depletion and heterochromatin accumulation is absent when 
cells lacking lamin A/C are infected with C. trachomatis. Remarkably, in these knockout cells, 
inclusions are larger and more bacterial progeny are produced. 
 
Computationally, chlamydial proteins of unknown function that may be translocated to the 
nucleus or NE were identified. A tool was developed to generate a consensus secondary 
sequence from multiple available prediction software. Using this tool, the chlamydial 
proteome was searched for proteins similar in secondary structure to known cellular NE or NE-
interacting proteins. Three proteins were identified, of which CT350 and CT384 are predicted 
to be type III secretion substrates. When ectopically expressed in HeLa cells, CT384 localised to 
the nucleus and resulted in aberrant nuclear architecture. 
 
Taken together, the data demonstrate that Chlamydia profoundly manipulates nuclear 
architecture from within the inclusion, and via interactions at the inclusion-proximal region of 
the NE constructs a lamin A/C-enriched platform to drive localised redistribution of 
heterochromatin and changes in host gene expression. 
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Slc1  SycE-like chaperone 1 
snRNP  Small ribonucleoprotein 
SPG  Sucrose-phosphate-glutamic acid 
SSC  Saline-sodium citrate 
SSE  Secondary structure element 
SNX  Sorting nexin 
SUN  Sas1, UNC-84 
T2S  Type II secretion 
T3S  Type III secretion 
Tarp  Translocated actin recruiting protein 
Tat  Twin-arginine translocation 
TCA  Tricarboxylic acid 
THP-1  Human acute monocytic leukaemia cell 
TLR  Toll-like receptor 
Tpr  Translocated promoter region 
WT  Wildtype 
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Chapter 1 – Introduction 
 
1.1 Chlamydia 
 
1.1.1 History and taxonomy 
 
The Chlamydiaceae are a family of bacteria belonging to the Chlamydiae phylum that in turn 
consists of two genera, Chlamydia and Chlamydophila, whose members are obligate 
intracellular pathogens that infect vertebrates causing disease. Due in part to their biphasic 
lifecycle and obligate intracellular development, the taxonomy of the Chlamydiaceae has been 
difficult to define and remains controversial to the present day. Chlamydial organisms from 
trachoma patients were first described in 1907 as protozoa by Halberstaedter and von 
Prowazek, in what unknowingly became the first description of Chlamydia trachomatis 
(reviewed in Nunes and Gomes, 2014). Chlamydophila psittaci was then identified in 1930 
after a worldwide pandemic of human psittacosis (Coles, 1930). However, C. psittaci, together 
with the causative agent of lymphogranuloma venereum (LGV), were incorrectly classified as 
viruses of the psittacosis-LGV as they could not grow on artificial media, and were not blocked 
by bacterial filters (reviewed in Nunes and Gomes, 2014). The trachoma causing agents were 
linked to the psittacosis-LGV viruses in 1942 by the discovery of a common (group) antigen 
(Rake, 1942). However it was not until 1966 that these organisms were classified as bacteria 
(Moulder, 1966), after studies showed they replicate by binary fission (Bedson and Gostling, 
1954), and have cell envelopes comparable in structure to Gram-negative bacteria (Armstrong 
and Reed, 1964; Moulder, 1966).  
 
Similarities in the morphology and lifecycle of these chlamydial organisms led to the creation 
of the genus Chlamydia. Within the genus, LGV and trachoma organisms were classified as 
Chlamydia trachomatis, and psittacosis organisms as Chlamydia psittaci, separated based on 
morphological and phenotypic differences. For example, C. trachomatis accumulates glycogen 
(Gordon and Quan, 1965) and is sensitive to sulphadiazine (Lin and Moulder, 1966), which is 
not the case for C. psittaci. Furthermore, C. psittaci propagates within multiple irregularly 
shaped compartments termed inclusions, whilst C. trachomatis propagates within a single 
spherical inclusion. The genus was further refined using DNA-based classification. Techniques 
such as DNA-DNA hybridisation and restriction endonuclease analysis led to the assignment of 
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new species into the Chlamydia genus such as Chlamydia pneumoniae (Grayston et al., 1989) 
and Chlamydia pecorum (Fukushi and Hirai, 1992). Proposed alterations to the taxonomy were 
made again in 1999, after phylogenetic analysis of the 16S and 23S ribosomal RNA genes 
revealed two major lineages of the Chlamydiaceae, C. trachomatis-like species and non-C. 
trachomatis-like species (Everett et al., 1999). Briefly, the 16S and 23S rRNA gene sequences 
varied by 4-7% and 7-9% respectively between the genera, whilst within the groups the 
variation was ≤ 5% and ≤ 3% for Chlamydia and Chlamydophila respectively (Everett et al., 
1999). The C. trachomatis-like species remained under the genus Chlamydia, and include  
C. trachomatis, C. suis and C. muridarum, whilst C. abortus, C. psittaci, C. caviae, C. felis,  
C. pneumoniae and C. pecorum form the genus Chlamydophila. The scientific community 
remains divided on these proposed changes, with some suggesting that not only are the 
sequence homology boundaries for genera separation arbitrary, but also that Chlamydiae 
evolution is so divergent from other bacteria, and the Chlamydiae lifecycle so intractable to 
genetic exchange, that classification based on 16S rRNA sequence divergence alone is not 
applicable (Schachter et al., 2001; Stephens et al., 2009). Indeed, Stephens et al. (2009) 
suggest a single genus Chlamydia as depicted in Figure 1.1. 
 
As the most significant human pathogen of the Chlamydiaceae, C. trachomatis is the focus of 
this thesis. This species is divided into two biovars, characterised by the clinical symptoms 
developed by the patient and the host tropism of the bacteria; trachoma and LGV. These 
biovars are divided into 19 serovars distinguishable by the specific antibodies produced by the 
patient. Serovars A-K comprise the trachoma biovar which infect epithelial surfaces such as the 
conjunctiva (serovars A-C), causing trachoma, and genital epithelial cells (serovars D-K), 
resulting in the archetypal urogenital Chlamydia infection. Serovars L1-L3 comprise the LGV 
biovar, which upon infection of urogenital epithelial cells can further penetrate into the 
lymphatic system, causing the disease of the same name, LGV. 
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Figure 1.1. Revised taxonomic structure of the order Chlamydiales. (A) Taxonomy of 
Chlamydiales as described in Stephens et al., 2009. (B) The natural host of each Chlamydia 
species are presented. * indicates zoonotic transmission to humans can occur. 
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1.1.2 Epidemiology, pathology and treatment 
 
Infections by members of the Chlamydiaceae cause a number of symptomatically distinct 
diseases dependent on the species, the strain and the host. The urogenital infection caused by 
C. trachomatis serovars D-K is the most common bacterial sexually transmitted infection in the 
world (Bébéar and de Barbeyrac, 2009), and as such represents a significant global health and 
economic burden. In 2012, the annual report of the UK National Chlamydia Screening 
Programme indicated that 7.7% of 15-24 year olds were positive for Chlamydia based on 
nucleic acid amplification tests (NCSP, 2012). Attempts to eradicate the disease have been 
hindered by the asymptomatic nature of the infection (up to 70% of cases in women and 50% 
in men), thus resulting in a significant asymptomatic carrier population (Stamm, 1999). Where 
symptomatic, C. trachomatis infection is characterised by cervicitis in women, and is 
frequently associated with endometriosis and pelvic inflammatory disease. Furthermore, 
reproductive complications such as ectopic pregnancy and neonatal pneumonia or 
conjunctivitis can occur. Chronic C. trachomatis infections have been linked to induction of 
squamous metaplasia in association with human papilloma virus infection, suggesting a 
synergistic effect in the development of cervical cancer (Silva et al., 2014). Urethritis occurs in 
men, which can progress to the upper genital tract causing epididymitis (Taylor Robinson and 
Thomas, 1980; Peipert, 2003). Reduced fertility has also been reported, although further 
studies have been conflicted (Idahl et al., 2007; Eggert Kruse et al., 2011). Dissemination 
beyond the epithelial layer occurs in C. trachomatis serovars L1-L3, resulting in LGV. In this 
variant, bacteria infect and spread systemically through the lymph nodes via macrophages, in 
some cases being isolated from the lower digestive tract (Zöllner et al., 1993). Initial symptoms 
of LGV often include a painless genital ulcer that goes unnoticed. Secondary and tertiary 
symptoms however can be much more severe, including inflammation of the lymph nodes that 
can progress to potentially permanent oedema and lymphatic obstruction (White, 2009). 
 
Ocular infections caused by C. trachomatis serovars A-C result in trachoma, the leading global 
cause of preventable infectious blindness. Trachoma is endemic to large areas of the 
developing world, including sub-Saharan Africa, Asia, parts of the Middle East and South 
America. The disease most often occurs in low-income rural communities due to a lack of 
sanitation and the limited access to healthcare and water, and is thus classified as a neglected 
tropical disease by the World Health Organisation. Transmission occurs via direct contact or by 
flies that come into prior contact with the eyes or nose of infected persons.  Blindness occurs 
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when recurrent infection results in chronic inflammation and scarring, leading to in-turning 
eyelashes (trichiasis) and subsequent damage to the cornea. In 2009, 40.6 million people were 
estimated to have active trachoma, of whom 8.2 million had already reached the stage of 
trichiasis (Mariotti et al., 2009). 
 
C. pneumoniae is considered to be the second most significant human pathogen of the 
Chlamydiaceae, able to cause pneumonia. C. pneumoniae infection is also linked with various 
chronic conditions such as atherosclerosis and reactive arthritis (Zeidler and Hudson, 2014). 
Less common human pathogens include C. psittaci, a primarily avian-infecting species that 
causes potentially lethal respiratory psittacosis in humans (Knittler et al., 2014), and  
C. abortus, a primarily ruminant-infecting species that can colonise the placenta to cause 
abortion or pre-term labour (Baud et al., 2008). Other species cause significant veterinary 
problems, with C. muridarum infecting mice and hamsters, C. suis infecting pigs, C. felis 
infecting cats and C. caviae infecting guinea pigs. 
 
Typical treatment for all species of Chlamydia involves the use of macrolide antibiotics such as 
azithromycin or tetracycline antibiotics like doxycycline. Antibiotic resistance is considered 
rare, despite significant selective pressure, although some incidences have been reported in 
vivo (Sandoz and Rockey, 2010). Screening programmes are in place in many developed 
countries to attempt to reduce the incidence of the sexually transmitted variant of the 
bacteria, although the impact and efficacy of these programmes has been somewhat limited. 
Vaccination is considered the favoured approach to reduce disease prevalence, however to 
date attempts to create a successful vaccine have been unsuccessful (Schautteet et al., 2011). 
 
1.1.3 Lifecycle and mechanisms of pathogenicity 
 
While the lifecycles, survival mechanisms and genetics of other bacterial pathogens have been 
extensively studied and elucidated, research into members of the Chlamydiaceae is 
comparatively less well developed. This can be largely attributed to the multiple challenges 
researchers face when studying Chlamydiaceae. Foremost of these difficulties is the obligate 
intracellular nature of the organism, which has until recently prevented traditional methods of 
genetic manipulation such as gene mutation or deletion commonly used to identify pathogen 
effectors (Wang et al., 2011; Ding et al., 2013; Agaisse and Derré, 2014; Bauler and Hackstadt, 
2014). To circumvent this, many researchers have focused on investigating clinical strains 
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containing natural mutations, including Suchland and co-workers (2000), who characterised an 
inclusion membrane protein by identifying and sequencing C. trachomatis strains that formed 
multiple non-fusogenic inclusions as opposed to the single large inclusion characteristic of this 
species. A more recent study utilised chemical mutagenesis techniques and high-throughput 
sequencing to generate a library of Chlamydia mutants for phenotypic analysis. Analysis of 99 
nonsense mutations in 84 open reading frames (ORFs) revealed that the metabolic pathways 
of C. trachomatis are remarkably plastic and that a number of uncharacterised secreted 
effector proteins (discussed later) are non-essential for infection (Kokes et al., 2015). These 
results were unexpected, as C. trachomatis possesses a small genome with just 894 ORFs 
(Stephens et al., 1998; Kalman et al., 1999) compared to 4554 ORFs in Salmonella (McClelland 
et al., 2001). During the course of this work, some genetic tools to transform Chlamydia have 
emerged, including the development of cloning vectors allowing both constitutive and 
inducible expression of fluorescent fusion-proteins and epitope-tagged chlamydial proteins 
(Wang et al., 2011; Ding et al., 2013; Agaisse and Derré, 2014; Bauler and Hackstadt, 2014). 
Tools to silence the expression of essential genes are yet to be developed, restricting the study 
of proteins such as virulence effectors using standard genetic methodology. 
 
1.1.3.1 General overview of the Chlamydia lifecycle 
 
A key factor in the genetic intractability of the Chlamydiae is their biphasic lifecycle, typically 
30-72 hours in culture, dependent on strain and host cell (Fig 1.2). During entry and exit from 
the host cell, Chlamydia exists as small (~0.3 μm diameter), highly compact elementary bodies 
(EBs) that are metabolically inert. In order to grow and replicate, EBs differentiate into larger 
(~1.0 μm diameter), non-infectious reticulate bodies (RBs) that are metabolically active 
(Moulder, 1991). RBs replicate by binary fission within a single large inclusion inside the host 
cell. The lifecycle can be described in five steps: (1) EB attachment and entry into the host cell; 
(2) Transport of EB-containing vesicles to the peri-nuclear region and fusion into a single 
inclusion, and EB to RB differentiation; (3) inclusion modification and expansion and RB 
replication; (4) RB to EB redifferentiation; (5) bacterial release from the host cell by lysis or 
egress. Under conditions of bacterial stress persistence, described as a long-term viable but 
non-cultivatable growth stage, can occur (Hogan et al., 2004). In vitro, a persistent state can be 
induced by antibiotic treatment, amino acid depletion or interferon gamma (IFNγ) treatment, 
and frequently involves RBs becoming enlarged and progressively more aberrant (Clark et al., 
1982; Coles et al., 1993; Beatty et al., 1994). Evidence for in vivo persistence also exists, with 
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multiple examples of morphologically aberrant chlamydial forms observed by electron 
microscopy (Nanagara et al., 1995; Skowasch et al., 2003). 
 
 
 
Figure 1.2. The biphasic life cycle of C. trachomatis. The life cycle of C. trachomatis can be 
described in five steps. (1) Elementary bodies (EBs, green spheres) attach to and enter cells, 
becoming encapsulated into vesicles (2) EB-containing vesicles migrate to and merge at the 
perinuclear region into a single inclusion and differentiate into reticulate bodies (RBs, red 
spheres) (3) RBs replicate and the inclusion begins to expand (4) RBs redifferentiate into EBs 
(5) Bacteria are released from the cell by lysis (5a) or inclusion egress (5b). 
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1.1.3.2 Secretion systems 
 
A key component of the Chlamydia lifecycle is the utilisation of functional secretion systems 
(Wolf et al., 2006; Chen et al., 2010). Six secretion systems have been identified in Gram-
negative bacteria to date, characterised by differences in the substrates of these systems and 
in the structure of the secretory apparatus (Costa et al., 2015). Chlamydia utilise both type II 
and type III secretion systems (Peters et al., 2007; Chen et al., 2010).  
 
In type II secretion (T2S), periplasmic proteins secreted by the Sec-dependent pathway are 
secreted through the type II machinery to pass the outer membrane into the extracellular 
milieu (Korotkov et al., 2012). Chlamydia encodes many homologues of both Sec-dependent 
and T2S pathway proteins and chaperones, although the functionality of these homologues 
has not been demonstrated experimentally (Stephens et al., 1998; Karunakaran et al., 2003). 
However, experiments by Chen et al. (2010) showed the T2S pathway to be functional. Firstly, 
the N-terminal sequence of chlamydial protease-like activity factor (CPAF) is sufficient to direct 
export of mature PhoA, an enzyme active after translocation into the bacterial periplasm, in a 
heterologous system (Chen et al., 2010). This translocation was blocked in both Escherichia coli 
strains lacking the Sec-pathway chaperone SecB, and strains lacking the translocase complex 
subunit SecY, an essential component for translocase activity (Chen et al., 2010). Secondly, 
CPAF secretion is blocked in cells treated with arylomycin C16, a peptidase I inhibitor that 
prevents cleavage of the N-terminal signal sequence and so secretion of the protein (Chen et 
al., 2010). Indeed, T2S is vital for the Chlamydia lifecycle, as shown by attenuated growth of a 
C. trachomatis LGV-L2 variant bearing a point mutation in the T2S ATPase GspE (Snavely et al., 
2014). 
 
Chlamydial type III secretion (T3S) is better characterised than T2S. The T3S apparatus is 
composed of >20 proteins arranged to form an ‘injectisome’ that spans the bacterial envelope 
to inject, with the aid of chaperones, effectors directly into the host cell (Ghosh, 2004). In 
contrast to other Gram-negative bacteria, which have T3S genes clustered within a single locus 
located in a chromosomal pathogenicity island or virulence-associated plasmid (Winstanley 
and Hart, 2001), chlamydial T3S genes are distributed throughout the genome across at least 
six loci (Stephens et al., 1998; Hefty and Stephens, 2007). This suggests that Chlamydia T3S 
genes have not been recently acquired by horizontal gene transfer in a single evolutionary 
event. Phylogenetic analyses show the Chlamydia virulence T3S system evolved from an 
ancestral flagella T3S system modified to retain only the protein export function, and this may 
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represent a primordial system from which all T3S systems are derived (Kim, 2001; Peters et al., 
2007). T3S systems are important for chlamydial development as demonstrated by inhibition 
with the small molecule inhibitor INP0400. Originally shown to block the T3S system in Yersinia 
pseudotuberculosis, INP0400 partially blocks entry of EBs, reduces intracellular RB replication 
and inhibits RB to EB differentiation (Muschiol et al., 2006; Wolf et al., 2006). 
 
T3S systems are first utilised during entry, notably in delivery of translocated actin recruiting 
protein (Tarp) (discussed in 1.1.4). Surface projections on EBs were first observed in 1981 by 
Akira Matsumoto, and in 2008 Betts et al. demonstrated CdsF, a needle subunit protein, 
localised to the periphery of EBs. However, it was not until 2014 that the presence of these 
T3S systems was confirmed (Nans et al., 2014; Pilhofer et al., 2014). Using cryo-electron 
tomography, Nans et al. (2014) showed C. trachomatis EBs are polarised, with the periplasmic 
space in one hemisphere expanded to accommodate an array of 14-20 T3S systems. In the 
presence of host cells EBs orientate to align this T3S system array to face the target plasma 
membrane, which is proposed to allow the concentrated delivery of effector proteins to 
facilitate bacterial entry (Nans et al., 2014). These cryo-electron tomography studies were 
taken further to derive the in situ structure of the chlamydial T3S system (Nans et al., 2015). 
Upon contact with the host membrane, the needle of the chlamydial T3S system elongates by 
up to 2 nm, the basal body compacts by up to 5 nm, and the sorting platform (a structure 
where effectors are sequentially loaded for delivery) is stabilised (Nans et al., 2015). As such, 
these ‘pump-action’ conformational changes suggest the chlamydial T3S system behaves as a 
‘molecular syringe’ to secrete effectors. The location of T3S system assembly is also important 
later in the Chlamydia lifecycle. At 22-24 hours post infection (hpi), the host rough 
endoplasmic reticulum (rER) is recruited to the inclusion periphery and rER proteins are 
enriched on and translocated into the inclusion. At these rER contact points, RBs assemble 
‘pathogen synapses’, ordered arrays of 20-100 T3S systems in contact with the luminal face of 
the inclusion membrane that bridge the RB envelope to the rER in the host cytosol. These 
batteries of T3S systems, similar to the arrays observed during EB entry, likely ensure effector 
delivery at high local concentrations (Dumoux et al., 2012). 
 
1.1.4 Attachment and entry 
 
At the initiation of the chlamydial development cycle, C. trachomatis EBs attach to the host 
plasma membrane and induce their uptake into non-phagocytic mammalian cells. Initial 
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attachment is mediated by interactions between heparin sulphate-like glycosaminoglycans 
(GAGs) present on the host cell and the cysteine-rich protein OmcB of the chlamydial outer 
membrane complex (COMC) in the EB envelope (Zhang and Stephens, 1992; Moelleken and 
Hegemann, 2008). The COMC also comprises the major outer membrane protein (MOMP), 
chlamydial polymorphic membrane proteins (Pmps) and a number of hypothetical chlamydial 
proteins (Caldwell et al., 1981)). C. trachomatis is similar to other Gram-negative bacteria in 
having both an inner and an outer membrane, lipopolysaccharide (LPS), the afore-mentioned 
T3S systems, and a peptidoglycan layer (Liechti et al., 2014). However, it is the COMC that is 
the major determinant of structural integrity via disulphide-linked oligomers formed between 
MOMP, OmcA and OmcB (Hatch et al., 1984). 
 
In addition to the interaction of GAGs and OmcB, multiple host cell receptors have been 
implicated in EB attachment. The high mannose oligosaccharide region of the Chlamydia 
MOMP mediates attachment through interactions with the host mannose receptor (Kuo et al., 
1996). Chlamydial LPS is involved in C. trachomatis serovar E infection through binding of the 
cystic fibrosis transmembrane conductance regulator (CFTR), and C. trachomatis serovar E EBs 
also bind and colocalise with the oestrogen receptor (Ajonuma et al., 2010; Hall et al., 2011). 
The platelet derived growth factor receptor (PDGFR) has been linked to C. muridarum infection 
as phosphorylated PDGFRβ is recruited to entry sites (Elwell et al., 2008). Finally, cells depleted 
of protein disulphide isomerase (PDI) exhibited a >97% reduction in attachment of 
Chlamydiae, marking PDI as the only host protein identified as essential for attachment of 
multiple Chlamydia species (Abromaitis and Stephens, 2009). 
 
After attachment, entry occurs via actin-dependent endocytosis. Upon EB binding to the host 
plasma membrane, the chlamydial protein Tarp is translocated across the plasma membrane 
by T3S systems (Clifton et al., 2004). This translocation is increased by the binding of 
chlamydial chaperone SycE-like chaperone 1 (Slc1) (Brinkworth et al., 2011). Following 
translocation into the host cell, Tarp is rapidly phosphorylated by host tyrosine kinases (Clifton 
et al., 2004). Phosphorylated-Tarp activates the Rac-dependent signalling cascade via binding 
of cellular Rac1 guanine nucleotide exchange factors (GEFs), resulting in Arp2/3 complex 
activation and actin reorganisation (Carabeo et al., 2004; Subtil et al., 2004; Jewett et al., 2006; 
Lane et al., 2008; Jiwani et al., 2012). Interestingly, Tarp phosphorylation is specific to  
C. trachomatis, indicating another mechanism for actin recruitment in other species of 
Chlamydia. This second mechanism is induced through the Tarp proline-rich C-terminal actin-
binding domain, which promotes Tarp oligomerisation to mediate filamentous actin (F-actin) 
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nucleation and polymerisation (Jewett et al., 2006). Following entry, the T3S effector CT166 
glycosylates Rac1 to inhibit further activation, thus ensuring a balanced uptake of Chlamydia 
into host-cells (Thalmann et al., 2010). 
 
Recent cryo-EM studies by Nans et al. (2014) have shed considerable light on the mechanism 
of chlamydial entry. Three-dimensional reconstructions of C. trachomatis LGV2 EBs in contact 
with host cells showed a striking diversity of entry structures. EBs were visualised proximal to 
complex membrane ruffles, generating a macropinosome-like structure that could trap EBs 
prior to internalisation (Nans et al., 2014).  EBs were also observed trapped under the bases of 
actin-rich filopodia in close association to the host cell membrane (Nans et al., 2014), 
representing an early entry structure and supporting previous live fluorescence and scanning 
electron microscopy data that showed C. trachomatis induce microvilli at entry sites (Carabeo 
et al., 2002). Lastly, curved membranes resembling phagocytic cups were observed that tightly 
zipper around individual EBs (Nans et al., 2014). Common to all of these ultrastructural 
snapshots of chlamydial internalisation are the ordered arrays of T3SSs, which were orientated 
towards and frequently in direct contact with the host plasma membrane. However, it remains 
unclear whether these intermediate states are interrelated or whether they represent 
independent entry pathways (Nans et al., 2014). 
 
1.1.5 Formation of the inclusion and acquisition of soluble nutrients 
 
1.1.5.1 Bacteria-containing vesicles migrate to the host centrosome 
 
After entry into the host cell, internalised EBs differentiate into RBs and migrate to the peri-
nuclear region. These vesicles do not acquire markers characteristic of the endocytic pathway 
as demonstrated by exclusion of early endosomal, late endosomal and lysosomal proteins 
(Fields and Hackstadt, 2002). Migration to the peri-nuclear region occurs via utilisation of the 
host microtubule motor, dynein, which transports bacteria-containing vesicles towards the 
minus-end of microtubules, resulting in their accumulation at the microtubule-organising 
centre (MTOC) (Clausen et al., 1997). Trafficking occurs independently of p50 dynamitin, the 
cargo-binding member of the dynactin complex, suggesting bacteria-containing vesicles 
migrate using a mechanistically distinct method to vesicular trafficking (Grieshaber et al., 
2003). Instead, an inclusion membrane protein (Inc) (described in 1.1.5.2), CT850, is proposed 
to mediate interactions with dynein due to a number of lines of evidence. Firstly, when 
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exogenously expressed in uninfected cells, CT850 localises to the MTOC (Mital et al., 2010). 
Secondly, CT850 is expressed as early as 1 hour post infection when trafficking to the MTOC 
occurs (Belland et al., 2003). Thirdly, a yeast 2-hybrid system revealed an interaction between 
CT850 and the dynein light chain DYNLT1, and depletion of DYNLT1 disrupts inclusion 
positioning at the MTOC (Mital et al., 2015). 
 
1.1.5.2 Inclusion membrane proteins mediate fusion of bacteria-containing vesicles and 
inclusion interactions 
 
Once at the MTOC, fusion of bacteria-containing vesicles is dependent on modification of the 
vesicle membrane with the IncA protein (Hackstadt et al., 1999). First identified in C. psittaci as 
a serine/threonine phosphoprotein (Rockey et al., 1997), IncA has since been identified in  
C. trachomatis and is structurally similar to C. psittaci IncA (Bannantine et al., 1998). Mutations 
in incA result in strains that form multiple non-fusogenic inclusions as opposed to the 
characteristic single large inclusion (Suchland et al., 2000). IncA is proposed to use structural 
mimicry of the SNARE motif, a heptad repeat in the C-terminal region of eukaryotic SNARE 
proteins involved in compartment fusion, to aid in the fusion of C. trachomatis-containing 
vesicles in cells infected with multiple EBs (Delevoye et al., 2008). Expression of a mutant IncA 
lacking one or both of the SNARE-like domains in an incA::bla mutant of C. trachomatis LGV2 
was insufficient to rescue homotypic fusion, whilst expression of wildtype (WT) IncA restored 
compartment fusion (Weber et al., 2016). IncA can also form complexes with host SNARE 
proteins Vamp3, Vamp7 and Vamp8 at the inclusion periphery, with these interactions 
proposed to permit fusion of cellular compartments with the inclusion membrane (Delevoye et 
al., 2008).  
 
In addition to IncA, the inclusion is modified using T3S with up to 62 inclusion membrane 
proteins (Incs), the majority of which have as yet unknown functions (Rockey et al., 2002; Li et 
al., 2008; Dehoux et al., 2011). Incs are predicted to share a common motif of a hydrophobic 
domain of 40 amino acids with two, short (<100 residue) soluble domains protruding into the 
cytoplasm that mediate host-pathogen interactions (Bannantine et al., 2000). Recently, in a 
major study to identify protein-protein interactions between Incs and host proteins, Mirrashidi 
et al. (2015) expressed 58 of the 62 predicted C. trachomatis Incs, including the full-length 
proteins and the predicted cytoplasmic domains, individually in host cells. These Incs were 
then affinity purified and analysed by mass spectrometry to identify binding partners. Notably 
IncE was found to bind sorting nexin (SNX) 5 and SNX-6, components of the retromer. SNX5 
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and SNX6 depletion led to the production of increased infectious progeny, suggesting 
retromer-dependent trafficking restricts Chlamydia infection (Mirrashidi et al., 2015). 
Simultaneously, a quantitative proteomics approach taken by Aeberhard et al. (2015) also 
identified components of the retromer when C. trachomatis inclusions were isolated from 
cells.  
 
IncB, CT101, CT222 and CT850 co-localise with members of the Src family of kinases at the 
inclusion membrane (Mital et al., 2010). Src family kinases are involved in a number of cellular 
signalling pathways that regulate functions including motility, apoptosis and membrane 
trafficking (Sandilands and Frame, 2008). IncB additionally forms round membranous vesicular 
compartments when ectopically expressed in HeLa cells, suggesting it may be important in 
influencing the membrane architecture of the inclusion (Mital et al., 2013). Further Incs 
include CT229, which interacts with the early endosome Rab GTPase protein Rab4A (Rzomp et 
al., 2006). Rab GTPases are important in regulation of various aspects of vesicular trafficking, 
including the formation, trafficking, docking and fusion of transport vesicles. Chlamydiae 
recruit a number of Rab GTPases to the inclusion during infection, and recruitment is species 
dependent. Rab1, Rab4 and Rab11 accumulate at C. trachomatis, C. muridarum, and  
C. pneumoniae inclusions, while Rab6 is associated solely with C. trachomatis inclusions and 
Rab10 associated with C. muridarum and C. pneumoniae inclusions (Rzomp et al., 2003).  
C. trachomatis development was not affected in cells expressing a mutant Rab4A protein 
however, suggesting additional Rab4 isoforms may perform redundant functions during 
infection (Rzomp et al., 2006). Additional Incs and their known pathogenic interactions with 
aspects of host cell biology, including hijacking of the host cytoskeleton, modulation of 
apoptosis and recruitment of host organelles to the inclusion, will be discussed in section 
1.1.6. 
 
1.1.5.3 Acquisition of soluble nutrients 
 
After establishing an intracellular niche within the inclusion, Chlamydiae must acquire 
essential nutrients for subsistence and replication. Over the course of millennia Chlamydia 
species have lost the genes required to synthesise many metabolites including ATP, and 
instead evolved to scavenge these from the host cell (Saka and Valdivia, 2010). The inclusion is 
permeable to small ions such as Ca2+ and soluble molecules smaller than 520 Da, suggesting 
passive diffusion supports acquisition of nucleotides, tricarboxylic acid (TCA) cycle substrates 
and amino acids (Heinzen and Hackstadt, 1997). Energy parasitism is a key feature of 
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intracellular pathogens like Chlamydia. Analysis of whole-genome sequences from chlamydial 
species has revealed the presence of two ATP transporters, Npt1Ct for ATP import coupled to 
ADP export, and Npt2Ct for generic nucleotide import in a proton-dependent manner (Tjaden 
et al., 1999). Furthermore, host ATP and glucose production are upregulated during the 
replicative stages of C. psittaci infection (Ojcius et al., 1998). This increase could be an active 
and direct consequence of infection promoted by the pathogen, but may also be indicative of 
a passive stress response, whereby the host cell compensates for substrate loss to the bacteria 
(Ojcius et al., 1998). C. trachomatis inclusions also accumulate glycogen by a combination of 
bulk translocation from the host cytoplasm in association with the glycogen-binding enzyme 
Gys1 (Gehre et al., 2016), and by de novo synthesis by Chlamydia, which encodes a full 
complement of enzymes necessary for glycogenesis and glycogenolysis (Stephens et al., 1998; 
Lu et al., 2013; Gehre et al., 2016). 
 
1.1.6 Manipulation of host cell processes by Chlamydia 
 
1.1.6.1 Hijacking of the host cytoskeleton 
 
Chlamydia uses Inc proteins to mechanically support the inclusion, which expands to occupy 
the majority of the host cytosol, by taking control of the host cytoskeleton. CT223, also termed 
inclusion protein acting on microtubules (IPAM), recruits and stimulates the centrosomal 
protein 170 kDa (CEP170) to hijack host microtubule organising activity. This leads to the 
formation of a microtubule cage and nest surrounding the inclusion to maintain cell and 
inclusion morphology, and so promote bacterial infectivity (Dumoux et al., 2015). Additionally, 
C. trachomatis remodels microtubules to coordinate Golgi stack recruitment to the inclusion 
(Al-Zeer et al., 2014), and intracellular growth of the bacteria is supported by microtubule-
associated protein 1 (MAP1) light chain 3 (LC3), which is recruited to the inclusion periphery in 
a microtubule-dependent manner together with MAP1 subunit A and MAP1 subunit B (Al-
Younes et al., 2011). Further cytoskeletal components are hijacked by Chlamydia, as F-actin 
and the intermediate filament protein vimentin form a network to encase and stabilise the 
inclusion (Kumar and Valdivia, 2008). The Inc protein inclusion membrane protein for actin 
assembly (InaC) is required for F-actin assembly at the inclusion by recruiting ADP-ribosylation 
factors and 14-3-3 proteins, and disruption of F-actin results in aberrant inclusion morphology 
and loss of inclusion integrity (Kumar and Valdivia, 2008; Kokes et al., 2015).  
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In addition to its role in regulating the cytoskeleton, CT223 also blocks cytokinesis as shown by 
a multi-nucleated phenotype observed in host cells when CT223 is ectopically expressed 
(Alzhanov et al., 2009). Indeed, up to 80% of HeLa cells infected with C. trachomatis are multi-
nucleated by 40 hpi (Greene and Zhong, 2003; Brown et al., 2012). However, it is controversial 
whether chlamydial factors are required for multi-nucleation, as experiments by Sun et al. 
(2011) show polystyrene beads of a similar size to the inclusion are also sufficient to block 
cytokinesis. 
 
1.1.6.2 Apoptosis and the immune response 
 
Upon Chlamydia infection, many host cell responses are initiated. Pathogen-associated 
molecular patterns (PAMPs) like chlamydial LPS are recognised by pattern recognition 
receptors (PRRs) such as toll-like receptors (TLRs), which trigger an innate immune response 
(Joyee and Yang, 2008; Takeuchi and Akira, 2010). Transcription of cytokines and chemokines 
is induced, as well as the type I interferon response to activate cell-autonomous resistance 
mechanisms (Monroe et al., 2010; Barker et al., 2013). Further antimicrobials such as reactive 
oxygen species are also produced for recruitment of immune cells (Rusconi and Greub, 2011). 
Despite this initial immune activation, Chlamydia is a highly effective pathogen, able to 
manipulate immune signalling and apoptosis to prevent bacterial detection and host cell death 
(Zhong et al., 1999; Dong et al., 2005). NF-κB is a key host transcription factor involved in 
regulating the immune response during infection, and functions downstream from PRRs. NF-κB 
consists of a heterodimeric complex composed of two subunits, p50 (NF-κB1) and p65 (RelA) 
(Siebenlist et al., 1994). Under normal conditions, NF-κB is inactivated in complex with IκB in 
the cytosol. Upon degradation of IκB, the freed NF-κB complex can translocate to the nucleus 
to transcriptionally activate target genes involved in innate immunity and inflammation 
(Siebenlist et al., 1994). Chlamydia interferes with the NF-κB pathway via the action of two 
effectors, CT441 and Chladub1 (Lad et al., 2007a; Lad et al., 2007b; Le Negrate et al., 2008). 
CT441 is a tail-specific protease that inhibits NF-κB activation by direct proteolysis of the p65 
subunit of NF-κB (Lad et al., 2007a; Lad et al., 2007b). Chladub1 binds to and inhibits the 
proteasomal degradation of IκB, and so prevents the subsequent activation and translocation 
of NF-κB to the nucleus (Le Negrate et al., 2008). 
 
Chlamydia additionally manipulates antigen presentation. Major histocompatibility complexes 
(MHCs) class I and class II present bacterial antigens to CD8+ and CD4+ lymphocytes (Neefjes et 
al., 2011). The transcription factors RFX5 and USF-1 are degraded during infection, preventing 
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IFNγ-dependent induction of MHC II genes and both constitutive expression and IFNγ-
dependent induction of MHC I genes (Zhong et al., 1999; Zhong et al., 2000). CD1d, an MHC-
like protein complex, is also degraded preventing signalling to natural killer (NK) and NK T cells 
(Kawana et al., 2007). In addition to targeting host proteins, Chlamydia also degrades a subset 
of its own effectors to prevent them being used as substrates for antigen presentation 
(Jorgensen et al., 2011). These effectors include those translocated during invasion, such as 
Tarp, and inclusion membrane proteins expressed early after invasion, notably the well-
characterised IncD (section 1.1.6.3) and IncE. 
 
Chlamydia also counteracts host cell death to protect its intracellular niche by interfering with 
multiple apoptotic and necrotic pathways. Infected cells become resistant to various pro-
apoptotic stimuli including DNA damaging agents such as etoposide and apoptosis-inducing 
molecules like tumour necrosis factor-α (Fan et al., 1998). Perhaps the most well studied 
mechanism for Chlamydia prevention of cell death is the degradation of pro-apoptotic BH3-
only proteins, Bad, Bim and Puma during infection (Dong et al., 2005; Ying et al., 2005). This 
degradation results in reduced activation of Bax and Bak, and so inhibits cytochrome c release 
and caspase 3/9 activation (Fan et al., 1998; Fischer et al., 2001). IncG also contributes to the 
prevention of apoptosis. Phosphorylated IncG interacts with the host protein 14-3-3β, a 
phosphoserine-binding protein, via a conserved binding motif (Scidmore and Hackstadt, 2001). 
14-3-3β sequesters the pro-apoptotic protein Bad at the inclusion membrane, thus the 
bacteria render the infected cell resistant to apoptotic stimuli (Verbeke et al., 2006).  
C. trachomatis also modulates pro-survival factors, up-regulating the cellular inhibitor of 
apoptosis protein 2 (cIAP-2) and the anti-apoptotic Bcl-2 family member Mcl-1 (Rajalingam et 
al., 2006; Rajalingam et al., 2008).  
 
Although Chlamydia is effective at inhibiting apoptosis, infection can nevertheless result in 
necrotic cell death, leading to an inflammatory response. During necrosis, poly(ADP-ribose) 
polymerase 1 (PARP-1) induces the translocation of the pro-inflammatory mediator high-
mobility group box 1 protein (HMGB1) to the cytosol, where it is released from the host cell 
after loss of plasma membrane integrity (Ditsworth et al., 2007). To reduce HMGB1 release, 
Chlamydia both degrades HMGB1 directly and cleaves PARP-1, preventing translocation of 
HMGB1 to the cytosol (Yu et al., 2010). 
 
The majority of the cleavage and degradation events described in this sub-section were 
attributed to a single type II secreted protein, CPAF. However, a study by Chen et al (2012) 
33 
 
showed proteolysis of 11 of the host proteins identified as targets for CPAF was due to residual 
enzyme activity during sample processing. Of those proteins already described, Puma, Bim, 
Bak, p65/RelA and golgin-84 were not cleaved or degraded when urea was used to denature 
CPAF during sample processing (Chen et al., 2012). Despite this, CPAF activity is important for 
the chlamydial lifecycle, as C. trachomatis strains possessing loss-of-function mutations in the 
gene encoding for CPAF, cpa, display impaired generation of infectious EBs (Snavely et al., 
2014). 
 
1.1.6.3 Acquisition of lipids 
 
Lipids are a crucial resource Chlamydia must appropriate from the host cell, and the bacteria 
accomplish this by manipulating host vesicular trafficking and by targeting organelles. The 
inclusion selectively interacts with exocytic vesicles travelling from the trans-Golgi to the 
plasma membrane to acquire sphingolipids such as ceramide and sphingomyelin (Hackstadt et 
al., 1995). Delivery of these sphingolipids involves the Golgi-associated protein Rab14, and is 
essential for expansion of the inclusion (Capmany and Damiani, 2010). Chlamydial infection 
also induces fragmentation of the Golgi apparatus via golgin-84 cleavage (Heuer et al., 2009). 
Depletion of Rab6a and Rab11a prevented golgin-84 cleavage, resulting in reduced lipid 
acquisition and inhibition of chlamydial development, whereas Golgi fragmentation prior to 
infection enhanced chlamydial propagation (Heuer et al., 2009; Lipinski et al., 2009). 
Multivesicular bodies (MVBs) are another major source of vesicle-derived lipids. MVB 
constituents CD63, metastatic lymph node 64 (MLN64) and lysobisphosphatidic acid (LBPA) are 
present in the lumen of the inclusion during Chlamydia infection, and inhibitors of MVB 
biogenesis reduce bacterial replication (Beatty, 2006). The GTPase Rab39a is important but not 
essential to mediate MVB-inclusion interactions, as Gambarte Tudela and colleagues (2015) 
showed MVB localisation at chlamydial inclusions is only reduced in cells depleted of Rab39a. 
 
Chlamydia also acquire lipids from lipid droplets (LDs), intracellular organelles used to store 
neutral lipids such as triacylglycerides as a source of energy or material for membrane 
biosynthesis (Walther and Farese, 2012). LDs accumulate at the inclusion periphery and are 
subsequently translocated into the inclusion lumen (Kumar et al., 2006; Cocchiaro et al., 2008). 
At the inclusion membrane, LDs associate with four inclusion membrane proteins, IncA, IncG, 
Cap1 and CTL0882 (Saka et al., 2015). Translocation of LDs into the inclusion lumen is 
hypothesised to occur at IncA-enriched subdomains that can mediate membrane invagination 
of the inclusion (Cocchiaro et al., 2008). Remarkably, the global LD proteome is modified 
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during C. trachomatis infection, with enrichment of proteins related to lipid metabolism, 
biosynthesis and LD-specific functions (Saka et al., 2015). This modification, as well as 
recruitment to the inclusion membrane, may occur due to association of LDs with three 
chlamydial LD-associated (Lda) proteins, Lda1-3, which are translocated into the host cell and 
localise to LDs, directing their traffic to the inclusion by as yet uncharacterised interactions 
(Kumar et al., 2006). 
 
As well as co-opting host organelles including the Golgi apparatus and lipid droplets, 
Chlamydia also targets the ER. IncD mediates recruitment of the ER to Golgi ceramide transfer 
protein CERT to the inclusion membrane, as well as the vesicle-associated membrane proteins 
VAPA and VAPB (Derré et al., 2011; Elwell et al., 2011; Agaisse and Derré, 2014). Depletion of 
either CERT or the VAP proteins led to a reduction in chlamydial growth, although the role of 
these proteins in C. trachomatis development was not determined. ER proteins, including ER-
resident proteins calreticulin and PDI, and ER scaffolding proteins Rtn4b and its interacting 
protein deleted in polyposis (DP-1), are also recruited to the inclusion membrane in a wider 
recruitment of the host ER (Dumoux et al., 2012). Calreticulin, PDI and Der1-like protein 1 
(derlin-1) also translocated into the lumen of the inclusion, often in close contact with the 
bacteria, suggesting ER membranes may be metabolised by Chlamydia to support growth.  
Indeed, an intact ER was found to be essential for inclusion biogenesis and chlamydial 
infectivity (Dumoux et al., 2012). However, the exact role of the ER in the infection cycle 
remains unknown. 
 
1.1.6.4 Interactions with the nucleus 
 
In addition to manipulating host organelles such as the ER, the Golgi apparatus and lipid 
droplets, Chlamydia infection is closely linked to the disruption of many nuclear processes that 
may prime cells for oncogenesis. For example, the tumour suppressor p53 is degraded from 24 
hpi following ubiquitination by phosphorylated murine double minute 2 (MDM2), resulting in 
an enhancement of the apoptotic resistance of Chlamydia-infected cells (González et al., 
2014). Disruption of p53 degradation stalls the redifferentiation of RBs into EBs, thus inhibiting 
the formation of infectious progeny (González et al., 2014). Furthermore, the telomerase 
catalytic subunit of human telomerase reverse transcriptase (hTERT) is transiently up-
regulated during early infection in association with ceramide recruitment to the inclusion, as 
ceramides are known inhibitors of hTERT transcription (Wooten-Blanks et al., 2007; Padberg et 
al., 2013). This alters cellular aging and survival pathways both during and following infection, 
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contributing to the prevention of proliferative blocks and increasing host cell resistance to 
DNA damage-induced apoptosis (Padberg et al., 2013). These effects are important for 
Chlamydia, as infection also results in sustained upregulation of γH2AX, a marker for DNA 
double-strand breaks and H3K9me3, a marker for senescence-associated heterochromatin foci 
(Chumduri et al., 2013). Simultaneously, Chlamydia infection impairs the DNA damage 
response by inhibiting recruitment of phosphorylated nuclear protein kinase ataxia 
telangiectasia mutated (pATM) and tumour protein 53 binding protein 1 (53BP1) to DNA 
damage sites (Chumduri et al., 2013). 
 
Chlamydia also translocates T3S effectors to the nucleus and nuclear envelope including NUE 
and CT311 in C. trachomatis infection, and SINC in C. psittaci infection. CT737, also named 
nuclear effector protein (NUE), contains an unusual nuclear localisation sequence (NLS), 
consisting of a C-terminal NLS and an internal NLS, resulting in its targeting to the host nucleus 
following translocation into the host cytosol (Pennini et al., 2010). NUE also contains a 
Su(var)3-9, Enhancer-of-zeste, Trithorax (SET) domain, a 130-residue amino acid sequence that 
mediates histone methyltransferase activity. Histone methylation modifies gene transcription 
dependent on the histone and lysine residue modified, as well as the number of methyl groups 
added. This modification to transcriptional activity occurs as methylation of these histones, as 
well as other post-translational modifications including acetylation, phosphorylation and 
citrullination, results in reduced or enhanced accessibility of the transcriptional machinery to 
chromatin (Tessarz and Kouzarides, 2014). For example, tri-methylation of histone 3 lysine 9 
(H3K9) is associated with transcriptional silencing (Rea et al., 2000), whilst di- or tri- 
methylation of histone 3 lysine 4 (H3K4) is associated with active transcription (Schneider et 
al., 2004). NUE methylates eukaryotic histones H2B, H3 and H4 in vitro, suggesting Chlamydia 
can directly alter host gene transcription. Whilst the specific lysine residues modified and the 
resulting methylation state was not determined, NUE could be utilised by Chlamydia to, for 
example, inhibit transcriptional activation of genes related to the immune response. Rolando 
et al. (2013) demonstrated this possibility in Legionella pneumophila. Here, Legionella modifies 
host chromatin directly using the type IV secreted protein RomA, which is a SET domain-
containing methyltransferase that methylates H3K14. Methylation of H3K14 reduces 
expression of innate immune genes, thus promoting Legionella pathogenesis (Rolando et al., 
2013). Listeria monocytogenes also targets the host nucleus. Firstly, the bacterial surface-
protein InlB triggers nuclear translocation of sirtuin 2 (SIRT2). SIRT2 deacetylates histone H3 at 
lysine 18 (H3K18), an enzymatic reaction associated with gene silencing (Eskandarian et al., 
2013). Secondly, the Listeria nuclear targeted protein A (LntA) is translocated to the host 
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nucleus where it binds bromo adjacent homology domain-containing protein 1 (BAHD1), a 
nuclear protein involved in gene silencing and heterochromatin formation, to modulate the 
interferon response (Lebreton et al., 2014). 
 
C. trachomatis translocates a second effector to the host nucleus, CT311, which accumulates in 
the nucleus late during the infection cycle but whose function is unknown (Lei et al., 2013).  
C. psittaci translocates an effector to the inner nuclear envelope, the secreted inner nuclear 
membrane-associated Chlamydia protein (SINC). Upon localisation at the inner nuclear 
envelope, SINC was identified in close proximity to 22 inner nuclear membrane proteins 
including the nucleoporin ELYS, lamin B1, emerin, MAN1, LAP1 and LBR. These proteins have 
diverse roles in the maintenance of nuclear shape and stability as well as chromatin tethering, 
and will be discussed in section 1.2. Remarkably, SINC accumulates in the nuclear envelope of 
non-infected cells, although the mechanism of transport and functional implications of this 
remain unclear (Mojica et al., 2015). 
 
1.1.7 Exit from the host cell 
 
Towards the latter stages of the Chlamydia lifecycle, RBs redifferentiate into EBs and exit from 
the host cell is initiated. A contact-dependent hypothesis has been proposed as the trigger for 
RB to EB differentiation. As the inclusion reaches the maximum size possible based on spatial 
constraints imposed by the host cell, dividing RBs in contact with the inclusion membrane 
begin to detach due to a decrease in the available space for T3S system contacts. This 
untethering of RBs is proposed to be a signal that triggers RB to EB redifferentiation (Wilson et 
al., 2006; Wilson et al., 2009). Progeny then exit the cell via two mechanisms, host cell lysis or 
extrusion of the whole inclusion. The former is mediated by cysteine-proteases which degrade 
the inclusion, nuclear and plasma membranes in an ordered sequence (Hybiske and Stephens, 
2007). The final step in this lysis pathway, rupture of the plasma membrane, is dependent on 
an influx of extracellular calcium ions. The latter, extrusion of the inclusion, requires actin 
polymerisation, the actin nucleation factor N-WASP, RhoA and myosin II (Hybiske and 
Stephens, 2007). In this process, intact inclusions are released from the host cell, and residual 
bacteria may contribute to persistent bacterial infection (Beatty, 2007).  
 
The exact molecular mechanisms that control which of these two exit pathways is employed 
are as yet unknown, however the inclusion membrane protein CT228 promotes extrusion by 
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association with a myosin light chain 2 phosphatase (MYPT1) (Lutter et al., 2013). Active 
MYPT1 is recruited peripherally around the inclusion early during infection, preventing 
activation of myosin light chain 2 to ensure premature release of the inclusion does not occur. 
Later during infection, inactive phosphorylated MYPT1 becomes enriched in Src-family kinase-
rich microdomains and co-localises with phosphorylated myosin light chain 2, myosin light 
chain kinase, myosin IIA and myosin IIB. This favours the local activation of myosin light chain 
2, engaging the myosin motor complex to promote egress of the intact chlamydial inclusion 
(Lutter et al., 2013). 
 
1.2 The Nucleus 
 
In the preceding section the extensive interactions between Chlamydia and major host 
organelles in infected cells, including the nucleus, have been outlined. Although interactions 
between Chlamydia and the nucleus have been characterised, much remains to be established 
about the relationship between the inclusion and this major organelle, especially given the 
close spatial proximity between the nucleus and inclusion at late stages of the infection cycle 
and the deformation of the nucleus that occurs due to pressure exerted by the expanding 
inclusion (Padberg et al., 2013; Brown et al., 2014; Sun et al., 2016). As Chlamydia 
manipulation of nuclear function is the focus of this thesis, the following section will 
summarise the functional architecture of the nucleus, how its structural integrity is maintained 
and how it is connected to the rest of the cell. 
 
1.2.1 The nuclear envelope 
 
1.2.1.1 General overview of the nuclear envelope 
 
The nucleus is partitioned from the cytoplasm by the nuclear envelope (NE), a lipid bilayer 
deriving from and contiguous with the ER (Fig 1.3). The inner nuclear membrane (INM) and 
outer nuclear membrane (ONM) are spaced at a distance of 40-50 nm, and this double 
membrane is punctuated by nuclear pore complexes (NPCs) where the INM and ONM fuse to 
form the pore membrane (Prunuske and Ullman, 2006). The nucleus is connected from the 
nuclear lamina to the cytosolic cytoskeleton via the linkers of nucleoskeleton and cytoskeleton 
(LINC) complexes, consisting of SUN (Sas1, UNC-84) proteins in the INM linked to KASH 
proteins (Klarischt, ANC-1, and Syne Homology) in the ONM (Crisp et al., 2006; McGee et al., 
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2006). Four KASH proteins are present in vertebrates (Starr and Fridolfsson, 2010). Nesprin-1 
and Nesprin-2 (also known as SYNE1 and SYNE2 respectively) interact with F-actin via their N-
terminal actin-binding domain, and Nesprin-3 and Nesprin-4 bind to plectin and kinesin-1, 
respectively (Razafsky and Hodzic, 2009; Roux et al., 2009; Starr and Fridolfsson, 2010). SUN 
proteins are integrated into the INM by transmembrane domains, with their N-termini 
exposed to the nucleoplasm and their C-termini protruding into the perinuclear space to 
enable binding to KASH proteins (Sosa et al., 2012). Of the five SUN proteins characterised, 
only SUN1 and SUN2 localise to the inner nuclear envelope and are able to bind the KASH 
proteins (Tzur et al., 2006). Together, SUN and KASH proteins form LINC complexes to connect 
the nucleus to intermediate filaments and microtubules, which is important for general cellular 
organisation, nuclear migration, anchorage and mechanosensing (Burke and Roux, 2009). As 
the focus of this thesis, the NPCs and nuclear lamina will now be described in more detail. 
 
 
 
 
 
Figure 1.3. The nuclear envelope (NE). The nucleus is partitioned from the cytosol by a lipid 
bilayer known as the NE (light grey). The NE is connected to cytoskeletal components [actin 
(orange), microtubules (light blue), intermediate filaments (pink)] via nesprins (purple), which 
are KASH (Klarischt, ANC-1, and Syne Homology) proteins in the outer nuclear membrane 
(ONM). Nesprins interact with SUN (Sas1, UNC-84) proteins (yellow) in the inner nuclear 
membrane (INM) to form linkers of nucleoskeleton and cytoskeleton (LINC) complexes. SUN 
proteins interact with the nuclear lamina (NL) (green) composed of lamin A/C and lamin B. The 
NL tethers chromatin (dark blue) at the nuclear periphery in association with other INM 
anchored proteins such as emerin (dark red) and lamin B receptor (LBR) (light red). Transport 
through the NE occurs through nuclear pore complexes (NPCs) (dark grey), transmembrane 
multimeric assemblies embedded in the membrane where the INM and ONM connect. 
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1.2.1.2 The nuclear pore complexes 
 
A major structural and functional component of the NE are the nuclear pore complexes (NPCs), 
125 MDa macromolecular assemblies spanning the NE through which highly selective 
nucleocytoplasmic transport occurs (Reichelt et al., 1990). The number of NPCs per cell varies 
depending on cell type and cell cycle phase, but proliferating human cells have on average 
2000-5000 pores per nucleus (Gerace and Burke, 1988). The NPC core is composed of two 
outer, two inner and one transmembrane ring, forming a pore through which transport occurs 
(Fig 1.4) (Alber et al., 2007). The rings are composed of eight asymmetrical repeat units termed 
‘spokes’. Between these spokes there are eight additional peripheral channels measuring 5-10 
nm diameter. These channels were originally proposed to mediate passive diffusion of ions 
and small proteins, however more recent studies suggest they are equally involved in selective 
transport (Mohr et al., 2009). Two filamentous structures extend from the outer rings into the 
cytoplasm or nucleoplasm, the cytoplasmic filaments and the nuclear basket respectively. 
 
NPCs are composed of approximately 30 proteins termed nucleoporins (Nups), the majority of 
which exist in multiples of eight, giving the NPCs pseudo-eightfold symmetry (Rout et al., 
2000). Nups are divided into three categories: transmembrane Nups, structural Nups and 
phenylalanine-glycine (FG)-repeat containing Nups (Cronshaw et al., 2002). Transmembrane 
Nups anchor the NPC within the nuclear envelope. Structural Nups form the scaffold of the 
NPC and number approximately half of total NPC proteins. They comprise the outer rings, or 
Nup107 sub-complexes, the inner rings, and the linker Nups that bridge these rings. FG-Nups 
are present in the pore, the cytoplasmic filaments and the nuclear basket and number 
approximately one third of total NPC proteins. FG-Nups in the pore allow highly selective 
transport whilst simultaneously blocking diffusion of molecules greater than 30-40 kilodaltons 
(kDa) in size (Fried and Kutay, 2003).  
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Figure 1.4. Structure of the nuclear pore complex. Nuclear pore complexes (NPCs) are 
macromolecular assemblies that span the nuclear envelope (grey) where the inner nuclear 
membrane (INM) and outer nuclear membrane (ONM) connect. The NPC is divided into three 
sections, the nuclear basket (dark blue), the cytoplasmic filaments (red) and the central 
channel through which transport occurs. Outer (light blue) and inner (purple) ring nucleoporins 
(Nups) provide a scaffold for the NPC architecture, connected by linker Nups (yellow). The 
membrane ring (orange) anchors the NPC within the nuclear envelope. Central pore Nups 
(green) mediate the selective transport of cargo into and out of the NPC. 
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Transport through the pore is mediated by nuclear transport receptors (NTRs), which 
recognise and subsequently bind to nuclear import or export signals on cargo proteins, often in 
conjunction with adaptor proteins (Pemberton and Paschal, 2005). The majority of these NTRs 
belong to the karyopherin family, including importin-β, importin-α and exportin-1. Nuclear-
localisation sequences are typically composed of one or more clusters of basic amino-acid 
residues (Dingwall and Laskey, 1991). Several models have been proposed for the mechanism 
of transport through the pore, but no studies have been conducted to conclusively prove one 
hypothesis for transport over another (Walde and Kehlenbach, 2010). All models describe NTR 
binding to FG-Nups in the central pore and exclusion of molecules larger than ~5 nm (~40 kDa) 
by FG-Nups (Walde and Kehlenbach, 2010). 
 
The filaments at the cytoplasmic face of the NPC are structurally disordered polypeptides that 
contribute to transport efficiency by providing docking sites for incoming cargo, or by 
promoting the release of nuclear export cargo into the cytoplasm during export (Strambio-De-
Castillia et al., 2010). Among the proteins forming the cytoplasmic filaments, Nup214 and 
Nup358 are involved in nuclear protein import and export, as well as recruiting mRNA export 
factors such as Dbp5 and Gle1 (von Moeller et al., 2009; Noble et al., 2011). The nuclear basket 
is comprised of eight filaments extending from the outer nuclear ring converging to form a 
basket-like structure (Goldberg and Allen, 1992). The nuclear basket also contributes to 
nucleocytoplasmic transport. The major molecular component of the nuclear basket is 
translocated promoter region (Tpr) protein, which functions in the nuclear export of proteins 
and mRNA via interaction with the CRM1 export receptor (Ben-Efraim et al., 2009). Nup153 
and Nup50 function in both import and export, with Nup153 providing a scaffold for Nup50 to 
bind and displace NLSs from NTRs, thus releasing cargo, or to bind export receptor-cargo 
complexes for transport through the pore (Guan et al., 2000; Matsuura and Stewart, 2005).  
 
In addition to its role in nucleocytoplasmic transport, the nuclear basket has many additional 
nuclear functions. Studies in Drosophila have shown Nup153 and the Tpr homologue 
mammalian target of rapamycin (mTOR) bind to 25% of the genome in continuous domains 
extending from 10 kb to 500 kb. These nucleoporin-associated regions contain predominantly 
highly expressed genes, enriched with markers of active transcription such as histone H4 lysine 
16 acetylation (Vaquerizas et al., 2010). Indeed, nuclear basket proteins such as Tpr establish 
heterochromatin exclusion zones to prevent the spread of self-propagating heterochromatin, 
and so gene silencing around the NPC (Shinkura and Forrester, 2002; Brown et al., 2014). 
These proteins further impact on chromatin structure by tethering certain genes for rapid 
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reactivation in a mechanism termed transcriptional memory. For example, in yeast INO1 and 
GAL1, encoding inositol-3-phosphatase synthase and galactokinase 1 respectively, are retained 
at the NPCs in association with the Tpr homolog myosin-like protein 1 (Mlp1) for several 
generations (Tan Wong et al., 2009). Finally, some nuclear basket proteins interact with the 
DNA repair machinery. Deletion of Mlp1/Mlp2 in yeast prevents telomere anchoring at the 
NPC and so significantly reduces double-strand break repair (Galy et al., 2000). 
 
1.2.1.3 The nuclear lamina 
 
NPC positioning within the NE is linked to the nuclear lamina (NL), a thin (15-20 nm) type-V 
intermediate filament network closely associated with the nuclear face of the INM of 
eukaryotic cells (Gerace et al., 1978; Gerace and Burke, 1988). Lamins are composed of a long 
central α-helical domain, flanked by globular N-terminal (head) and C-terminal (tail) domains 
(Fisher et al., 1986). All these domains are required for lamins to self-assemble into higher-
order structures consisting of a coiled-coil dimer formed by in parallel and in register 
interactions (Foeger et al., 2006; Ben-Harush et al., 2009). There are two types of lamins. B-
type lamins include lamin B1 and lamin B2 (LMNB1 and LMNB2 respectively), which are widely 
expressed in somatic cells, and lamin B3, a splice variant derived from LMNB2 which is 
expressed in the testis only (Peter et al., 1989; Vorburger et al., 1989; Furukawa and Hotta, 
1993). A-type lamins, which include the major lamins A and C widely expressed in somatic 
cells, the minor lamin AΔ10 weakly expressed in somatic cells, and lamin C2 expressed 
exclusively in the testis, are encoded by a single gene, LMNA (Lin and Worman, 1993; Wilson 
and Foisner, 2010). Originally proposed as a framework for the nuclear envelope, more recent 
evidence suggests the NL has major roles in chromatin organisation, gene transcription and 
DNA replication and repair (Amendola and van Steensel, 2014).  
 
Mammalian genomes have ~1100-1400 lamina-associated domains (LADs), nucleotide 
sequences ranging from 10 kb to 10 Mb, which cover nearly 40% of the genome (Guelen et al., 
2008). These LADs dynamically associate with the NL, and are enriched with histone 
modifications associated with transcriptional repression, including H3K9me3 and H3K27me3 
(Towbin et al., 2012; Zullo et al., 2012). As such, the majority of chromatin anchored on the 
nucleoplasmic face of the NE is in the tightly packed heterochromatin form, limiting 
accessibility of transcription factors, and so gene expression can be modulated by re-
localisation towards or away from the NL at the nuclear periphery (Finlan et al., 2008). 
Tethering of LADs at the nuclear periphery is proposed to occur by complexes formed between 
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chromatin-bound proteins, the NL, and transmembrane proteins localised in the INM including 
the lamin B receptor (LBR) and members of the LAP2-emerin-MAN1 (LEM)-domain protein 
family, emerin, lamina-associated-polypeptide 2 and MAN1 (Amendola and van Steensel, 
2014). For example, LBR preferentially binds B-type lamins and tethers LADs by interacting 
directly with heterochromatin protein 1 (HP1) and methyl CpG binding protein 2 (MeCP2) 
(Makatsori et al., 2004; Olins et al., 2010; Babbio et al., 2012). Emerin binds lamin A, and 
tethers LADs by forming a ternary complex with the chromatin protein barrier-to-
autointegration factor (BAF) (Lee et al., 2001). 
  
In addition to tethering chromatin at the nuclear periphery, the NL provides structural and 
mechanical support essential to maintaining nuclear shape and stability (Dahl et al., 2004). 
Mechanical forces exerted on the nucleus emanate from cytoskeletal connections to lamins A 
and C via the LINC complexes, and so determine nuclear shape (Crisp et al., 2006). Through 
these connections, nuclear architecture can be manipulated to alter function in response to 
stimuli or forces exerted on the cell in a process termed mechanotransduction (Dahl et al., 
2008). A-type lamins are the main proponents in providing mechanical support to the nucleus, 
as cells lacking lamin A/C but not lamin B1 exhibit reduced nuclear stiffness, misshapen nuclei, 
increased nuclear fragility and decreased cell viability under strain (Broers et al., 2004; 
Lammerding et al., 2006). Controlling nuclear shape and stiffness is critical for the cell. 
Extracellular or cytoskeletal forces can lead to the remodelling of chromatin and nuclear 
organisation (Booth-Gauthier et al., 2012; Iyer et al., 2012; Fedorchak et al., 2014). For 
example, mechanical forces applied to cells using magnetic particles induce a rapid 
decompaction of chromatin concomitant with actin remodelling (Iyer et al., 2012). 
Additionally, the G-actin-associated transcriptional cofactor megakaryoblastic acute leukaemia 
factor-1 (MKL), which modulates expression of genes related to cytoskeletal architecture and 
dynamics, is translocated to the nucleus upon application of force (Iyer et al., 2012). 
 
1.2.2 The nucleoplasm and nuclear organisation 
 
Within the nucleoplasm there exists a complex environment that ensures the multiple 
functions of the nucleus. In this section, the most relevant components and structures for this 
thesis will be presented. 
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1.2.2.1 Nucleoplasmic lamins 
 
Whilst more than 90% of lamins are localised to the nuclear periphery, a sub-pool of A-type 
lamins are present in the nucleoplasm (Dorner et al., 2007). A-type and B-type lamins have an 
18 amino acid farnesyl group-containing C-terminus which functions as a hydrophobic 
anchorage site for the nuclear membrane (Hozak et al., 1995; Moir et al., 2000). This C-
terminal region is proteolytically cleaved in mature lamin A, allowing lamin A to untether from 
the nuclear periphery (Moir et al., 2000). A sub-fraction of lamin C, which lacks the 
farnesylated C-terminal region of lamin A, is also located in the nucleoplasm. Nucleoplasmic 
lamin A/C is predominantly associated with lamina-associated polypeptide 2α (LAP2α). These 
LAP2α-lamin A/C complexes bind the cell cycle and differentiation regulator retinoblastoma 
protein (pRb). LAP2α-lamin A/C is proposed to stabilise and lock pRb in an active hypo-
phosphorylated state, thus repressing cell cycle progression (Johnson et al., 2004). LAP2α-
lamin A/C complexes can also influence gene expression by interactions with the chromatin 
protein BAF (Dechat et al., 2004), as well as through interactions with nuclear actin and 
transcription regulators including c-Fos, SREBP1 and MOK-2 (Sasseville and Langelier, 1998; 
Dreuillet et al., 2002; Lloyd et al., 2002; Ivorra et al., 2006). 
 
1.2.2.2 Chromosome territories 
 
Perhaps the most important factor governing gene expression however is the organisation of 
the nucleus and genome as a whole. The mammalian genome is packaged into chromosomes, 
which are spatially organised within the interphase nucleus into chromosome territories. This 
compartmentalisation allows active and inactive genome regions to be separated from each 
other, and allows co-regulation of the activation or repression of the expression of specific 
genes (Cremer and Cremer, 2010). For instance, the gene-rich chromosome 19 is located in a 
central position in the nucleus, whilst the gene-poor chromosome 18 is located at the nuclear 
periphery (Croft et al., 1999). As previously discussed, transcriptionally repressive regions or 
heterochromatin are predominantly localised to the nuclear periphery, tethered by the 
nuclear lamina, but they are also associated with Polycomb group (PcG) bodies. PcG proteins 
are present in two complexes, polycomb repressive complex 1 (PRC1) and 2 (PRC2). PRC1 
catalyses histone H2A ubiquitination, whilst PRC2 catalyses H3K27 di- and tri-methylation, 
resulting in transcriptional repression (Wang et al., 2004; Margueron and Reinberg, 2011). 
Transcriptionally active regions are termed euchromatin, and are localised towards the centre 
of the nucleus. Whilst heterochromatin is characterised by histone modifications such as 
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histone H3 lysine 9 methylation, euchromatin is marked by epigenetic modifications including 
histone H3 and H4 acetylation and histone H3 lysine 4 methylation (Shilatifard, 2006). 
 
1.2.2.3 Nuclear speckles 
 
Pre-mRNA splicing factors are organised into a multitude of punctate interchromatin granule 
clusters termed nuclear speckles, which are localised in the interchromatin regions of the 
nucleoplasm and number between 20-50 per nucleus (Spector, 1993). Proteins of the nuclear 
speckles include pre-mRNA splicing factors such as small ribonucleoproteins (snRNPs), 
transcription factors, 3’-end RNA processing factors and structural proteins such as Son, an 
essential protein in maintaining organisation of the aforementioned factors (Sharma et al., 
2010; Spector and Lamond, 2011). Speckles are highly dynamic structures, varying in size, 
shape and number according to the levels of gene expression and other signals. Upon 
transcriptional inhibition, speckles become round and increase in size, suggesting they 
function in the storage or assembly of splicing factors (Melčák et al., 2000; Spector et al., 
1991). 
 
1.2.2.4 The nucleolus 
 
Ribosomal RNA (rRNA) synthesis, processing and partial ribosome assembly all occurs at the 
nucleolus, the largest compartment of the nucleus. There are between 1 to 5 nucleoli per 
nucleus, formed around nucleolar organiser regions (NORs) (Spector, 1993). These NORs are 
‘chromosomal landmarks’, consisting of tandemly repeated sequences of the ribosomal genes 
coding for 18S, 5.8S and 28S rRNA. The nucleolus is organised into three sub-domains, the 
fibrillar centres, the dense fibrillar component and the granular component. Ribosomal DNA 
transcription, rRNA processing and assembly of new ribosomal subunits occurs as a 
progression through these compartments (Fatica and Tollervey, 2002). Approximately 30% of 
nucleoli proteins are predicted to have a function related to the production of ribosomal 
subunits. The remaining proteins are predicted to be associated with the additional functions 
of the nucleoli, including regulation of RNA polymerase II transcription, cell cycle progression, 
DNA repair, the stress response and the biogenesis of ribonucleoprotein particles (Boisvert et 
al., 2007). 
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1.2.2.5 Cajal and promyelocytic leukaemia protein bodies 
 
Other nuclear structures include the cajal bodies, of which there are typically 1-10 per nucleus, 
and the promyelocytic leukaemia protein (PML) bodies, of which there are typically 10-30 per 
nucleus (Gall, 2000). Cajal bodies are the site of pre-mRNA splicing factor biogenesis. The 
major protein of cajal bodies, coilin, is involved in the assembly and subsequent maintenance 
of cajal body structure, and acts as a binding factor for most of the cajal body interactions 
(Tucker et al., 2001). PML bodies are nuclear structures primarily made up of the protein PML 
(Maul et al., 2000). These structures have been functionally implicated in a number of cellular 
functions, including DNA repair, transcriptional regulation, cell senescence and apoptosis 
(Bernardi and Pandolfi, 2007). 
 
1.3 Thesis aims 
 
Throughout the course of its development cycle, Chlamydia interacts with and hijacks many 
host cell organelles, including the ER, the Golgi, the MVBs and LDs, to promote its intracellular 
lifestyle (Kumar et al., 2006; Heuer et al., 2009; Dumoux et al., 2012). In recent years, a 
number of studies have described the effects of Chlamydia infection upon the largest 
organelle in the host cell, the nucleus, such as the manipulation of histone methylation, the 
induction of DNA double-strand breaks and the depletion of the tumour suppressor p53 
(Pennini et al., 2010; Chumduri et al., 2013; González et al., 2014). The inclusion is positioned 
in close spatial proximity to the host nucleus even in the earliest phase of Chlamydia 
development. The expanding inclusion exerts pressure on the nucleus leading to its 
deformation into a crescent shape (Padberg et al., 2013; Brown et al., 2014; Sun et al., 2016). 
Surprisingly, the implications of these observations have not been studied, especially given the 
emerging importance of chromosome positioning and the impact of mechanical forces on the 
regulation of gene transcription (Cremer and Cremer, 2010; Fedorchak et al., 2014). Thus, this 
thesis aims to examine and characterise in detail the relationship between the nucleus and the 
inclusion in infected cells. 
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Chapter 2 – Materials & Methods 
 
2.1 Cell Culture 
 
Unless otherwise stated all cell culture materials were purchased from Gibco (Invitrogen, 
Waltham, MA, USA). All sterile plasticware was purchased from Triple Red (Long Crendon, 
Buckinghamshire, UK). All centrifugation steps were performed using a Rotina 420R centrifuge 
(Hettich Lab Technology, Tuttlingen, Germany). Foetal calf serum (FCS) was decomplemented 
(50°C, 30 min) before use. 
 
2.1.1 Cell lines and culture conditions 
 
2.1.1.1 Cell lines 
 
HeLa cervical epithelial cells were previously prepared in the laboratory and stored in liquid 
nitrogen. Cells were and grown and maintained in Dulbecco’s modified eagle medium (DMEM) 
high glucose and GlutaMAX supplemented with 10% FCS and penicillin (100 units/ml) / 
streptomycin (100 μg/ml) (P/S) antibiotic mixture as recommended by the American Type 
Culture Collection (ATCC). 2x106 cells were cultured to 70-90% confluence in 75 cm2 tissue 
culture flasks in a humidified incubator at 5% (v/v) CO2, 37°C before passage every 2-3 days. 
Human telomerase reverse transcriptase (hTERT) immortalised retinal pigment epithelial (RPE-
1) cells (a gift from Dr. Emmanuel Boucrot, UCL) were cultured and maintained as with HeLa 
cells with one modification; the culture medium was altered to DMEM:F12 and supplemented 
with 0.25% (w/v) sodium bicarbonate. Human acute monocytic leukaemia (THP-1) cells (a gift 
from Dr. Kaila Srai, UCL) were cultured and maintained in RPMI-1640 medium supplemented 
with 10% FCS and P/S antibiotic mixture. Fresh media was added every 2-3 days and cells 
passaged every 7 days. Wildtype (WT) and LMNA-/- mouse embryonic fibroblasts (MEF) cells 
were a generous gift from Professor Brian Burke (A*STAR, Singapore) and grown and 
maintained in DMEM supplemented with 20% FCS, 1x Eagle’s minimum essential medium 
(MEM) non-essential amino acids (Sigma Aldrich, St. Louis, MO, USA) and P/S antibiotic 
mixture. Cells were grown to 70-90% confluence and passaged. 
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2.1.1.2 Passage 
 
Cells were passaged at 70-90% confluence (HeLa, RPE1, MEFs), or after 1 week (THP-1). For 
HeLa, RPE1 and MEF lines, cells were first washed in Hank’s balanced salt solution (HBSS) to 
remove excess FCS. Cells were then dissociated from the flask using trypsin/EDTA solution 
[0.05% (w/v) trypsin, 200 μg/ml ethylenediaminetetraacetic acid (EDTA)] at 37°C for 5 min 
before collection in HBSS supplemented with 10% FCS. The resulting suspension was 
centrifuged (1200 rpm, 4°C, 10 min), and the cell pellet suspended in HBSS/FCS for counting 
and seeding in 75 cm2 tissue culture flasks. For HeLa and RPE1 cell lines, 2x106 cells were 
seeded, for MEF cell lines 1x106 cells were seeded. As non-adherent cells, THP-1 cells were 
passaged first by centrifugation (1200 rpm, 4°C, 10 min), followed by resuspension in 
HBSS/FCS for counting and seeding (1x106 cells). 
 
2.1.1.3 Counting and seeding 
 
Following resuspension of cell pellet in HBSS/FCS, cells were counted. An equal volume of cell 
suspension was added to 0.4% (w/v) trypan blue solution. The resulting mixture was added to 
a KOVA Glasstic counting chamber (Hycor, Indianapolis, IN, USA) and the number of cells 
counted under a light microscope. Non-viable cells are permeable to trypan blue and so were 
not counted. Viable cells were counted and seeded, as outlined in Table 2.1 unless otherwise 
stated, in sterile cell culture plates and incubated for 18-24h [37°C, 5% (v/v) CO2] to allow cell 
adherence. Prior to further experiments, THP-1 cells were differentiated by addition of 
phorbol myristate acetate (PMA) (Sigma Aldrich) to medium to 0.25 μM final concentration 
and incubated for 18-24 h [37°C, 5% (v/v) CO2] to allow cell adherence. 
 
Culture plate Cells/volume (ml) media added 
6 well plate 2.7 x 105 / ml 
24 well plate 1.4 x 105 / ml 
35 mm glass bottomed petri dish (MatTek Corporation, 
Ashland, MA, USA) 
2 x 105 / ml 
100 mm tissue culture dish 3 x 105 / ml 
200 mm tissue culture dish 4 x 105 / ml 
 
Table 2.1. Cell plating. 
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2.1.1.4 Coverslip preparation 
 
Cells prepared for fluorescence microscopy were seeded on 12 mm glass coverslips (VWR) in a 
24 well plate. Prior to seeding, cover slips were washed with 70% ethanol for 10 min then 
washed three times in excess HBSS. 
 
2.1.1.5 Preparation of cells for live experiments 
 
For live experiments, cells were seeded in glass-bottomed petri dishes. Immediately prior to 
live imaging, growth medium was removed, cells were washed in HBSS and medium was 
replaced with Fluorbrite DMEM supplemented with 10% (v/v) FCS. 
 
2.1.2 Chlamydia infection 
 
2.1.2.1 Chlamydia stocks 
 
Chlamydia trachomatis serovar LGV2 stocks were prepared by Dr. Maud Dumoux (Birkbeck). 
HeLa cells were infected with C. trachomatis LGV2 (2.1.2.2) for 72 hours prior to collection by 
scraping in sucrose-phosphate-glutamic acid (SPG) buffer (220 mM sucrose, 17.4 mM 
Na2HPO4, 2.6 mM NaH2PO4, 20 mM L-glutamic acid). Bacteria were then released by 
repeatedly flushing the SPG medium through a 23g needle. The resulting EB-containing 
suspension was aliquoted and stored at -80°C. 
 
2.1.2.2 Infection protocol 
 
For infection medium, culture medium was prepared as normal except P/S was replaced with 
25 μg/ml gentamicin. Adherent cells were infected with bacteria diluted in cell infection 
medium to achieve 90-100% infection across the population. Cells were centrifuged [900 rpm, 
room temperature (RT), 10 min] to synchronise infections and then incubated [37°C, 5% (v/v) 
CO2, 90 min]. Finally, the medium was replaced 80 min later with fresh infection medium to 
remove any cell debris or dead bacteria. 
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2.1.3 Sample preparation for mEos2-importin-β import assay 
 
Samples were prepared to study nucleocytoplasmic transport in living cells as described 
previously (Lowe et al., 2010), with the following modifications. Non-infected or Chlamydia-
infected cells were washed for 3 x 2 min with phosphate buffered saline (PBS) (137 mM NaCl, 
2.7 mM KCL, 8 mM Na2HPO4, 1.46 mM KH2PO4 in H2O, pH 7.4), followed by a 2 min wash with 
permeabilisation buffer [50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 
50 mM KOAc, 8 mM MgCl2, pH 7.3], followed by a 5 min permeabilisation with digitonin (Sigma 
Aldrich) at a concentration of 50 μg/ml supplemented with an energy regenerating system of 
100 μM ATP (Roche), 100 μM GTP (Roche), 4 mM creatine phosphate (Roche) and 20 U/ml 
creatine kinase (Roche) in permeabilisation buffer. The digitonin was subsequently removed by 
washing for 3 x 3 min with transport buffer [20 mM HEPES, 110 mM KOAc, 5 mM NaOAc, 2 
mM MgOAc, 2 mM dithiothreitol (DTT), pH 7.3]. After the final wash excess liquid was 
removed, the mEos2-importin-β reaction mix [importin-β (0.5 mM), RanGDP (5 μM), NTF2 (4 
μM), 2 mM GTP, 0.1 mM ATP, 4 mM creatine phosphate, 20 U/ml creatine kinase in transport 
buffer] immediately added, and cells imaged live. 
 
2.1.4 Transfections 
 
Cells were seeded for 24 h prior to transfection using Turbofect (Thermofischer, Waltham, MA, 
USA), according to manufacturer’s instructions with some modifications. Briefly, plasmid DNA 
(Table 2.3) was added to 50 μl DMEM with 0.7 μl Turbofect, mixed vigorously and incubated 
(RT, 15 min). The resulting solution constituted 1 volume of transfection mixture, and the 
number of volumes of transfection mixture added to cells was dependent on the cell culture 
dish used (Table 2.2). Medium was replaced with fresh culture/infection medium prior to 
addition of, and following 24 h incubation with transfection mixture. The amount of plasmid 
DNA added was determined by titration and observation of the number of successfully 
transfected cells (Table 2.3). 
 
Culture plate Number of volumes of transfection mixture 
added per well 
6 well plate 3 
24 well plate 1 
35 mm glass bottomed petri dish 3 
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100 mm tissue culture dish 20 
200 mm tissue culture dish 40 
 
Table 2.2. Volumes of transfection mixture used per culture dish. 
 
Encoded protein Plasmid Origin Amount of DNA / 50 μl 
transfection mix (ng) 
CT350-2xGFP pEGFP-C2 this work 150 ng 
CT384-2xGFP pEGFP-C2 this work 300 ng 
Nup37-3xGFP pEGFP-C3 EUROSCARF, Frankfurt, 
Germany 
300 ng 
Nup85-3xGFP pEGFP-C3 EUROSCARF, Frankfurt, 
Germany 
300 ng 
Pom121-3xGFP pEGFP-C3 Dr. Guillaume Charras, UCL 300 ng 
Sun1-GFP pEGFP-C1 Professor Brian Burke 
(A*STAR, Singapore) 
150 ng 
Sun2-GFP pEGFP-C1 Professor Brian Burke 
(A*STAR, Singapore) 
150 ng 
mEos2-importin-β pCDNA3.1(+) GenScript, Piscataway, NJ, 
USA 
300 ng 
 
Table 2.3. Constructs used for transfection of cells. EGFP: enhanced green fluorescent 
protein, produced either singularly (pEGFP-C1), in duplicate (pEGFP-C2) or in triplicate (pEGFP-
C3) as an N-terminal fusion to the protein of interest. mEos: monomeric form of the 
photoactivatable fluorescent protein, Eos. 
 
2.1.5 Polystyrene bead engulfment assay 
 
Prior to incubation with cells, 15 μm diameter polystyrene beads (Polysciences, Warrington, 
PA, USA) were opsonised by incubation with human AB+ sera [1:1 (v/v), 37°C, 1 h]. The 
bead/sera solution was then centrifuged (15,871 g, RT) using an Eppendorf 5424 benchtop 
centrifuge (Eppendorf, Hamburg), and the pelleted beads resuspended in PBS. Following PMA 
differentiation (section 2.1.3), THP-1 cells were incubated with 15 μm diameter opsonised 
polystyrene beads at a 2:1 cell to bead ratio for 48 h prior to fixation. 
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2.1.6 Drug treatments 
 
2.1.6.1 Penicillin G 
 
10,000 U/ml penicillin G stock solution was diluted to 10 U/ml final concentration as described 
by Dumoux et al. (2013) in culture or infection medium and the resulting medium added to 
cells at specified times. 
 
2.1.6.2 Nigericin 
 
5 mg nigericin sodium salt was dissolved in 6.7 ml dimethyl sulphoxide (DMSO) to yield a 1 mM 
stock solution. For treatment, nigericin solution was diluted in culture or infection medium to 
1 μM final concentration and the resulting medium added to cells at specified times. This 
concentration was determined to be optimal previously (Andrew, 2014). Nigericin removal was 
performed by renewing medium with fresh culture or infection medium. 
 
2.2 Fluorescence microscopy 
 
2.2.1 Sample preparation 
 
2.2.1.1 Preparation of fixed samples 
 
Cells were fixed using paraformaldehyde (PFA) or methanol as required. For PFA fixation, 
growth medium was removed and cells were fixed in 4% (w/v) PFA diluted in PBS for 20 min at 
RT before the addition of an equal volume of neutralisation buffer (50 mM NH4Cl in PBS) and 
incubation (4°C, minimum 1 h). For methanol fixation, growth medium was removed and cells 
were fixed in cold (-20°C) methanol (on ice, 3 min). 
 
2.2.1.2 Permeabilisation 
 
Fixed cells were washed in PBS prior to permeabilisation with either 0.05% (w/v) Triton X-100 
dissolved in PBS (RT, 10 min) or cold (4°C) methanol/ethanol [1:1 (v/v), on ice, 5 min] before 
labelling. 
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2.2.2 Labelling 
 
2.2.2.1 Antibody labelling 
 
All antibodies were diluted in blocking buffer [1% (w/v) bovine serum albumin (BSA) (Sigma 
Aldrich) in PBS] as required using fixation/permeabilisation conditions shown in Table 2.4. Cells 
were washed in washing buffer [0.1% (w/v) BSA in PBS] prior to incubation with primary 
antibody (RT, 2 h). Following primary antibody incubation coverslips were washed with PBS 
and washing buffer before application of appropriate secondary antibodies as shown in Table 
2.4 (RT, 1 h). Finally, cells were washed again as previously described and mounted in MOWIOL 
mounting medium [20% (w/v) MOWIOL 4-88 (Sigma Aldrich), 30% (v/v) glycerol in PBS] on 
glass microscope slides (VWR). 
 
2.2.2.2 Fluorescent probe labelling 
 
Fluorescent probes were diluted either alone in PBS or in conjunction with secondary 
antibodies as required. For double-stranded nucleic acid labelling, 1,5-bis{[2-(di-
methylamino)ethyl]amino}-4,8-dihydroxyanthracene-9,10-dione (DRAQ-5) (Abcam, 
Cambridge, UK) at 5 mM stock concentration was diluted 1:1000 (v/v) in PBS. 
 
2.2.2.3 Fluorescent in-situ hybridisation (FISH) 
 
Oligonucleotide probes for FISH were designed and purchased from Sigma Aldrich. Probes 
consisted of a 5’ AlexaFluor© 488-tagged, 30 base poly thymine (polyT) or poly adenine 
(polyA) oligonucleotide. FISH was conducted prior to antibody labelling. Cells were washed in 
PBS followed by washing in 2X saline-sodium citrate (SSC) buffer [diluted in H2O from 20X SSC 
(Sigma Aldrich)]. Cells were then incubated in hybridisation buffer [4X SSC, 0.5 mM EDTA, 10% 
dextran sulphate, 10% deionised-formamide in diethylpyrocarbonate (DEPC) H2O] mixed with 
0.2 μM probe and incubated (37°C, 3 h). Cells were briefly washed in 2X SSC followed by PBS, 
before further labelling as required, and mounting. 
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Antibody Host Source Fixation/permeabilisation Dilution 
FG-Nups (mAb414) Mouse Abcam 4% PFA / Triton X-100 1:2000 
anti-Nup62 Mouse BD Biosciences 4% PFA / Triton X-100 1:200 
anti-Nup153 Mouse Abcam 4% PFA / Triton X-100 1:100 
anti-Lamin B1 Rabbit Abcam 4% PFA / Triton X-100 1:200 
anti-Lamin A/C Mouse Santa Cruz 
Biotechnology 
4% PFA / Triton X-100 1:500 
anti-Lamin A Rabbit Abcam 4% PFA / Triton X-100 1:500 
anti-PDI Rabbit Sigma Aldrich 4% PFA / Triton X-100 1:500 
anti-IncA Mouse Gift from Dr. Dan 
Rockey (Oregon 
State University) 
4% PFA / Triton X-100 1:50 
anti-H3K9me3 Rabbit Abcam methanol 1:500 
anti-H3K4me3 Rabbit Abcam methanol 1:500 
anti-CdsF Rabbit Gift from Dr. 
Kenneth Fields 
(University of 
Kentucky) 
4% PFA / Triton X-100 1:100 
anti-Emerin Mouse Abcam 4% PFA / Triton X-100 1:500 
anti-Chlamydia spp. Mouse Argene (Now 
BioMérieux) 
4% PFA / Triton X-100 1:300 
AlexaFluor© 
conjugated secondary 
antibodies (488, 546, 
633) 
Goat Invitrogen 4% PFA / Triton X-100; 
methanol 
1:300 
 
Table 2.4. Antibodies used for immunofluorescence. 
 
2.2.3 Image acquisition and analysis 
 
Unless otherwise stated, coverslips were observed using a confocal microscope (TCS SP5 
AOBS; Leica Microsystems, Wetzlar, Germany) equipped with a 65 mW Argon laser, 1 mW 
HeNe 543 laser and a 10 mW HeNe 633 laser. Images were obtained sequentially using a 63x 
oil immersion objective (numerical aperture = 1.4) at 1024x1024 resolution with 400 Hz 
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scanning speed and a 2 frame average. z-sections were acquired at 0.33 μm intervals. Laser 
lines and emission windows were selected to avoid cross talk between channels in cells 
labelled with multiple antibodies. For GFP and AlexaFluor© 488, the 488 laser was selected 
and emission collected from 498 to 548 nm. For AlexaFluor© 546, the 543 laser was selected 
and emission collected from 555 to 633 nm. For AlexaFluor© 633 and DRAQ-5, the 633 laser 
was selected and emission collected from 660 to 746 nm. Image analysis was conducted using 
the open-source image processing package Fiji (Schindelin et al., 2012), a distribution of 
ImageJ (Schneider et al., 2012) and CellProfiler, an open-source image analysis software 
developed by Carpenter and co-workers (2006). In confocal images of Chlamydia-infected cells 
stained with DRAQ-5 to visualise DNA or anti-Chlamydia to visualise bacteria, the inclusion 
periphery was determined by tracing the edge of the inclusion using the bacterial DNA or 
bacteria respectively as a guide. In confocal images without DNA or Chlamydia staining, the 
inclusion position was traced by virtue of the exclusion of cellular markers upon overexposure. 
It should be noted that the inclusion periphery does not necessarily represent the true 
trajectory of the inclusion membrane. 
 
2.2.3.1 Nuclear shape analysis 
 
Maximum intensity projections of confocal xy-sections of HeLa cell nuclei labelled with lamin 
B1 were manually curated for the extent of lobulation. Nuclei were scored dependent on the 
number of invaginations of lamin B1 at the nuclear membrane, with single-lobed nuclei having 
no invaginations, bi-lobed nuclei having a single invagination and multi-lobed nuclei having 
multiple invaginations. 
 
2.2.3.2 Intensity analysis of the nuclear envelope 
 
To measure intensity of signal across the NE, the region of interest (ROI) was traced in Fiji 
using the ‘segmented line’ tool with a width of 5 pixels to match the thickness of the NE, and 
the ‘Plot Profile’ function was used, which displays a two-dimensional graph where the x-axis 
represents distance along the line and the y-axis the mean pixel intensity. 
 
2.2.3.3 Quantification of the frequency of nuclear envelope alterations 
 
The frequency of nuclear envelope alterations, including the lamin A/C ‘patch’, the FG-Nup 
‘gap’, reduction in lamin B, and enrichment of H3K9me3, was manually curated in fixed non-
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infected and infected HeLa/MEF cells. The lamin A/C patch was defined as an enrichment of 
lamin A/C staining on one face of the NE greater than 1 μm in diameter in both the xy and z 
dimensions, with at least 50% higher fluorescence intensity than the lamin A/C located on the 
distal face of the NE. The threshold of 50% was chosen to ensure differences in fluorescence 
are not due to natural variations. An FG-Nup gap was defined as a complete depletion of FG-
Nup fluorescence intensity in the NE greater than 1 μm in both the xy and z dimensions. A 
lamin B reduction was defined as a region on one face of the NE greater than 1 μm in diameter 
in both the xy and z dimension, with at least 50% lower fluorescence intensity than the lamin B 
located on the distal face of the NE. For enrichment of H3K9me3, the requirement was for a 
region of enriched H3K9me3 on one face of the nucleus greater than 1 μm in both the xy and z 
dimensions with fluorescence intensity at least 50% higher than the H3K9me3 on the distal 
face of the nucleus. 
 
2.2.3.4 Quantification of nuclear mRNA 
 
Non-infected and C. trachomatis LGV2-infected RPE1 cells were prepared as described 
previously (section 2.1 and 2.2), and fixed and labelling for poly(A) mRNA and lamin B (section 
2.7). Lamin B signal of nuclei in infected cells was identified using the ‘IdentifyPrimaryObjects’ 
function in CellProfiler to generate a mask covering the nuclear volume. Total intensity of 
poly(A) mRNA signal was then determined within this mask and calculated relative to area. The 
resulting average pixel intensity corrected for the area was then summed across the z-stack 
and divided by the number of z-sections to give mean nuclear pixel intensity per unit volume 
or mean nuclear voxel intensity. 
 
2.2.3.5 Measuring inclusion size  
 
Inclusion size was measured in infected cells labelled for Chlamydia as described by Dumoux et 
al. (2012). Briefly, the inclusion was segmented by applying grey level thresholding on wavelet-
transformed images. B-Spline wavelets ‘à trous’ were used for convolution. A mask was 
created with the ‘Fill Holes’ option leading to the creation of a volume that represents the 
inclusion.  
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2.2.3.6 Measuring the roundness of inclusions 
 
The roundness of inclusions (or contour ratio) was calculated from maximum intensity 
projections of confocal xy-sections of inclusions according to equation 1, where a perfect circle 
has a contour ratio of 1. 
𝐶𝑜𝑛𝑡𝑜𝑢𝑟 𝑟𝑎𝑡𝑖𝑜 =
4𝜋𝑥𝐴𝑟𝑒𝑎
𝑃𝑒𝑟𝑖𝑚𝑒𝑡𝑒𝑟2
 
 
Equation 1. Equation for the calculation of contour ratio. 
 
2.3 Bacteria infectivity assay 
 
2.3.1 Sample preparation 
 
For quantification of infectivity in WT and LMNA-/- MEFs, an inclusion forming unit (IFU) assay 
was conducted. MEF cells were infected as previously described (section 2.2.2). At an 
appropriate time post infection, the infection medium was removed and cells and bacteria 
collected by scraping into SPG buffer (220 mM sucrose, 17.4 mM Na2HPO4, 2.6 mM NaH2PO4, 
20 mM L-glutamic acid) prior to freezing at -80°C. After partial lysis by defrosting, cells 
containing bacteria were further lysed by flushing the SPG medium repeatedly through a 23g 
needle releasing Chlamydia into the medium. Bacteria were then diluted in infection medium 
and used to infect a fresh monolayer of HeLa cells prior to fixation at 24 hours post infection 
(hpi). 
 
2.3.2 IFU quantification 
 
Fixed HeLa cells were labelled with DRAQ-5 and anti-Chlamydia spp. antibody. The number of 
cells and inclusions were counted in duplicate across six randomly selected fields of view 
(FOVs) to calculate an average number of infections per FOV. This number was then multiplied 
by the dilution factor (1:20 for the cell layer, 1:2 for the infection medium) and a correction 
factor (area of coverslip / area of field of view) to obtain the IFU/ml. 
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2.4 Electron microscopy 
 
Electron microscopy was conducted as described by Dumoux et al. (2012). Briefly, HeLa or 
RPE1 cells were cultured and infected directly on gold-coated copper membrane carriers with 
a 100 μm well depth (Leica) previously treated with DMEM/1% P/S for 3 days and FCS/1% P/S 
for 4 days. Cells were infected with C. trachomatis LGV2 as previously described. At 48 hpi, the 
membrane carriers were transferred to the Leica EM HPM100 for rapid freezing with liquid 
nitrogen at a pressure of 210,000 kilopascals and a cooling rate of approximately 25000 K/s. 
The frozen carriers were embedded in resin [freeze-substitution (FS)] using the Leica EM AFS2. 
Briefly, membrane carriers were incubated in dry acetone containing 0.2% uranyl acetate (FS 
cocktail) by warming from -160°C to -90°C. Samples were further warmed to -50°C while the FS 
cocktail was removed, and the samples washed in ethanol. Samples were then infiltrated with 
HM20 resin and the resin polymerised using UV light. The samples were finally warmed to RT 
and then sectioned using a Leica UC7 microtome. Sections were obtained at a 200 nm 
thickness and imaged using a Tecnai T10 microscope equipped with a Gatan 1k CCD camera. 
 
2.5 Immuno (Western) blotting 
 
2.5.1 Sample preparation 
 
HeLa cells were seeded in 6 well plates and incubated for 18-24 h [37°C, 5% (v/v) CO2] to allow 
cell adherence. Cells were infected as required and then detached by incubation in 500 μl 
versene (Gibco) [37°C, 5% (v/v) CO2, 15 min]. An equal volume of HBSS/FCS was added, and 
the resulting cell suspension counted before centrifugation (1200 g, 10 min, 4°C). Cell pellets 
were suspended in 50 μl Laemmli buffer [125 mM Tris-HCL pH 6.8, 20% (v/v) glycerol, 4% (w/v) 
sodium dodecyl sulphate (SDS), 20% (v/v) β-mercaptoethanol, 0.02% (w/v) bromophenol blue] 
per million cells, boiled at 95°C for 10 min and stored (-20°C). 
 
2.5.2 SDS-PAGE 
  
Resolving and stacking gels were prepared as in Table 2.5. First, the resolving gel was pipetted 
into the 0.75 mm space in the gel caster. Propan-2-ol (VWR, Radnor, PA, USA) was added to 
ensure an even surface whilst the gel set. The propan-2-ol was then removed, the stacking gel 
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added and a 0.75 mm comb inserted. Once set, the gel was assembled in an electrophoresis 
tank, filled with migration buffer [25 mM Tris base, 192 mM glycine, 0.1% (w/v) SDS] and the 
comb removed. Samples were clarified (15,871 g, RT, 15 min) using an Eppendorf 5424 
benchtop centrifuge prior to loading. Full-range rainbow molecular weight marker 
(Thermofischer) was added. Samples were electrophoresed at 30 mA per gel until the required 
separation of molecular weight markers was achieved. 
 
 
Gel Recipe 
14% (resolving gel) 32% (v/v) ProSieveTM 50 gel solution (Lonza), 0.4 mM Trizma® 
hydrochloride pH 8.8, 0.1% (w/v) SDS, 0.15% (w/v) ammonium 
persulphate (APS), 2.15 mM N,N,N’,N’-Tetramethylethylenediamine 
(TEMED) in H2O 
12% (resolving gel) 27% (v/v) ProSieveTM 50 gel solution, 0.4 mM Trizma® hydrochloride pH 
8.8, 0.1% (w/v) SDS, 0.15% (w/v) APS, 2.15 mM TEMED in H2O 
10% (resolving gel) 23% (v/v) ProSieveTM 50 gel solution, 0.4 mM Trizma® hydrochloride pH 
8.8, 0.1% (w/v) SDS, 0.15% (w/v) APS, 2.15 mM TEMED in H2O 
8% (resolving gel) 18% (v/v) ProSieveTM 50 gel solution, 0.4 mM Trizma® hydrochloride pH 
8.8, 0.1% (w/v) SDS, 0.15% (w/v) APS, 2.15 mM TEMED in H2O 
5% (stacking gel) 4.5% (v/v) ProSieveTM 50 gel solution, 0.25 mM Trizma® hydrochloride 
pH 6.8, 0.2% (w/v) SDS, 0.1% (w/v) APS, 3.5 mM TEMED in H2O 
 
Table 2.5. Gel recipes. 
 
2.5.3 Transfer 
 
SDS-PAGE gels, 0.34 mm Whatmann blotting paper (Thermofischer) and nitrocellulose 
membrane (GE Healthcare, Little Chalfont, Buckinghamshire, UK) were equilibrated in transfer 
buffer [3.5 mM Tris base, 192 mM glycine, 20% (v/v) ethanol] at 4°C for 15 min. The cassette 
was then assembled as follows: foam, 3x filter paper, gel, membrane, 3x filter paper, foam. 
Transfers were run at 2 W per cassette (4°C, overnight). 
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2.5.4 Immunoblotting 
 
Membranes were blocked in TBS-Tween (20 mM Tris HCL, 150 mM NaCl, 0.05% Tween-20) 
with 5% milk powder (w/v) (blocking solution) for 3 x 20 min at RT. Membranes were 
incubated with primary antibody diluted in blocking solution as required (Table 2.6) overnight 
at 4°C. Membranes were washed 3 x 20 min in TBS-Tween prior to incubation with goat anti-
mouse HRP-coupled secondary antibody (1:10000, Invitrogen) (RT, 1 h). Membranes were 
washed again in TBS-Tween, dried, and incubated in enhanced chemiluminescence (ECL) 
detection reagent (GE Healthcare) prepared as per manufacturer instructions (RT, 5 min). 
Luminescence was detected using high performance chemiluminescence film (GE Healthcare) 
and the film was developed using a Compact X4 developing machine (Xograph Imaging 
Systems, Stonehouse, Gloucestershire, UK). 
 
Antibody Host Source Dilution 
Anti-Lamin A/C [EPR4100] Rabbit Abcam 1:2000 
Anti-γ-tubulin Mouse Abcam 1:2000 
 
Table 2.6. Antibodies for immunoblotting. Primary antibodies for immunoblotting were 
diluted in blocking solution [5% milk powder (w/v) in TBS-Tween]. 
 
2.5.5 Quantification of lamin A/C protein levels 
 
The developed film was digitally scanned to allow densitometry analysis. The density of bands 
in each lane was calculated by using the ‘Plot Lanes’ function in Fiji and measuring the area of 
each peak. The protein levels of lamin A and lamin C relative to γ-tubulin were calculated by 
dividing the area of the peaks corresponding to lamin A or lamin C by the area of the peak 
corresponding to γ-tubulin. 
 
2.6 Remote sequence homology and fold recognition 
 
For remote sequence homology detection, amino acid sequences of proteins of interest were 
submitted to the HHblits server (Remmert et al., 2011) using the HHblits UniProt20 hidden 
Markov model (HMM) database and default settings (three iterations, local alignment mode, 
MAC realignment threshold of 0.35). For fold detection, amino acid sequences of proteins of 
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interest were submitted to the HHpred homology detection and structure prediction server  
(Hildebrand et al., 2009) using the HHpred PDB70 HMM database and default settings (HHblits 
MSA generation method, three iterations, secondary structure scored, local alignment mode). 
 
2.7 Identification of α-solenoid folds using secondary structure 
prediction 
 
A tool for calculating and visualising consensus secondary structure prediction sequences from 
three secondary structure element (SSE) prediction software [Jpred (Cuff et al., 1998), Psipred 
(McGuffin et al., 2000), RaptorX (Källberg et al., 2012)] was written using the Python 
programming language. For each amino acid residue of the protein sequence of interest, the 
SSE type (helix, strand or coiled coil) and corresponding confidence value (scored from 0-9, 
with 9 being high confidence) are recorded and summed across the three prediction software. 
The SSE type with the highest confidence value is then selected as the consensus SSE for this 
position, and the confidence value of this consensus SSE is recalculated by dividing the sum of 
the confidence values for the SSE type by the maximum confidence value possible, which is 27 
(3*9). The resulting consensus SSE sequence was output visually using the PostScript 
programming language for creating vector graphics. Code for the SSE consensus tool can be 
found in the appendix. 
 
Parameters for identification of α-solenoid folds were then determined using the consensus 
SSE sequence of known α-solenoid fold-containing proteins (Nup85, Nup107, Nup133, 
Nup160, importin-β) which were determined to be minimally 450 amino acids in length, have a 
minimal uninterrupted sequence of alpha helix/loop residues of 200, and were comprised of 
over 90% α-helix/loop SSEs and over 40% α-helix SSEs. 
 
2.8 Prediction of bacterial secretion 
 
Amino acid sequences of proteins of interest were submitted to signal peptide [SignalP 4.0 
(Petersen et al., 2011)] and type III secretion [EffectiveT3 (Arnold et al., 2009), BPBAac (Wang 
et al., 2011), ANN (Löwer and Schneider, 2009), T3_MM (Wang et al., 2013) and BEAN 2.0 
(Dong et al., 2015)] prediction servers using default settings. 
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Chapter 3 – Examining the impact of infection with  
C. trachomatis on nuclear architecture 
 
3.1 Introduction 
 
Chlamydiae replicate within a membrane bound compartment termed an ‘inclusion’. This 
inclusion localises to the peri-nuclear region in close proximity to the microtubule organising 
centre (Clausen et al., 1997). Briefly, as the infection progresses, the inclusion expands to 
occupy the majority of the host cytosol; recruiting, fragmenting or ingesting many cellular 
organelles including the endoplasmic reticulum (ER), the Golgi apparatus, multi-vesicular 
bodies and lipid droplets (as discussed in section 1.1.6) (Beatty, 2006; Kumar et al., 2006; 
Heuer et al., 2009; Dumoux et al., 2012). In HeLa cells, the infection cycle lasts 48-72 hours for 
C. trachomatis LGV2 (Andrew, 2014). In addition to targeting at least one type III effector, the 
histone methyltransferase NUE, to the nucleus (Pennini et al., 2010), Chlamydia infection also 
impacts upon cellular processes controlled by the nucleus, including inhibition of apoptosis by 
degrading p53, alteration of cellular aging pathways by upregulating hTERT and suppressing 
DNA double-strand break repair (Chumduri et al., 2013; Padberg et al., 2013; González et al., 
2014). However, little is known about the mechanism of interactions with this major organelle. 
 
Whilst images of late-stage Chlamydia-infected cells frequently show nuclei distorted into a 
crescent shape, any consequences of these changes have not been investigated (Padberg et 
al., 2013; Brown et al., 2014; Sun et al., 2016). Alterations to nuclear shape are associated with 
a number of pathologies and conditions, including laminopathies and cancer. In the 
laminopathies, lamina proteins are either mutated or mislocalised due to aberrant processing. 
These diseases are characterised by abnormal nuclear architecture, increased sensitivity to 
mechanical stress and alterations in gene expression (Burke and Stewart, 2002). For example, 
individuals with Hutchinson-Gilford progeria syndrome (HGPS) prematurely age due to a 
mutation in the LMNA gene, leading to an incompletely processed form of prelamin A known 
as progerin incorporating into the NL and altering the mechanical properties and organisation 
of the NL (Eriksson et al., 2003; Dahl et al., 2006). This results in nuclear shape abnormalities, 
aberrant organisation of heterochromatin and changes in the expression patterns of 352 genes 
(McCord et al., 2013). Additionally, nucleoplasmic progerin sequesters DNA replication and 
repair factors at foci leading to genomic instability (Musich and Zou, 2009), and reductions in 
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levels of nucleoplasmic lamin A/C result in impaired cell proliferation and down-regulation of 
extracellular matrix components (Vidak et al., 2015). The connection between aberrant 
nuclear shape and some cancers is less well established, but relates to the nuclear lamina as 
many tumours are characterised by down-regulation of A-type lamin expression (de las Heras 
et al., 2013). It is also interesting to note that abnormal nuclear shape is implicated in aging, in 
this case due to sporadic production of the HGPS lamin A isoform (Scaffidi and Misteli, 2006). 
 
As exampled by the laminopathies, nuclear shape and function are therefore closely 
interrelated. Nuclear shape is determined by mechanical forces on the nucleus emanating 
from cytoskeletal connections to lamins A and C through the transmembrane LINC complexes. 
As a result of these connections, nuclear architecture can be manipulated to alter function in 
response to external stimuli or forces exerted on the cell in a process termed 
mechanotransduction. Indeed, these extracellular or cytoskeletal forces can induce distal 
remodelling of chromatin and nuclear organisation with subsequent impact on gene 
expression (Booth-Gauthier et al., 2012; Iyer et al., 2012; Fedorchak et al., 2014). Lamins are 
major determinants of structural and mechanical support in the nucleus, and the NL is further 
stabilised by lamin binding proteins such as emerin (Lammerding et al., 2005). Cells lacking 
lamin A/C, but not B-type lamins, exhibit reduced nuclear stiffness and increased nuclear and 
cellular fragility (Broers et al., 2004; Lammerding et al., 2006), whilst the aforementioned 
HGPS cells exhibit increased nuclear stiffness but also corresponding sensitivity to mechanical 
strain (Dahl et al., 2006). As might be expected, mutations in LINC complex proteins can also 
result in disease states due to interruption of nuclear-cytoskeletal connections. For instance, in 
Emery-Dreifuss muscular dystrophy (EDMD), mutations in the LINC complex proteins SUN1 and 
SUN2 contribute to increased disease severity (Meinke et al., 2014). Whilst nuclear shape is 
not known to be specifically manipulated by any intracellular pathogens, overexpression of the 
LINC complex protein SUN2 induces a multi-lobular nuclear shape similar to progeria cells that 
inhibits replication of certain HIV-1 and HIV-2 strains by blocking nuclear entry following 
reverse transcription (Donahue et al., 2016). 
 
Therefore, given the importance of nuclear architecture in nuclear function, and the previously 
reported effect of the inclusion on the nucleus, the aim of this chapter is to examine in detail 
the impact of Chlamydia infection on nuclear shape and components of the nuclear envelope. 
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3.2 Assessment of nuclear shape in cultured mammalian cells 
 
Prior to assessing the influence of chlamydial infection on nuclear architecture, it was first 
necessary to develop qualitative and quantitative approaches to study nuclear shape in 
cultured mammalian cell lines.  The NE was visualised by confocal microscopy in fixed cells by 
labelling with an antibody raised against Lamin B1 and an appropriate AlexaFluor®-conjugated 
secondary antibody. In the majority of HeLa cells, nuclei were typically an ovoid shape with a 
uniform nuclear envelope (Fig 3.1A). However, a small proportion of cells exhibited bi-lobed or 
multi-lobed nuclei (Fig 3.1A). These non-ovoid shapes are typical in certain cell types, such as 
neutrophils, but have also been reported in HeLa cells, other transformed epithelial cell lines 
and aged cells (Scaffidi and Misteli, 2006; Imbalzano et al., 2013; Kawaguchi et al., 2015), and 
are dependent upon the nuclear lamina and cytoskeletal forces (Hoffmann et al., 2007; Olins 
et al., 2008). To assess nuclear shape, three nuclear morphologies were defined based on 
previously published studies: single lobed/ovoid, bi-lobed and multi-lobed, thus representing 
progressive distortion of nuclear shape (Goldman et al., 2004; Olins and Olins, 2004; Imbalzano 
et al., 2013). Cells that exhibited signs of apoptosis such as DNA fragmentation and membrane 
blebbing were excluded. When nuclear shape in cultured HeLa cells was assessed using these 
parameters, 75 ± 6.1% of nuclei are ovoid, 14 ± 4.5% are bi-lobed and 11 ± 1.7% are multi-
lobed (Fig 3.1B). These approaches allowed the subsequent qualitative and quantitative 
analysis of nuclear architecture in Chlamydia-infected cells. 
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Figure 3.1. Assessment of nuclear shape in HeLa cells. Fixed HeLa cells were stained with anti-
lamin B1 primary antibody and an AlexaFluor® 488-conjugated secondary antibody (grey) to 
visualise lamin B (A) Maximum intensity projections of confocal xy-sections of HeLa nuclei. 
Examples of single-lobed, bi-lobed and multi-lobed nuclei are shown. White arrowheads 
indicate points at which additional lobules can be observed. Scale bars, 10 µm. (B) Nuclei 
(n=200) were scored for the number of lobes based on the categories shown in (A). Error bars 
show standard deviation (***p<0.01 using Student’s t-test between single lobed and bi/multi 
lobed). 
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3.3 Nuclear lobulation progressively increases during Chlamydia 
infection 
 
Having characterised nuclear morphology in cultured HeLa cells, cells were infected with  
C. trachomatis LGV2 and nuclear shape identically quantified. The NE was visualised as 
previously with anti-Lamin B1, and an antibody raised against IncA, a Chlamydia inclusion 
protein, was used to visualise the inclusion membrane (IM). At 24 hours post infection (hpi), 
when the inclusion is relatively small, nuclear shape was distorted with an invagination of the 
NE adjacent to the inclusion (Fig 3.2A). As the infection progressed the inclusion expanded 
significantly causing the nuclei to become further distorted and crescent shaped (Fig 3.2B) 
(Brown et al., 2012). The inclusion-proximal face of the NE adopted a regular shape that 
closely followed the contours of, but did not co-localise with, the IM. However, the distal face 
of the NE was much more irregular, with multiple invaginations reminiscent of multi-lobed 
nuclei. Nuclear shape was therefore assessed using the morphology parameters described 
previously (Fig 3.2C).  
 
At 24 hpi the proportion of nuclei with a single lobe was 52 ± 4.6%, significantly lower than 
non-infected HeLa cells. This value reduced further as the infection continued to progress, with 
just 37 ± 2.0% of nuclei being ovoid by 72 hpi. Correspondingly, the number of infected cells 
with bi- or multi-lobed nuclei increased during infection, with a trend from 24 to 72 hpi of an 
increasing proportion of multi-lobed nuclei. These data suggest that Chlamydia infection 
impacts upon nuclear shape more profoundly than previously thought with nuclei, in addition 
to distortion into a crescent shape, becoming increasingly lobulated. 
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Figure 3.2. Nuclear shape is distorted during chlamydial infection. HeLa cells were infected 
with C. trachomatis LGV2 and fixed at the indicated time post infection. Cells were double-
stained with anti-IncA primary antibody and an AlexaFluor® 488-conjugated secondary 
antibody (grey, green) to visualise the inclusion membrane, and anti-lamin B1 primary 
antibody and an AlexaFluor® 546-conjugated secondary antibody (red) to visualise lamin B. (A) 
24 hours post infection (hpi). (B) 48 hpi. (C) Nuclei at each time point post infection (n=100) 
were scored for the number of lobes based on the categories shown in Fig 3.1. White bars: 
single lobed, grey bars: bi-lobed, black bars: multi-lobed. NI: non-infected. Error bars show 
standard deviation (**p<0.05 using Student’s t-test between NI single lobed and 24/48/72 hpi 
single lobed, and with a Q value greater than the critical Q value for significance to 0.05 using 
One-way analysis of variance (ANOVA) followed by post-hoc Tukey’s honest significant 
difference (HSD) test). 
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3.4 A consistent distance is maintained between the inclusion 
membrane and nuclear envelope 
 
The chlamydial inclusion contacts multiple host organelles, notably the ER, where it assembles 
a ‘pathogen synapse’ at which ordered arrays of type III secretion complexes link the bacterial 
envelope, the inclusion membrane and the rough ER (Dumoux et al., 2012). The outer nuclear 
membrane (ONM) of the NE also possesses ribosomes, and is contiguous with both the rough 
and smooth ER (Gerace and Burke, 1988). Given the biochemical similarity between the ONM 
of the NE and the ER and the close proximity of the inclusion membrane to the NE as the 
inclusion expands into and deforms the host nucleus, it is conceivable that Chlamydia may also 
establish an array of T3SS at this location to target effectors such as NUE directly into the 
nucleus. 
 
To investigate this, chlamydial type III secretion complexes were labelled using an antibody 
raised against the major needle subunit protein, CdsF (Fig 3.3). DRAQ-5 was used to label 
double-stranded nucleic acids such as host and bacterial DNA and cytosolic RNA (Martin et al., 
2005). Serial confocal z-sections showed that at 24 hpi, when the majority of the bacteria are 
metabolically active reticulate bodies (RBs), there is consistent labelling of CdsF around the IM 
but no specific polarisation towards the NE (Fig 3.3A). At 48 hpi, where there are significantly 
fewer RBs and more of the infectious, metabolically inactive elementary bodies (EBs), CdsF 
labelling became more irregular around the IM (Fig 3.3B). Whilst CdsF was still present at the 
IM adjacent to the NE, there was no apparent polarisation of CdsF facing the nucleus. 
 
The lack of enrichment of T3S complexes suggests a pathogen synapse with the nucleus similar 
to that formed with the ER is unlikely. However, this does not exclude the existence of other 
membrane contact sites (MCSs). To investigate whether any evidence of contact sites exists, 
electron microscopy was used to observe phenomena that are not visible at the resolution of 
light microscopy. HeLa cells infected with C. trachomatis LGV2 were vitrified at 48 hpi by high-
pressure freezing, freeze-substituted, embedded in HM20 resin, and observed by electron 
microscopy (Fig 3.4A). These higher resolution views showed that RBs do not specifically 
cluster adjacent to the nucleus or exhibit specific structural rearrangements. The inclusion-
proximal face of the NE closely tracked the contours of the IM but did not come into contact, 
and a patch of increased electron density formed at the IM where the IM and NE are closely 
apposed (indicated by cyan arrows), suggesting the composition of the IM in this region is 
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altered. Intriguingly, the IM and NE appeared to be separated by a consistent distance. To 
quantify this, linear distances between the IM and NE at approximately 100 nm intervals were 
measured from the electron micrographs (Fig 3.4B). The average distance in 10 infected cells 
was 163 nm with a minimum distance of 104 nm and a maximum distance of 240 nm. This 
range of distances between cells was much larger than the range of distances for 
measurements within each cell, with an average standard deviation of 44.6 nm compared to 
23.5 nm respectively, indicating that measurements within each cell are relatively more 
constant. However, it is difficult to draw conclusions from this difference as measurements 
were taken from single EM sections and not tomograms, and so the relative position in z 
between different sections, and therefore the relative z position of the NE in relation to the 
inclusion, is unknown. 
 
Nonetheless, these distances far exceed the proximity of both the pathogen synapse and 
canonical MCSs, which are typically less than 30 nm (Dumoux et al., 2012; Helle et al., 2013). 
Taken together, these data suggest a classical MCS existing between the IM and the NE such as 
that seen between, for example, the ER and the mitochondria is unlikely (Helle et al., 2013), 
but the existence of increased electron density at the IM and a relatively constant distance 
between the IM and NE hint at the possibility of some form of novel junction.  
72 
 
 
 
 
 
 
 
 
Figure 3.3. Chlamydia type III secretion systems are not enriched at the inclusion membrane 
proximal to the nucleus. HeLa cells were infected with C. trachomatis LGV2 and fixed at the 
indicated time post infection. The exposed needle of the chlamydial T3SS was labelled with an 
anti-CdsF primary antibody and an AlexaFluor® 546-conjugated secondary antibody (grey, red), 
and double-stranded nucleic acids stained with DRAQ-5 (blue). Left panels: confocal images of 
infected cells in the xy-plane, with the inclusion (I) periphery indicated by the white dashed 
line (Methods 2.8). Right panels: confocal xy-sections of the inclusion, ascending in the z 
dimension through the cell (1-8) with a step of 0.34 µm. Red borders indicate the sections 
equivalent to the left panels. (A) 24 hours post infection (hpi). (B) 48 hpi. Scale bars, 10 µm. 
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Figure 3.4. Electron microscopy reveals a consistent distance between the inclusion 
membrane and nuclear envelope. HeLa cells infected with C. trachomatis LGV2 were vitrified 
at 48 hours post infection by high-pressure freezing, negatively stained using uranyl acetate 
during freeze-substitution, embedded in HM20 resin and sectioned. (A) Upper left: 
transmission electron micrograph of a 200 nm thick section with an infected HeLa cell. Lower 
left and right: Magnifications of the inclusion and nucleus, showing a consistent distance 
between the inclusion membrane (IM) and the nuclear envelope (NE). Cyan arrows mark a 
region of increase electron density in the IM. Scale bars: upper, 5 µm; lower left, 1 µm; lower 
right, 0.2 µm. (B) Measurements of the linear distance perpendicular from the NE to the IM 
(left; yellow dashes) where the NE tracks the contours of the IM were taken at 100 nm 
intervals and plotted for each cell (n=10) (right), with white circles as the individual distance 
measurements and red dashes indicating mean distance. 
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3.5 Lamin A/C is enriched at the inclusion-proximal face of the 
NE during Chlamydia infection 
 
The experiments presented so far have shown a pathogen synapse between the inclusion and 
nucleus similar to that observed between the inclusion and ER is not present, but a novel 
junction-like structure may exist (section 3.4). Additionally, gross nuclear architecture is 
distorted into a crescent structure and nuclei in infected cells become progressively lobulated 
at the inclusion-distal face of the NE (section 3.3). Lobulated nuclei are most frequently 
associated with immune cells such as granulocytes in which lamin A/C and lamin B levels are 
reduced (Olins et al., 2001), and the laminopathies, rare genetic disorders caused by mutations 
in genes encoding for the NL, classically LMNA which encodes lamin A/C (Goldman et al., 
2004). It was therefore hypothesised that the NL might be altered during Chlamydia infection. 
 
HeLa cells infected with C. trachomatis LGV2 were fixed and labelled to visualise lamin A/C and 
DNA. In non-infected cells, lamin A/C labelling was evenly distributed throughout the NE as 
expected from previous studies using this antibody (Fig 3.5) (Dreuillet et al., 2002; Reynolds et 
al., 2004). This was replicated at 24 hpi where labelling was again evenly distributed despite 
the inclusion-induced distortion in gross nuclear architecture (Fig 3.6). At 48 hpi and 72 hpi 
however, major changes to lamin A/C distribution occurred (Fig 3.7 and Fig 3.8). At the 
inclusion-proximal face of the NE, where the inclusion compresses the nucleus leading to the 
associated distortion of gross nuclear architecture, a ‘patch’ of enriched lamin A/C was 
formed. Around the remainder of the NE, lamin A/C levels appeared depleted compared to 
control cells. To confirm this, the intensity of lamin A/C fluorescence was measured around the 
NE in non-infected and infected cells and plotted relative to distance (Fig 3.9A). The lamin A/C 
levels were ~50% higher in non-infected cells compared to infected cells, except within the 
region of the NE in infected cells corresponding to the patch of enrichment, where lamin A/C 
levels were equal to or greater than lamin A/C levels around the NE of non-infected cells. It is 
also interesting to note that the reduction in lamin A/C levels on the inclusion-distal face of the 
NE occur in the same region of the NE where the nuclei is more lobulated, suggesting these 
two observations may be linked (section 3.3). 
 
The frequency of the enriched patch of lamin A/C was quantified in control and infected cells. 
A lamin A/C patch was defined as an enrichment of lamin A/C staining on one face of the NE 
greater than 1 μm in diameter in both the xy and z dimension, with at least 50% higher 
75 
 
fluorescence intensity than the lamin A/C located on the distal face of the NE. In infected cells, 
enrichment of lamin A/C exclusively occurred in the NE adjacent to the inclusion membrane, 
suggesting proximity to the inclusion may be important in forming the lamin A/C patch. 
Quantification showed that the frequency of lamin A/C patches increases as infection 
progresses (Fig 3.9B). At 24 hpi, 7.1 ± 0.2% of cells had nuclei with lamin A/C patches 
compared to 1.3 ± 0.4% of nuclei in non-infected cells. At 48 hpi this frequency rose to 52.9 ± 
2.5% and at 72 hpi to 72.1 ± 11.5%. Thus, during the mid-stage of infection at 24 hpi, where 
the majority of bacteria are in the RB form, lamin A/C patches begin to form, but at late (48 
hpi) and very late stages (72 hpi), where the bacteria are increasingly differentiating back into 
EBs, the lamin A/C patches occur in approximately half and three quarters of all infected cells 
respectively. These data support the conclusion that lamin A/C patch occurrence is associated 
with the latter stages of the Chlamydia lifecycle. 
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Figure 3.5. Lamin A/C is evenly distributed at the nuclear envelope in cultured HeLa cells. 
Fixed HeLa cells were double stained with anti-lamin A/C primary antibody and an AlexaFluor® 
546-conjugated secondary antibody [red, grey (lower)] to visualise lamin A/C, and DRAQ-5 to 
visualise DNA [blue, grey (upper left)]. (A) Confocal images of a HeLa cell in the xy-plane. (B) 
Confocal xy-sections of the nucleus, ascending in the z dimension through the cell (1-9) with a 
step of 0.34 µm. The section equivalent to (A) is indicated with a red border. Scale bars, 10 µm. 
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Figure 3.6. Lamin A/C is evenly distributed at the nuclear envelope at 24 hours during 
chlamydial infection. HeLa cells were infected with C. trachomatis LGV2, fixed at 24 hours post 
infection (hpi) and double stained with anti-lamin A/C primary antibody and an AlexaFluor® 
546-conjugated secondary antibody [red, grey (lower)] to visualise lamin A/C, and DRAQ-5 to 
visualise DNA [blue, grey (upper left)]. (A) Confocal images of an infected cell in the xy-plane, 
with the inclusion (I) periphery indicated by the white-dashed line (Methods 2.8). (B) Confocal 
xy-sections of the nucleus, ascending in the z dimension through the cell (1-12) with a step of 
0.34 µm. The section equivalent to (A) is indicated by the red border. Scale bars, 10 µm. 
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Figure 3.7. Lamin A/C is enriched at the inclusion-proximal face of the nuclear envelope at 48 
hours during chlamydial infection. HeLa cells were infected with C. trachomatis LGV2, fixed at 
48 hours post infection (hpi) and double stained with anti-lamin A/C primary antibody and an 
AlexaFluor® 546-conjugated secondary antibody [red, grey (lower)] to visualise lamin A/C, and 
DRAQ-5 to visualise DNA [blue, grey (upper left)]. (A) Confocal images of an infected cell in the 
xy-plane, with the inclusion (I) periphery indicated by the white-dashed line (Methods 2.8). (B) 
Confocal xy-sections of the two nuclei, ascending in the z dimension through the cell (1-12) 
with a step of 0.34 µm. The sections equivalent to (A) are indicated by the red border. White 
arrows highlight areas of lamin A/C enrichment. Scale bars, 10 µm. 
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Figure 3.8. Lamin A/C is enriched at the inclusion-proximal face of the nuclear envelope at 72 
hours during chlamydial infection. HeLa cells were infected with C. trachomatis LGV2, fixed at 
72 hours post infection (hpi) and double stained with anti-lamin A/C primary antibody and an 
AlexaFluor® 546-conjugated secondary antibody [red, grey (lower)] to visualise lamin A/C, and 
DRAQ-5 to visualise DNA [blue, grey (upper left)]. (A) Confocal images of an infected cell in the 
xy-plane, with the inclusion (I) periphery indicated by the white-dashed line (Methods 2.8). (B) 
Confocal xy-sections of the nucleus, ascending in the z dimension through the cell (1-15) with a 
step of 0.34 µm. The section equivalent to (A) is indicated by the red border. White arrows 
highlight areas of lamin A/C enrichment. Scale bars, 10 µm. 
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Figure 3.9. Changes in lamin A/C distribution at the nuclear envelope occur more frequently 
late during chlamydial infection. (A) Fluorescence intensity was measured around the 
circumference of the nucleus starting at the inclusion-proximal face of the NE and averaged 
(n=10) across the nuclei of non-infected (grey) or late-stage (48 or 72 hours) infected (red) 
HeLa cells with patches of lamin A/C enrichment (defined as a region of lamin A/C on one face 
of the NE greater than 1 μm in diameter in both the xy and z dimensions with at least 50% 
higher fluorescence intensity than the lamin A/C located on the distal face of the NE). Shaded 
areas represent standard deviation. AU: Arbitrary units. (B) Histogram showing the proportion 
of non-infected (white bars) or C. trachomatis LGV2 infected (black bars) HeLa cells (n=150) 
exhibiting a lamin A/C patch scored at each time point. Error bars show standard deviation 
(**p<0.05, ***p<0.01 using Student’s t-test as indicated). 
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3.6 Cellular lamin A/C levels are reduced in infected cells late 
during chlamydial infection 
 
Quantification of fluorescence in the nuclei of infected cells containing the lamin A/C patch 
showed fluorescence is enriched at the inclusion-proximal face of the NE, and depleted 
elsewhere from the nuclear periphery (section 3.5). However, it is unclear as to whether this 
represents a net reduction in cellular lamin A/C in infected cells. To determine this, lamin A/C 
levels were examined by immunoblotting lysates collected from non-infected HeLa cells and 
comparing to lysates collected from C. trachomatis LGV2 infected HeLa cells at 24, 48 and 72 
hpi (Fig 3.10A). Protein species were detected at ~76 kilodaltons (kDa) corresponding to lamin 
A, at ~68 kDa corresponding to lamin C, and at ~50 kDa corresponding to γ-tubulin. 
Qualitatively, lamin A and lamin C levels were reduced at 48 and 72 hpi, although levels were 
comparable in the non-infected cells and infected cells at 24 hpi. Despite this reduction, no 
cleavage products were detected, and no protein species were detected with molecular 
weights corresponding to aberrant splice variants such as progerin, the mutant form of lamin A 
detected in HGPS cells. To confirm the effect of Chlamydia infection on lamin A/C, the 
intensities of protein species were quantified by densitometry and normalised against γ-
tubulin (Fig 3.10B). Surprisingly, at 24 hours the ratio of lamin A/C present in infected cells 
when compared to non-infected cells increases by approximately 0.1 for lamin A and 0.2 for 
lamin C. However, at 48 hours and 72 hours, both lamin A and lamin C are reduced compared 
to non-infected cells, with levels falling to 73 ± 9.8% and 81 ± 7.1% respectively at 48 hours, 
and 65 ± 10.7% and 83 ± 15.3% respectively at 72 hours. Thus, there is an overall reduction in 
lamin A/C levels in the host cell during the latter stages of infection with C. trachomatis LGV2. 
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Figure 3.10. Cellular lamin A/C protein levels are reduced late during chlamydial infection. 
Lysates were prepared from non-infected or C. trachomatis LGV2-infected HeLa cells at 24, 48 
and 72 hours post infection (hpi). (A) Proteins were separated by SDS-PAGE and analysed by 
immunoblotting using antibodies against lamin A/C and γ-tubulin. The position of the 
molecular weight markers are shown in kilodaltons (kDa, left). (B) Lamin A (white) and lamin C 
(grey) band intensity was quantified using ImageJ (average of two repeats), normalised relative 
to γ-tubulin and plotted as a ratio of mean levels in infected to non-infected cells. Error bars 
show standard deviation (**p<0.05 using Student’s t-test between lamin A/lamin C at 24 hpi 
and lamin A/lamin C at 48 or 72 hpi, and with a Q value greater than the critical Q value for 
significance to 0.05 using One-way analysis of variance (ANOVA) followed by post-hoc Tukey’s 
honest significant difference (HSD) test).  
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3.7 Lamin B is reduced at the inclusion-proximal face of the NE 
during Chlamydia infection 
 
Given the changes described previously in A-type lamins (section 3.5), lamin B was re-
examined to confirm whether or not any alterations to lamin B levels or localisation occur, and 
so determine whether all lamins are modified during infection or specifically lamin A/C. During 
C. trachomatis infection, at 24 hours, no discernible changes in lamin B fluorescence were 
observed relative to non-infected cells (Fig 3.11A). Later during infection, at 48 and 72 hours, 
lamin B fluorescence was partially depleted at the inclusion-proximal face of the NE (Fig 3.11B 
and C). Lamin B across the remainder of the NE was unchanged in comparison to control cells. 
For quantification, a ‘lamin B reduction’ was defined as a region on one face of the NE greater 
than 1 μm in diameter in both the xy and z dimension, with at least 50% lower fluorescence 
intensity than the lamin B located on the distal face of the NE. At 24 hpi there was no 
significant difference in the frequency of lamin B reduction compared to control. However, at 
48 hpi and 72 hpi lamin B reduction occurred more frequently, in 16.5 ± 0.3% and 21.0 ± 4.5% 
of infected cells respectively (Fig 3.12). These data show that in addition to lamin A/C, lamin B 
is also affected late during Chlamydia infection at the inclusion-proximal region of the NE. 
However, whilst lamin A/C was enriched adjacent to the inclusion, lamin B was reduced, and 
lamin B around the rest of the NE was unaffected. 
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Figure 3.11. Lamin B is reduced at the inclusion-proximal face of the nuclear envelope late 
during chlamydial infection. HeLa cells were infected with C. trachomatis LGV2, fixed and 
double stained with anti-lamin B1 primary antibody and an AlexaFluor® 546-conjugated 
secondary antibody (red, grey) to visualise lamin B, and DRAQ-5 to visualise DNA (blue). Left 
panels: confocal images of infected cells in the xy-plane, with the inclusion (I) periphery 
indicated by the white dashed line (Methods 2.8). Right panels: confocal xy-sections of the 
midsection of the nuclei, ascending in the z dimension through the cell (1-6) with a step of 
0.34 µm. Full z-stacks are available in the appendix. Red borders indicate the sections 
equivalent to the left panels. White arrows highlight areas of lamin B reduction. (A) 24 hours 
post infection (hpi). (B) 48 hpi. (C) 72 hpi. Scale bars, 10 µm. 
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Figure 3.12. Reduction of lamin B occurs more frequently late during chlamydial infection. 
Histogram showing the proportion of non-infected (white bars) or C. trachomatis LGV2 
infected (black bars) HeLa cells (n=150) exhibiting a reduction in lamin B scored at each time 
point. A lamin B reduction was defined as a region of lamin B on one face of the NE greater 
than 1 μm in both the xy and z dimensions with at least 50% lower fluorescence intensity than 
the lamin B located on the distal face of the NE. Error bars show standard deviation (**p<0.05 
using Student’s t-test as indicated). 
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3.8 Phenylalanine-glycine-repeat containing nucleoporins are 
depleted at the inclusion-proximal face of the NE during 
chlamydial infection 
 
The nuclear lamina is essential for anchoring the nuclear pore complexes (NPCs) within the NE 
via direct interactions with nucleoporins (Nups), and ensures stable NPC positioning by 
counteracting dynein forces on the NPCs (Al Haboubi et al., 2011; Lussi et al., 2011; Guo and 
Zheng, 2015). RNA interference studies in Caenorhabditis elegans, which has only a single 
lamin gene, show lamin depletion causes changes in nuclear shape and clustering of NPCs (Liu 
et al., 2000). Additionally, distinct NE subdomains on the nuclear surface exist in proliferating 
mammalian cells termed ‘pore-free islands’, which are characterised by the depletion of NPCs 
and lamin B and an associated enrichment of lamin A/C (Maeshima et al., 2006). Given the 
importance of the NL in NPC positioning, and the previously demonstrated modifications to 
the NL in cells infected by Chlamydia (section 3.5), NPC distribution was investigated during 
chlamydial infection. 
mAb414 is a widely used antibody that recognises epitopes in phenylalanine-glycine (FG) 
repeat regions, which are present in a subset of Nups in the cytoplasmic filaments, central 
pore and nuclear basket of the NPCs, allowing simultaneous labelling of multiple components 
of the NPCs (Davis et al., 1986). HeLa cells were therefore infected with C. trachomatis LGV2, 
fixed and labelled with mAb414 to visualise FG-Nups. Serial confocal z-sections of non-infected 
HeLa cells in the xy-plane show punctate FG-Nup labelling which was evenly distributed 
throughout the central z-sections, or midsection, of the NE, but absent in distinct regions of 
the nuclear surface consistent with pore-free islands (Fig 3.13). At 24 hpi, C. trachomatis LGV2 
infection had no effects on FG-Nup distribution (Fig 3.14A). However, later during the 
chlamydial infection cycle, at 48 and 72 hpi, striking changes were observed. At this later stage 
there was a localised depletion in FG-Nup labelling, once again on the inclusion-proximal face 
of the NE, forming a ‘gap’ in the distribution of NPCs (Fig 3.14B and C). Similar to the lamin A/C 
patch and lamin B reduction, the gap in FG-Nups occurs in the central z-sections of the 
nucleus, distinct from the pore-free islands reported by Maeshima et al. (2006), which occur 
on the nuclear surface adjacent to the growth surface.  
To quantify the frequency of FG-Nup depletion, an FG-Nup gap was conservatively defined as a 
complete depletion of FG-Nup fluorescence intensity greater than 1 μm in both the xy and z 
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dimensions. Consistent with the qualitative observations, at 24 hpi there was no significant 
difference in FG-Nup gap frequency compared to non-infected cells (Fig 3.15). At 48 and 72 
hpi, FG-Nup depletion occurred in 21.3 ± 5.6% and 24.7 ± 9.7% of infected cells respectively, 
confirming NPC changes occur more frequently late in infection. These data show similarities 
to known cellular phenomena such as the pore-free islands. However in C. trachomatis 
infected cells the NPC gap is specifically adjacent to the chlamydial inclusion in the midsection 
of the NE, rather than on the nuclear surface.  
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Figure 3.13. Phenylalanine-glycine repeat-containing nucleoporins (FG-Nups) are evenly 
distributed across the nuclear periphery in cultured HeLa cells. Fixed HeLa cells were double 
stained with mAb414 primary antibody and an AlexaFluor® 488-conjugated secondary 
antibody [green, grey (lower)] to visualise FG-Nups, and DRAQ-5 to visualise DNA [blue, grey 
(upper left)]. (A) Confocal images of a HeLa cell in the xy-plane. (B) Confocal xy-sections of the 
nucleus, ascending in the z dimension through the cell (1-16) with a step of 0.34 µm. The 
section equivalent to (A) is indicated by the red border. Scale bars, 10 µm. 
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Figure 3.14. Phenylalanine-glycine containing nucleoporins (FG-Nups) are depleted at the 
inclusion-proximal face of the nuclear envelope late during chlamydial infection. HeLa cells 
were infected with C. trachomatis LGV2, fixed and double stained with mAb414 primary 
antibody and an AlexaFluor® 488-conjugated secondary antibody (green, grey) to visualise FG-
Nups, and DRAQ-5 to visualise DNA (blue). Left panels: confocal images of infected cells in the 
xy-plane, with the inclusion (I) periphery indicated by the white dashed line (Methods 2.8). 
Right panels: confocal xy-sections of the midsection of the nuclei, ascending in the z dimension 
through the cell (1-6) with a step of 0.34 µm. Full z-stacks are available in the appendix. Red 
borders indicate the sections equivalent to the left panels. White arrows highlight areas of FG-
Nup depletion. (A) 24 hours post infection (hpi). (B) 48 hpi. (C) 72 hpi. Scale bars, 10 µm. 
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Figure 3.15. Depletion of phenylalanine-glycine containing nucleoporins (FG-Nups) occurs 
more frequently late during chlamydial infection. Histogram showing the proportion of non-
infected (white bars) or C. trachomatis LGV2 infected (black bars) HeLa cells (n=150) exhibiting 
a depletion of phenylalanine-glycine containing nucleoporins (FG-Nups) scored at each time 
point. An FG-Nup depletion was defined as a complete depletion of FG-Nups fluorescence 
intensity greater than 1 μm in both the xy and z dimensions. Error bars show standard 
deviation (**p<0.05 using Student’s t-test as indicated). 
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3.9 Specific components of NPCs are depleted during 
chlamydial infection 
 
The previous experiments demonstrated FG-Nups are depleted at the inclusion-proximal face 
of the NE in 20-25% of late-stage Chlamydia-infected cells (section 3.8). As previously 
mentioned, mAb414 recognises epitopes in FG-repeat regions of NPC proteins, of which there 
are 13 FG-repeat containing Nups. To confirm these FG-Nups are being depleted, specific 
antibodies against representative FG-Nups were selected that recognise epitopes either within 
or away from the FG-repeat region. Anti-Nup153 recognises a region in the C-terminus of 
Nup153 that contains FG-repeats and so would also be recognised by mAb414, whereas anti-
Nup62 recognises a region at the N-terminus of Nup62 that does not contain FG-repeats, and 
so would not be recognised by mAb414. Additionally, to confirm whether the depletion of FG-
Nups represents modifications to existing nuclear pores or removal of nuclear pores entirely, 
Nups from other components of the NPCs that do not have FG-repeats were observed, such as 
members of the transmembrane ring or the outer ring/Y-complex. Experiments using 
antibodies to Nups from the outer ring were unsuccessful however as labelling was non-
specific. Therefore an alternative method was undertaken, whereby mammalian expression 
constructs were used to transiently express components of the NPC in HeLa cells with 
fluorescent fusion proteins. 
Images of control cells labelled with anti-Nup153 or anti-Nup62, or cells expressing Nup37-
3xGFP (outer ring), Nup85-3xGFP (outer ring) or Pom121-3xGFP (transmembrane ring) are 
shown in Figure 3.16. Whilst Nup153, Nup62 and Pom121-3xGFP were evenly distributed 
across the midsection of the NE as expected, Nup37-3xGFP and Nup85-3xGFP localised 
incorrectly to the nucleoplasm and cytosol respectively. This was surprising as these constructs 
allowing the expression of structural Nups fused to fluorescent proteins have been shown 
previously to localise to the NE (Szymborska et al., 2013). Nevertheless, C. trachomatis LGV2 
infected HeLa cells either expressing or labelled for the correctly localised Nup proteins were 
prepared (Fig 3.17). Gaps in the localisation of Nup153, Nup62 and Pom121-3xGFP can be 
observed at 48 hpi at the inclusion-proximal face of the NE, consistent with the FG-Nup 
labelling shown previously. The absence of Nup153 and Nup62 in this region suggest it is likely 
that all FG-repeat containing nucleoporins are depleted. Additionally, proteins were examined 
from each region of the NPC. Whilst Pom121 was the only protein not containing FG repeats 
that was successfully tested, it is a key nucleoporin in anchoring nuclear pores in the nuclear 
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envelope (Funakoshi et al., 2007). Therefore, as Pom121 was also depleted at the inclusion-
proximal region of the NE, it is likely that entire nuclear pores are being removed in this region 
rather than a modification of a subset of components in existing NPCs.  
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Figure 3.16. Visualisation of individual components of the nuclear pore complexes. Cultured 
HeLa cells or HeLa cells transiently expressing Nup37-GFP, Nup85-GFP or Pom121-GFP fusion 
proteins were fixed and stained with DRAQ-5 to visualise DNA. (A) Nup62 was visualised by 
staining with anti-Nup62 primary antibody and an AlexaFluor® 488-conjugated secondary 
antibody. (B) Nup153 was visualised by staining with anti-Nup153 primary antibody and an 
AlexaFluor® 488-conjugated secondary antibody. (C) Nup37-GFP. (D) Nup85-GFP. (E) Pom121-
GFP. Left panels: confocal images of HeLa cells in the xy-plane showing NPC components 
(green) and DNA (blue). Right panels: confocal xy-sections of the midsection of the nuclei 
showing NPC components (grey), ascending in the z dimension through the cell (1-6) with a 
step of 0.34 µm. Red borders indicate the sections equivalent to the left panels. Scale bars, 10 
µm. 
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Figure 3.17. NPC components are depleted at the inclusion-proximal face of the nuclear 
envelope during chlamydial infection. Cultured HeLa cells or HeLa cells transiently expressing 
Pom121-GFP fusion protein were infected with C. trachomatis LGV2 for 48 hours, fixed and 
stained with DRAQ-5 to visualise DNA. (A) Nup62 was visualised by staining with anti-Nup62 
primary antibody and an AlexaFluor® 488-conjugated secondary antibody. (B) Nup153 was 
visualised by staining with anti-Nup153 primary antibody and an AlexaFluor® 488-conjugated 
secondary antibody. (C) Pom121-GFP. Left panels: confocal images of infected cells in the xy-
plane showing NPC components (green) and DNA (blue). The inclusion (I) periphery is indicated 
by the white dashed line (Methods 2.8). Right panels: confocal xy-sections of the midsection of 
the nuclei showing NPC components (grey), ascending in the z dimension through the cell (1-6) 
with a step of 0.34 µm. Red borders indicate the sections equivalent to the left panels. White 
arrows indicate regions of NPC component depletion. Scale bars, 10 µm. 
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3.10 Localisation of SUN proteins is unaffected during 
Chlamydia infection 
 
Given the changes in nuclear shape observed during infection, it could be hypothesised that 
the protein levels or localisation of components of the LINC complex, such as the SUN proteins, 
could be also be impacted. LINC complexes mediate the physical connection between the 
nucleus and cytosolic cytoskeleton, and are therefore key in regulating nuclear-cytoplasmic 
communication in response to, for example, external stimuli, and also regulate nuclear 
position (Martins et al., 2012). Both of the two major SUN proteins, SUN1 and SUN2, interact 
with lamin A/C (Crisp et al., 2006; Haque et al., 2006), and SUN1 has a role in determining the 
distribution of the NPCs (Liu et al., 2007). Thus, it may follow that there could be a reduction in 
either SUN protein where lamin A/C is depleted, or a loss of SUN1 at the NPC depleted region. 
Due to the lack of commercial antibodies available against SUN proteins for use in 
immunofluorescence, SUN-GFP constructs previously used to study SUN protein function were 
utilised (Padmakumar et al., 2005; Liu et al., 2007; Lu et al., 2008). HeLa cells transiently 
expressing either SUN1-GFP or SUN2-GFP were infected with C. trachomatis LGV2, fixed and 
examined by confocal microscopy (Figs 3.18 and 3.19). In control cells both SUN-GFP proteins 
localised as expected to the NE (Figs 3.18A and 3.19A). However, no changes in localisation or 
fluorescence intensity could be observed in infected cells transiently expressing either SUN 
protein, suggesting these proteins are not remodelled during C. trachomatis infection (Figs 
3.18B and 3.19B).  
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Figure 3.18 SUN1-GFP localisation is unaffected during chlamydial infection. (A) Non-infected 
(NI) or (B) 48 hour post infection (hpi) C. trachomatis LGV2 infected HeLa cells transiently 
expressing SUN1-GFP were fixed and stained with DRAQ-5 to visualise DNA. Left panels: 
confocal images of a non-infected and an infected cell in the xy-plane, showing SUN1-GFP 
(green) and DNA (blue). The inclusion (I) periphery is indicated by the white dashed line 
(Methods 2.8). Right panels: confocal xy-sections of the midsection of the nuclei showing 
SUN1-GFP (grey), ascending in the z-dimension through the cell (1-6) with a step of 0.34 µm. 
Red borders indicate the sections equivalent to the left panels. Scale bars, 10 µm. 
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Figure 3.19 SUN2-GFP localisation is unaffected during chlamydial infection. (A) Non-infected 
(NI) or (B) 48 hour post infection (hpi) C. trachomatis LGV2 infected HeLa cells transiently 
expressing SUN2-GFP were fixed and stained with DRAQ-5 to visualise DNA. Left panels: 
confocal images of a non-infected and an infected cell in the xy-plane, showing SUN2-GFP 
(green) and DNA (blue). The inclusion (I) periphery is indicated by the white dashed line 
(Methods 2.8). Right panels: confocal xy-sections of the midsection of the nuclei showing 
SUN2-GFP (grey), ascending in the z-dimension through the cell (1-6) with a step of 0.34 µm. 
Red borders indicate the sections equivalent to the left panels. Scale bars, 10 µm. 
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3.11 Nuclear envelope alterations occur more frequently in 
multi-nucleated Chlamydia infected cells 
 
The NE alterations occur with increasing frequency towards the latter stages of the Chlamydia 
lifecycle (Fig 3.9, 3.12 and 3.15). As described in chapter 1, proliferating Chlamydia-infected 
cells typically become multi-nucleated late during infection in cell culture due to a failure in 
cytokinesis at the end of the cell cycle. Whether this is a direct effect of Chlamydia infection, or 
an indirect effect caused by a large object occupying the majority of the cell remains to be 
determined (Alzhanov et al., 2009; Sun et al., 2011). Nevertheless, it is advantageous for 
Chlamydia to reside in a multi-nucleated cell. Multi-nucleated cells possess a higher Golgi 
content, allowing C. trachomatis to intercept Golgi-derived lipids faster than mono-nucleated 
cells, enhancing inclusion expansion and formation of infectious particles (Sun et al., 2016). 
Given that the NE alterations also occur more frequently late in infection when there are more 
multi-nucleated cells, it could be reasoned that there may be a relationship between multi-
nucleation and NE alteration frequency. 
The enrichment of lamin A/C and depletion of NPCs at the inclusion-proximal face of the NE 
were quantified separately in mono- and multi-nucleated cells, and the relative frequency 
compared (Fig 3.20). At both 48 and 72 hpi, lamin A/C patches and NPC gaps occurred more 
often in the multi-nucleated infected cells. At 48 hpi there was an ~1.5 fold increase in lamin 
A/C patch frequency in multi-nucleated infected cells compared to mono-nucleated infected 
cells, and an ~4 fold increase in NPC gap frequency. At 72 hpi there was an ~1.4 fold increase 
in lamin A/C patch frequency and an ~3 fold increase in NPC gap frequency. Notably, it was 
rare that more than one nucleus of a multi-nucleated infected cell had an enrichment in lamin 
A/C or depletion of NPCs, suggesting the nuclei are not identical. Taken together, these data 
indicate there is a relationship between multi-nucleation of infected cells and increased 
frequency of NE alterations.  
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Figure 3.20 Nuclear envelope alterations occur more frequently in multi-nucleated 
Chlamydia infected cells. Histograms showing the proportion of mono-nucleated (white) or 
multi-nucleated (black) C. trachomatis infected cells (n=100) exhibiting an (A) lamin A/C patch 
or (B) FG-Nup depletion, scored at each time point. Error bars show standard deviation 
(**p<0.05 using Student’s t-test as indicated). 
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3.12 Nuclear envelope alterations occur independently of host 
cell type and Chlamydia trachomatis serovar, but are 
dependent on Chlamydia species 
 
Although HeLa cells are an accepted model for the in vitro reconstitution of chlamydial 
infection, it is important to determine whether the observed NE changes occur uniquely in this 
cell line. Additionally, variations may exist between Chlamydia serovar and species. For 
example, serovars A, D and L2 have significantly different Tarp proteins. Tarp from LGV 
serovars has two actin binding domains and up to nine tyrosine-rich repeat regions, whereas 
Tarp from serovars A and D have four and three actin binding domains respectively but only 
three tyrosine-rich repeat regions (Lutter et al., 2010). More significant differences exist 
between C. trachomatis and C. muridarum, although these species share similar gene number 
and order (Read et al., 2000). One of the best characterised of these variations is the 
differential response to IFN-γ. Human genital chlamydial strains can overcome the tryptophan-
depleting effect of IFN-γ induced indoleamine 2,3-dioxygenase (IDO) expression in human 
epithelial cells by producing tryptophan synthase, whereas C. muridarum lack a functional 
tryptophan synthase (Roshick et al., 2006). Conversely in murine cells, C. muridarum can grow 
by interfering with IFN-γ-inducible p47 GTPases, whereas C. trachomatis does not (Nelson et 
al., 2005; Bernstein-Hanley et al., 2006). Thus, whether the NE alterations are Chlamydia 
species or strain dependent was also determined. 
 
Retinal pigment epithelial 1 (RPE1) cells are a non-transformed hTERT immortalised cell line. 
RPE1 cells were chosen as they are karyotypically normal yet have similar infection kinetics to 
HeLa cells (Boiko et al., 2015; Ford, 2016). Cultured RPE1 cells infected with C. trachomatis 
LGV2 were fixed and labelled with anti-lamin A/C and mAb414 (Fig 3.21). Patches of lamin A/C 
enrichment and localised depletion of FG-Nup labelling were present in the NE adjacent to the 
inclusion in cells infected for 48 hours, consistent with observations in HeLa cells infected with 
C. trachomatis LGV2. These data suggest C. trachomatis LGV2 is able to induce NE alterations 
in RPE1 cells, despite them being an ocular cell type.  
 
To investigate whether the NE alterations are specific to this species and/or serovar of 
Chlamydia, lamin A/C and NPC distribution were studied during infection with C. trachomatis 
serovar A, a trachoma causing serovar, and during infection with C. muridarum, a Chlamydia 
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species that naturally infects only mice and hamsters. In addition to other factors, the infection 
kinetics of C. trachomatis A and C. muridarum differ significantly from C. trachomatis LGV2. C. 
trachomatis A has a slower lifecycle, typically 72-96 hours, whilst C. muridarum has a faster 
lifecycle, lasting 30-42 hours (Lyons et al., 2005; Miyairi et al., 2006). Therefore, HeLa cells 
were prepared and infected with either C. trachomatis A or C. muridarum and fixed at time 
points approximately equivalent to 48 hpi during C. trachomatis LGV2 infection (72 and 30 hpi 
respectively). At 72 hpi during C. trachomatis A infection, lamin A/C patches and NPC gaps 
could be observed, which were similar in size and location to the NE alterations in cells 
infected with C. trachomatis LGV2 (Fig 3.22). However, at 30 hpi during infection with C. 
muridarum, the NE remains unchanged (Fig 3.23). Taken together, these data suggest NE 
alterations are specific to C. trachomatis but not C. muridarum, and NE alterations are not 
serovar specific. 
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Figure 3.21. Nuclear envelope alterations occur in RPE1 cells infected with C. trachomatis 
LGV2. RPE1 cells were infected with C. trachomatis LGV2, fixed at 48 hpi and double stained 
with anti-lamin A/C primary antibody and an AlexaFluor® 546-conjugated secondary [grey 
(upper left, lower left), red] to visualise lamin A/C, and mAb414 primary antibody and an 
AlexaFluor® 488-conjugated secondary [grey (upper centre, lower right), green] to visualise 
phenylalanine glycine-containing nucleoporins (FG-Nups). (A) Confocal images of an infected 
cell in the xy-plane, with the inclusion (I) periphery indicated by the white-dashed line 
(Methods 2.8). (B) and (C) Confocal xy-sections of the midsection of the nuclei showing lamin 
A/C or FG-Nups, ascending in the z dimension through the cell (1-6) with a step of 0.34 µm. 
Red borders indicate the sections equivalent to (A). White arrows highlight areas of lamin A/C 
enrichment and FG-Nup depletion. Scale bars, 10 µm. 
  
111 
 
 
 
 
Figure 3.22. Nuclear envelope alterations occur in HeLa cells infected with C. trachomatis 
serovar A. HeLa cells were infected with C. trachomatis A, fixed at 72 hpi and double stained 
with anti-lamin A/C primary antibody and an AlexaFluor® 546-conjugated secondary [grey 
(upper left, lower left), red] to visualise lamin A/C, and mAb414 primary antibody and an 
AlexaFluor® 488-conjugated secondary [grey (upper centre, lower right), green] to visualise 
phenylalanine glycine-containing nucleoporins (FG-Nups). (A) Confocal images of an infected 
cell in the xy-plane, with the inclusion (I) periphery indicated by the white-dashed line 
(Methods 2.8). (B) and (C) Confocal xy-sections of the midsection of the nuclei showing lamin 
A/C or FG-Nups, ascending in the z dimension through the cell (1-6) with a step of 0.34 µm. 
Red borders indicate the sections equivalent to (A). White arrows highlight areas of lamin A/C 
enrichment and FG-Nup depletion. Scale bars, 10 µm. 
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Figure 3.23. Nuclear envelope alterations do not occur in HeLa cells infected with C. 
muridarum. HeLa cells were infected with C. muridarum, fixed at 30 hpi and double stained 
with anti-lamin A/C primary antibody and an AlexaFluor® 546-conjugated secondary [grey 
(upper left, lower left), red] to visualise lamin A/C, and mAb414 primary antibody and an 
AlexaFluor® 488-conjugated secondary [grey (upper centre, lower right), green] to visualise 
phenylalanine glycine-containing nucleoporins (FG-Nups). (A) Confocal images of an infected 
cell in the xy-plane, with the inclusion (I) periphery indicated by the white-dashed line 
(Methods 2.8). (B) and (C) Confocal xy-sections of the midsection of the nuclei showing lamin 
A/C or FG-Nups, ascending in the z dimension through the cell (1-6) with a step of 0.34 µm. 
Red borders indicate the sections equivalent to (A). Scale bars, 10 µm. 
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3.13 Nuclear envelope alterations are independent of existing 
pore-free islands 
 
The results presented in this chapter so far have demonstrated Chlamydia trachomatis 
infection causes aberrant nuclear architecture with increased lobulation of nuclei (section 3.3). 
These changes are concurrent with alterations to the nuclear envelope, including a lamin A/C 
patch, lamin B reduction and NPC gap which are adjacent to the inclusion, and a depletion of 
lamin A/C in the NE distal from the inclusion (sections 3.5-3.8). This arrangement of nuclear 
lamina and NPCs is strikingly similar to ‘pore-free islands’ (PFIs), previously observed in 
proliferating mammalian cells by Maeshima et al (2006). PFIs are characterised by the absence 
of NPCs and the enrichment of lamin A/C at the base or top of the nucleus. The NE alterations 
observed during chlamydial infection could therefore represent a rearrangement of existing 
PFIs towards to the inclusion periphery. To investigate this, cultured HeLa cells infected with  
C. trachomatis LGV2 were fixed and labelled to visualise lamin A/C and NPCs (Fig 3.24). In 
these cells, pore-free islands at the base of the nucleus could be observed, although lamin A/C 
fluorescence in these patches appeared unchanged, likely due to the reduction in lamin A/C in 
the NL not adjacent to the inclusion membrane (Fig 3.24A). In these same cells, both lamin A/C 
patches and NPC gaps could still be observed in the midsection of the nuclei adjacent to the 
inclusion (Fig 3.24A). To confirm this observation, the frequency of PFIs in non-infected cells 
versus infected cells was quantified and found to be similar (Fig 3.24B). These data suggest the 
Chlamydia-related NE alterations are not a rearrangement of existing PFIs, but instead co-exist 
with cellular PFIs. 
 
Maeshima et al (2006) also noted that PFIs are characterised by enrichment in emerin, a 
lamina-associated inner nuclear membrane protein, and excluded from the ER that normally 
surrounds the nucleus (Maeshima et al., 2006). Interestingly, emerin was also identified as 
potentially interacting with SINC, the C. psittaci type III effector, although no homologous 
effectors have been identified in C. trachomatis (Mojica et al., 2015). Therefore, to verify the 
extent to which the Chlamydia-related NE alterations are reminiscent of PFIs, the localisation 
of emerin and an ER resident protein, protein disulphide isomerase (PDI) (Luz and Lennarz, 
1996), was observed during chlamydial infection. HeLa cells were infected with C. trachomatis 
LGV2, fixed at 48 hpi and labelled for emerin or PDI. For emerin, labelling was evenly 
distributed across the base of nuclei in both non-infected and infected cells, in apparent 
contrast to the observations reported by Maeshima et al. (2006), and evenly distributed across 
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the central z-sections of the nuclei (Fig 3.25). As emerin was not enriched at the base of the 
nuclei as expected, it is not possible to conclude whether the Chlamydia-related NE alterations 
are similar or distinct from the PFIs in this aspect. For PDI, labelling was absent in the cytosol 
around the base of the nucleus in non-infected cells, similar to NPCs, but is present around the 
nucleus in the central z-sections, consistent with the pore-free island phenotype (Fig 3.26A). In 
infected cells this localisation was repeated, with PDI again absent in the cytosol around the 
base of the nuclei and present in the central z-sections proximal to the inclusion (Fig 3.26B). 
This suggests that the Chlamydia-related NE alterations not only coexist with the PFIs, but are 
also phenotypically distinct from the existing PFIs. 
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Figure 3.24. Nuclear envelope alterations which form during chlamydial infection are 
independent of existing pore-free islands. HeLa cells were infected with C. trachomatis LGV2, 
fixed at 48 hours post infection and double stained with anti-lamin A/C primary antibody and 
an AlexaFluor® 546-conjugated secondary (red) to visualise lamin A/C, and mAb414 primary 
antibody and an AlexaFluor® 488-conjugated secondary (green) to visualise phenylalanine 
glycine-containing nucleoporins (FG-Nups). (A) Left: confocal xy-section at the base of the cell, 
with the inclusion (I) periphery indicated by the white-dashed line (Methods 2.8) and pore-free 
islands in the nuclei indicated by yellow arrows. Right: confocal xy-section of the midsection of 
the same cell, with NE alterations indicated by the white arrows. Scale bars, 10 µm. (B) 
Histogram of the frequency of pore-free islands scored in infected cells and compared relative 
to non-infected cells at the same time point (n=100). Error bars show standard deviation. 
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Fig 3.25 Pore-free island associated emerin changes could not be observed in non-infected or 
Chlamydia-infected HeLa cells. (A) Non-infected or (B) HeLa cells infected with C. trachomatis 
LGV2 for 48 hours were fixed and stained with an anti-emerin antibody and an AlexaFluor® 
488-conjugated secondary (grey) to visualise emerin. Left panels: confocal xy-sections at the 
base of the cells. Right panels: confocal xy-sections of the midsection of the same cells. Scale 
bars, 10 µm. 
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Fig 3.26 Pore-free island associated endoplasmic reticulum (ER) changes do not occur 
proximal to the inclusion in Chlamydia-infected HeLa cells. (A) Non-infected or (B) HeLa cells 
infected with C. trachomatis LGV2 for 48 hours were fixed and stained with an anti-protein 
disulphide isomerase (PDI) antibody and an AlexaFluor® 488-conjugated secondary (grey) to 
visualise the ER. Left panels: confocal xy-sections at the base of the cells, with regions of PDI 
exclusion indicated by yellow arrows. Right panels: confocal xy-sections of the midsection of 
the same cells. Scale bars, 10 µm. 
 
119 
 
3.14 Discussion 
 
The data presented in this chapter establish a novel link between Chlamydia infection and 
nuclear architecture. Nuclear lobulation is increased at all stages of infection (Fig 3.2), and 
nuclear envelope changes occur with increasing frequency late during infection. These changes 
include an apparent enrichment in lamin A/C on the face of the NE close to the inclusion, 
termed a ‘lamin A/C patch’, with depletion in lamin A/C elsewhere in the NE (Figs 3.7-3.10). 
Additionally, a reduction in lamin B (Fig 3.11) and depletion of NPCs (or ‘NPC gap’) (Fig 3.14) is 
observed at the inclusion-proximal face of the NE with no disruption around the remainder of 
the NE. These changes coexist with and are independent of existing cellular pore-free islands 
(Figs 3.24 and 3.26), and occur in C. trachomatis but not C. muridarum (Fig 3.23).  
 
Based on the frequency of occurrence, the lamin A/C patches appear to be more predominant 
than the lamin B reduction and NPC gap. Precedent exists for lamin A/C changes driving 
further alterations to the NE, such as in a subset of genetic diseases termed laminopathies. In 
the case of HGPS, a mutation in the prelamin A/C gene LMNA induces activation of a cryptic 
splice site, deleting 150 nucleotides at exon 11 and resulting in the production of a modified 
lamin A protein with a 50 amino acid deletion near the C terminus, termed LAΔ50 or progerin 
(Eriksson et al., 2003). Progerin incorporates into the NL, leading to the formation of a thicker 
and more stable lamin A/C network in HGPS cells, which, over time, results in increased 
lobulation of nuclei. Within these lobulated regions, lamin B is depleted and NPCs cluster, 
resulting in large areas of the NE depleted of NPCs (Goldman et al., 2004). These changes in 
the NE are remarkably similar to the alterations observed during infection with C. trachomatis. 
However, they differ in the positioning around the nuclear periphery. The lamin A/C patch, 
lamin B reduction and NPC gap occur proximal to the inclusion where the NE is uniform, away 
from the regions of lobulation on the inclusion-distal face of the NE where lamin A/C is 
depleted. Conversely, the changes to lamin B and NPCs in progeria cells occur within the 
lobulated regions, suggesting the underlying mechanisms are distinct (Goldman et al., 2004). 
The link between accumulation of lamin A/C and changes to other NE components is further 
supported by a cellular structure termed pore-free islands. PFIs are present on the nuclear 
surface of proliferating cells and are characterised by an area enriched in lamin A/C and 
depleted in lamin B and NPCs (Maeshima et al., 2006). It is therefore highly likely that the 
lamin A/C patch, lamin B reduction and NPC gap observed during chlamydial infection are 
inter-related, and this relationship will be explored in chapter 4. 
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At this stage, it is difficult to speculate on the mechanism by which infection with Chlamydia 
results in NE changes proximal to the inclusion. Given the similarities to previously observed 
cellular structures, it could be hypothesised that the lamin A/C patch is a host response to 
chlamydial infection rather than being driven by the pathogen. For example, the host nucleus 
could be strengthened in this region against the pressure of the expanding inclusion. However, 
a lamin A/C patch is not formed during C. muridarum infection, where the inclusion similarly 
distorts nuclear shape. Whilst it is necessary to examine the NE changes during C. muridarum 
infection of murine cells such as mouse embryonic fibroblasts (MEFs) to determine whether an 
atypical host cell type has any impact, these data suggest that bacterial factors present in  
C. trachomatis infection and not C. muridarum are required. Although the identity of bacterial 
factors is unknown, there is some evidence of a link between the NE alterations and cell 
division. Experiments showed the NE modifications occurred more frequently in multi-
nucleated infected cells than in mono-nucleated infected cells, with a 1.5 fold increase in 
occurrence of the lamin A/C patch and a 3-4 fold increase in NPC gaps (Fig 3.19). This suggests 
that the NE alterations may be more prevalent following abortive cell division. During mitosis, 
the nuclear envelope breaks down and is reassembled, and as such represents an opportunity 
for Chlamydia to manipulate nuclear architecture with minimal energy, rather than during 
interphase where the NL is highly stable (Broers et al., 1999). Further evidence as to how the 
lamin A/C patch is formed lay in its positioning close to the inclusion. Transmission electron 
microscopy experiments revealed a relatively constant distance of ~160 nm is maintained 
between the NE and IM. This constant spacing between the IM and NE suggest there may be 
as yet unknown complexes bridging the gap. 
 
In addition to the lamin A/C patch proximal to the inclusion, lamin A/C is also depleted from 
the remainder of the NL late during infection. This observation raises the possibility of an 
alternate model for the formation of the lamin A/C patch, where Chlamydia selectively 
destructs lamin A/C distal to the inclusion rather than stabilising or enriching lamin A/C 
proximal to the inclusion. Intriguingly, nuclear shape becomes more lobulated in the region of 
lamin A/C depletion.  In granulocytes, increased lobulation correlates with reduced lamin A/C 
and lamin B levels (Olins et al., 2001), however lamin B levels remained constant in the region 
of lamin A/C depletion. Additionally, the increased lobulation of nuclei during chlamydial 
infection occurs as early as 24 hpi, whilst NE changes such as the lamin A/C patch, NPC gap and 
reduction in lamin A/C levels, do not occur until 48 hpi. Therefore, changes to nuclear shape 
precede NE alterations and so may, initially, be induced by other factors. Nuclear shape can be 
influenced by cytoskeletal forces transmitted through the LINC complexes (Maniotis et al., 
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1997; Olins and Olins, 2004). During chlamydial infection, the cytosolic cytoskeleton is 
extensively remodelled, with Inc proteins such as IPAM hijacking host microtubule organising 
activity to form a microtubule cage and nest that surrounds the inclusion (Dumoux et al., 
2015), and F-actin and the intermediate filament vimentin forming a network to encase the 
inclusion in association with the Inc protein InaC (Kumar and Valdivia, 2008; Kokes et al., 
2015). These changes to the host cytoskeleton may therefore influence nuclear shape, 
resulting in the increased lobulation of nuclei observed during chlamydial infection. 
 
Cytoskeletal forces can also result in remodelling of chromatin with effects on gene expression 
in a process termed mechanotransduction (Dahl et al., 2008). These forces are transmitted 
through the LINC complexes to the NL (Lombardi and Lammerding, 2011). The localisation of 
the SUN proteins, components of the LINC complex in the inner nuclear membrane, was not 
altered during chlamydial infection (Figs 3.18 and 3.19). However, the levels of NL proteins 
were modified, with a depletion of lamin A/C from the inclusion-distal face of the NE, and 
enrichment of lamin A/C and reduction of lamin B in the NE proximal to the inclusion. Thus, 
the cellular response to forces upon the nucleus, such as pressure exerted by the expanding 
inclusion, could be altered. For example, expression of the mechanosensitive genes egr-1 and 
iex-1 in response to mechanical strain in cells lacking lamin A/C is impaired (Lammerding et al., 
2004). Functionally, the nuclear lamina is also important in the organisation and tethering of 
chromatin at the nuclear periphery via lamina associated domains (LADs) (Guelen et al., 2008). 
By constructing a patch of highly enriched lamin A/C whilst depleting lamin A/C elsewhere, 
infection with C. trachomatis could be resulting in a zone to enable manipulation of chromatin, 
and therefore gene expression and cellular processes. 
 
Finally, the NPCs are depleted at the inclusion-proximal face of the NE (Fig 3.14). The primary 
function of the NPCs it to mediate the bidirectional transport of proteins between the cytosol 
and the nucleus, and to mediate export of mRNA. Nucleocytoplasmic transport may therefore 
be inhibited during chlamydial infection in the region of the NPC gap. Additionally, NPCs, like 
the nuclear lamins, are important in chromatin positioning at the nuclear periphery. Nuclear 
basket proteins such as Tpr form ‘chromatin boundaries’ to prevent the spread of 
heterochromatin gene silencing, and tether genes at the nuclear periphery for rapid 
reactivation (Shinkura and Forrester, 2002; Tan-Wong et al., 2009; Krull et al., 2010). Nuclear 
basket proteins also interact with the DNA repair machinery, which is of particular interest as 
C. trachomatis infection impairs the DNA damage response (Chumduri et al., 2013), and so 
depletion of NPCs may contribute to the malignant transformation of cells. 
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Chapter 4 – Determining the functional impact of 
modifications to the host nuclear envelope during 
infection with C. trachomatis 
 
4.1 Introduction 
 
The data presented in chapter 3 demonstrate that Chlamydia infection results in a number of 
alterations to nuclear architecture, including increased lobulation of the nucleus on the 
inclusion-distal face of the NE (Fig 3.2), enrichment in lamin A/C (termed a lamin A/C patch) at 
the inclusion-proximal face of the NE with depletion in the remainder of the NL (Figs 3.7-3.10), 
and an associated reduction in lamin B (Figs 3.11 and 3.12) and depletion of NPCs (termed an 
NPC gap) (Figs 3.14-3.15 and 3.17).  
 
At this stage it is unclear whether these NE changes are directly induced by Chlamydia via the 
expression of virulence factors, or represent a host response to the presence of an exogenous 
compartment applying pressure to and distorting the host nucleus or nuclei. The NE changes 
occur in C. trachomatis but not C. muridarum (Fig 3.23), and during the infection cycle of both 
of these species the inclusion expands sufficiently to distort nuclear shape, suggesting the NE 
alterations are a C. trachomatis induced effect rather than a host response. However, further 
studies are required to confirm this conclusion, and so experiments will be conducted in this 
chapter to decipher more details about the mechanism by which the NE modifications occur. 
 
The functional consequences of the NE changes for both the host and the bacteria are 
unknown. Although a number of pathogens, including Chlamydia, secrete effectors targeted to 
the nucleus (as discussed in 1.1.6.4), to date no other bacterial pathogens are known to 
specifically manipulate the composition of the NE. NPCs are essential for the specific transport 
of proteins between the nucleoplasm and the cytosol, and for the nuclear export of mRNA 
(Görlich and Kutay, 1999). Depletion of pores may therefore impact upon these processes on a 
local or global level. Experiments will therefore be undertaken in this chapter to investigate 
the impact of NPC depletion on protein transport and mRNA distribution in infected cells. 
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Additionally, the nuclear basket of NPCs is necessary for the formation of chromatin 
boundaries to prevent the spread of heterochromatin and tether highly expressed genes at the 
nuclear periphery for efficient mRNA export (Krull et al., 2010). Thus, chromatin organisation 
at the nuclear periphery may be impacted by depletion of NPCs. The NL and nuclear shape are 
also important for the regulation of chromatin organisation in the nucleus (Iyer et al., 2012; 
Zullo et al., 2012). Nuclear shape can be influenced by the composition of the NL as increased 
lobulation of the nuclei of neutrophils is accompanied by a reduction in lamin A/C and lamin B 
levels (Olins et al., 2001), and by cytoskeletal forces as microtubule depolymerisation reduces 
nuclear lobulation (Olins and Olins, 2004). Nuclear shape is inherently important in chromatin 
organisation due to the distribution of chromatin within chromosome territories, which allow 
the genome to be spatially organised within the interphase nucleus and active and inactive 
regions of the genome to be compartmentalised (Cremer and Cremer, 2010). Alterations to 
nuclear shape are therefore hypothesised to disrupt the distribution of chromosome 
territories and so impact the regulation of gene expression (Webster et al., 2009). The 
connection between the NL and chromatin positioning is better defined. Lamins tether 
chromatin to the nucleoplasmic face of the NE in the tightly packed heterochromatin form that 
associates with transmembrane proteins in the inner nuclear membrane such as emerin 
(Guelen et al., 2008; Amendola and van Steensel, 2014). Thus, the simultaneous enrichment of 
lamin A/C at the inclusion-proximal face of the NE and depletion of lamin A/C from the 
remainder of the NL may have a profound impact on chromatin organisation within the 
nucleus. Experiments to investigate whether chromatin organisation is altered during 
Chlamydia infection as a result of the NPC depletion, change in NL distribution and increased 
lobulation of the nucleus will therefore be conducted in this chapter. 
 
4.2 Nuclear envelope alterations are independent of the size of 
the inclusion and require bacterial factors 
 
The NE alterations occur more frequently towards the latter stages of the chlamydial life cycle 
(Figs 3.9, 3.12 and 3.15), when the inclusion is large and occupies the majority of the host 
cytosol. Conversely, early during infection when the inclusion is small, NE alterations do not 
occur (Figs 3.9, 3.12 and 3.15). It is therefore possible to conclude that the physical pressure of 
the inclusion on the nucleus induces a host-mediated reorganisation of lamin A/C towards the 
inclusion to strengthen this face of the nucleus against further distortion. 
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If NE alterations are related to physical pressure, one might expect a larger inclusion to cause a 
proportional increase in the size of lamin A/C patches and NPC gaps. To investigate this 
hypothesis, lamin A/C patch and NPC gap size was first measured in relation to inclusion size 
(Fig 4.1). The size of lamin A/C patches and NPC gaps were approximated as rectangles by 
measuring the longest distance in the xy dimension and multiplying by the length in the z 
dimension. Inclusion size was estimated by the average of two perpendicular measurements of 
diameter. The results showed the lamin A/C patches were significantly larger than the NPC 
gaps, at an average of 72.8 μm2 compared to 19.1 μm2 (Fig 4.1C). For both lamin A/C patches 
and NPC gaps, there was no correlation with corresponding inclusion diameter. Thus a larger 
inclusion was not associated with larger lamin A/C patches and NPC gaps, suggesting that it is 
unlikely the physical pressure exerted by the inclusion on the nucleus induces NE alterations 
(Fig 4.1A and B).  
 
To further confirm that physical pressure alone is insufficient to cause NE alterations, 
experiments to simulate the inclusion size and nuclear distortion without the presence of 
bacterial factors were conducted. This approach was used by Sun et al (2011) to investigate 
multi-nucleation of cells following Chlamydia infection. The authors used CHO-IIA cells 
expressing an Fcγ receptor to ingest large polystyrene beads of a similar size to the Chlamydia 
inclusion, and showed that bacterial factors were not required to form multi-nucleated cells. 
For the experiments presented in this thesis, THP-1 macrophages were used to ingest 
polystyrene beads of a similar size to C. trachomatis LGV2 inclusions at 48 hpi. Polystyrene 
beads approximately 15 μm in diameter were opsonised with human AB+ serum for one hour 
at 37°C. Beads were then incubated with THP-1 macrophages for 48 hours to allow ingestion 
and distortion of the nucleus, before fixation and labelling to visualise lamin A/C or NPCs (Fig 
4.2A and B). Although the nuclei in bead-containing cells were clearly deformed to the 
crescent-like shape observed in Chlamydia-infected cells, no lamin A/C patches or NPC gaps 
were present. To confirm NE alterations still occur in this cell line, THP-1 macrophages were 
infected with C. trachomatis LGV2 for 48 hours, a time point when inclusions are similar in size 
to inclusions in HeLa cells at 48 hpi, before fixation and labelling for lamin A/C or NPCs (Fig 
4.2C and D). As in HeLa cells, lamin A/C patches and NPC gaps were present in the central z-
sections, or midsection, of the nucleus proximal to the IM. Quantification of the frequency of 
NPC gaps in infected THP-1 cells and THP-1 cells that have ingested polystyrene beads 
conclusively demonstrated that C. trachomatis infection is required for induction of NPC gaps 
(Fig 4.3). It can therefore be concluded that NE alterations are not exclusively associated with 
physical pressure and that bacterial factors are required. 
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Figure 4.1. The dimensions of the lamin A/C patch and NPC gap are independent of the size 
of the inclusion. HeLa cells infected with C. trachomatis LGV2 for 48 (white) or 72 hours (grey) 
were fixed and stained with anti-lamin A/C primary antibody and an AlexaFluor® 488-
conjugated secondary antibody to visualise lamin A/C, or mAb414 primary antibody and an 
AlexaFluor® 488-conjugated secondary antibody to visualise NPCs. The dimensions of the 
lamin A/C patch and NPC gap were approximated by measuring the longest distance in the xy 
dimension and multiplying by the length in the z dimension. The inclusion size was estimated 
by averaging two perpendicular measurements of diameter. (A) Lamin A/C patch area versus 
inclusion diameter. (B) NPC gap area versus inclusion diameter. (C) Lamin A/C patch (red) and 
NPC gap (green) versus inclusion diameter. 
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Figure 4.2. Chlamydial factors are required for nuclear envelope modifications. THP-1 cells 
were incubated with human A/B serum opsonised polystyrene beads (A, B) or infected with  
C. trachomatis LGV2 for 48 hours (C, D) prior to fixation. Cells were then double stained with 
DRAQ-5 to visualise DNA (blue), and mAb414 primary antibody and an AlexaFluor® 488-
conjugated secondary antibody (green) to visualise NPCs or anti-lamin A/C primary antibody 
and an AlexaFluor® 488-conjugated secondary antibody (red) to visualise lamin A/C. Left 
panels: confocal images of infected cells in the xy-plane, with the inclusion (I) periphery 
indicated by the white dashed line (Methods 2.8). Right panels: confocal xy-sections of the 
midsection of the nuclei, ascending in the z dimension through the cell (1-6) with a step of 
0.34 µm. (A, B) THP-1 cells with ingested polystyrene beads visualised by differential 
interference contrast (grey). (C, D) C. trachomatis LGV2-infected THP-1 cells. White arrows 
highlight areas lamin A/C enrichment or NPC depletion. Scale bars, 10 µm. 
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Figure 4.3. Chlamydial factors are essential for depletion of phenylalanine-glycine containing 
nucleoporins (FG-Nups). Non-infected (NI), C. trachomatis LGV2 infected (24, 48, 72 hours 
post infection) and polystyrene bead engulfing (Beads) THP-1 cells were fixed and stained with 
mAb414 primary antibody and an AlexaFluor® 488-conjugated secondary antibody to visualise 
NPCs. The frequency of the FG-Nup depletion, defined as a complete depletion of FG-Nups 
fluorescence intensity greater than 1 μm in both the xy and z dimensions, was scored as a 
proportion of total cells (n=100) for each time point or condition. Error bars show standard 
deviation (**p<0.05 using Student’s t-test between NI and indicated). 
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4.3 Chlamydia-induced nuclear envelope modifications require 
a viable bacterial infection 
 
The experiments presented previously demonstrated that nuclear envelope alterations are not 
induced by physical pressure distorting nuclear shape and require bacterial factors to be 
present in the host cell (section 4.2). Two scenarios therefore remain, that NE changes are a 
host response to Chlamydia, or that chlamydial effectors induce NE changes directly or 
indirectly. Penicillin G (pG) is a β-lactam antibiotic that causes RBs to become much larger (5-
10 μm) and aberrant in morphology. These ‘pG-forms’ are unable to recover following 
withdrawal of pG and no longer express pre-16S rRNA, a marker of bacterial viability (Dumoux 
et al., 2013). However, the inclusion continues to expand as lysosomal compartments 
penetrate the inclusion to fuse with bacteria, so maintaining contact between the IM and NE 
and distortion of nuclear shape. Thus, pG was used as a tool to kill the bacteria at different 
stages of infection without clearing the bacteria from the cell, so maintaining the presence of 
bacterial factors that may stimulate a host response whilst inhibiting the expression of 
Chlamydia effectors. 
 
HeLa cells were infected with C. trachomatis LGV2 for 48 or 72 hours before fixation, with pG 
added at 3, 24 or 48 hpi. Fixed cells were labelled for lamin A/C or NPCs (Fig 4.4A and B). As 
expected, bacteria became significantly larger and aberrant in treated cells, consistent with 
previous observations in the literature (Johnson and Hobson, 1977; Skilton et al., 2009; 
Dumoux et al., 2013). The frequency of the lamin A/C patch and NPC gap was quantified at 
each time point (Fig 4.4C and D) using parameters described previously (Methods 2.8.3). When 
pG was added at 3 hpi, a time point established in the literature to effectively kill the bacteria 
(Dumoux et al., 2013), the frequency of lamin A/C patch formation was dramatically reduced 
compared to non-treated infected cells to 14.2 ± 4.0% at 48 hpi and 12.5 ± 1.0% at 72 hpi, a 
3.7- and 5.8-fold reduction respectively. Simultaneously, the frequency of NPC gap formation 
was reduced to levels close to that observed in non-infected cells, to just 3.8 ± 0.9% at 48 hpi 
and 4.7 ± 1.6% at 72 hpi, a 5.6 and 5.3-fold reduction respectively. pG was also added at 24 
hpi, prior to NPC gap formation and when lamin A/C changes occur rarely, and at 48 hpi, when 
nuclear envelope changes have already occurred. When treated at 24 hpi, NE changes were 
again reduced compared to non-treated infected cells although not as significantly as when 
treated at 3 hpi. Lamin A/C patch frequency was reduced by 3.1- and 5.1-fold at 48 and 72 hpi, 
and NPC gap frequency was reduced by 2.7- and 3.2-fold. Treatment at 48 hpi had the smallest 
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effect, with lamin A/C patch and NPC gap frequency reduced by 1.7- and 1.5-fold respectively. 
In summary, there was a greater reduction in frequency when pG was added prior to 
occurrence of lamin A/C patches and NPC gaps, suggesting viable bacteria, and so chlamydial 
effectors, are required. Additionally, as there was little difference between treatment at 3 hpi 
and 24 hpi, it can be concluded that the effector or effectors required are secreted later during 
infection, after 24 hpi. As the frequency of lamin A/C patches and NPC gaps was not reduced 
to control levels, it is likely the antibiotic is not maximally efficient at killing the bacteria. There 
was a small but significant reduction in frequency when pG was added following the formation 
of lamin A/C patches and NPC gaps at 48 hpi, suggesting that constant release of an effector or 
effectors is required to maintain the NE changes. 
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Figure 4.4. Nuclear envelope changes require an active chlamydial infection. HeLa cells were 
infected with C. trachomatis LGV2 and treated with 10U/ml penicillin G (pG) at 3, 24 or 48 
hours post infection (hpi) prior to fixation at 48 or 72 hpi. Fixed cells were then double stained 
with DRAQ-5 to visualise DNA (grey), and mAb414 primary antibody and an AlexaFluor® 488-
conjugated secondary antibody (green) to visualise NPCs or anti-lamin A/C primary antibody 
and an AlexaFluor® 488-conjugated secondary antibody (red) to visualise lamin A/C. (A, B) 
Chlamydia-infected cells treated with pG at 24 hpi and fixed at 48 hpi. The inclusion (I) 
periphery is indicated by the white dashed line (Methods 2.8). (C) Lamin A/C patch or (D) NPC 
gap frequency was quantified (Methods 2.8.3) in untreated (-) cells or cells treated with pG, 
with non-infected (NI) cells used as a control. Error bars show standard deviation (**p<0.05 
using Student’s t-test between NI and indicated). 
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4.4 Nuclear envelope damage is repaired after bacterial 
clearance 
 
As demonstrated, treatment of Chlamydia-infected cells with pG antibiotics reduced the 
frequency of NE modifications (section 4.3). However, the frequency of the lamin A/C patches 
and NPC gaps did not return to levels present in non-infected cells. This suggests there may be 
permanent damage to the NE in infected cells. Chlamydia has been linked to cancer; both 
epidemiologically by a positive association with HPV-linked cervical cancers (Silva et al., 2014), 
and at a molecular level by perturbing chromatin, DNA double-strand break repair and cell 
cycle regulation (Introduction 1.1.6.4) (Chumduri et al., 2013; Padberg et al., 2013; González et 
al., 2014). If the NE changes are permanent it may represent a novel molecular mechanism by 
which Chlamydia is associated with cellular transformation. Indeed, studies have identified an 
association between both increased and decreased expression of lamin A/C in different cancer 
types (Wu et al., 2009; Kong et al., 2012; Bell and Lammerding, 2016).  
 
One approach to studying whether NE damage is permanent would be to kill the bacteria late 
during infection and observe the frequency of NE alterations. However, pG treatment, while 
effectively killing the bacteria, does not immediately clear the large inclusion and aberrant 
bodies from the cell (Dumoux et al., 2013), and other antibiotics such as chloramphenicol or 
doxycycline do not function effectively late in infection when the majority of RBs have re-
differentiated into EBs, and so would only be effective in subsequent infection cycles. Thus an 
alternative approach was required to clear the bacteria from the host cell. Nigericin is a 
potassium ionophore used in the Hayward laboratory by Andrew (2014) to investigate the role 
of potassium ions in Chlamydia development. An interesting unpublished observation was that 
nigericin, when added to late-stage Chlamydia infected cells, induced the ejection of 
inclusions, and so nigericin could potentially be applied as a tool to investigate NE 
modifications after the clearance of the inclusion from the previously infected cells. To confirm 
the efficiency of treatment, HeLa cells were infected with C. trachomatis for 48 hours prior to 
treatment with nigericin, and the proportion of infected cells compared to untreated infected 
cells fixed at the same time to determine the rate of inclusion clearance (Fig 4.5A). Inclusion 
clearance was progressive over time, with 18.7 ± 1.9% of inclusions cleared after 1 hour of 
treatment and 100% cleared after 48 hours. 
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To measure the effect of inclusion clearance on NE modifications, NPC gap frequency was 
scored. The frequency of NPC gaps was quantified in cells without inclusions (n=300) in 
duplicate (Fig 4.5B). A small but significant increase in NPC gap frequency from 1.4 ± 0.1% in 
the untreated population of cells to 4.2 ± 0.5% was initially observed after 6 hours of 
treatment, where 39.4% of inclusions had been cleared. The increase in NPC gap frequency 
remained stable from 6 to 24 hours after treatment, by which point 90.9% of inclusions had 
been cleared, and then declined to 1.5 ± 0.2% after 48 hours of treatment. There was 
therefore a short period of time where the NPC gap remained following clearance of 
inclusions, but NPC gap frequency then returned to levels observed in populations of cells that 
have never been infected. Thus, these data indicate the aberrant NPC distribution in infected 
cells returns to normal following inclusion clearance, and suggests there is no significant legacy 
of damage to NE composition following Chlamydia infection. 
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Figure 4.5 NPC gaps repair following nigericin-induced inclusion clearance. HeLa cells 
infected with C. trachomatis LGV2 were incubated with 1 µM nigericin at 48 hours post 
infection for 1, 6, 24 or 48 hours prior to fixation. Cells were then tripled stained with mAb414 
primary antibody and an AlexaFluor® 488-conjugated secondary antibody to visualise NPCs, 
anti-Chlamydia primary antibody and an AlexaFluor® 546-conjugated secondary antibody (red) 
to visualise infected cells, and DRAQ-5 to visualise DNA. (A) The number of inclusions and 
nuclei were scored across 5 fields of view (totalling minimally 400 nuclei) in duplicate in 
nigericin-treated infected cells and compared to non-treated infected cells to determine the 
percentage of inclusion clearance following treatment. (B) The frequency of NPC gaps was 
quantified in cells without inclusions across 5 fields of view (totalling minimally 400 nuclei) in 
duplicate in non-treated (NT) and nigericin-treated populations of infected cells. Error bars 
show standard deviation (**p<0.05 using Student’s t-test between (A) 24 and indicated or (B) 
NT and indicated). 
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4.5 Host nucleocytoplasmic transport does not occur proximal 
to the inclusion membrane 
 
The experiments presented in this chapter thus far have demonstrated that the modifications 
to the NE observed during infection with C. trachomatis are induced and maintained by 
bacterial effectors. However, the functional consequences of these NE changes were not 
investigated. Nuclear pore complexes mediate selective transport between the nucleus and 
the cytosol (Fried and Kutay, 2003). In chapter 3, it was shown that NPCs are depleted from 
the NE proximal to the IM (Figs 3.14 and 3.17). However, attempts to visualise the structural 
components of the pores were unsuccessful (Fig 3.16), although Pom121, a transmembrane 
Nup required for NPC assembly, was depleted (Stavru et al., 2006). Nevertheless, it is possible 
that the core scaffold of the NPCs is still present in these regions without the nuclear basket, 
central pore and cytoplasmic filaments, essentially forming a partial non-selective pore 
through which Chlamydia could efficiently target effectors into the nucleus. For molecules 
greater than 30-40 kDa in size, transport through the pore requires binding to a nuclear 
transport receptor such as importin-β, which shuttles between the nucleus and cytosol. The 
localisation of importin-β can therefore be analysed to determine whether nucleocytoplasmic 
transport occurs in the NE proximal to the inclusion, and so confirm whether pores are 
depleted in this region. 
 
Ex-vivo approaches to study nucleocytoplasmic transport have used purified importin-β in 
conjunction with RanGDP and an energy regenerating system added to permeabilised cells to 
study nucleocytoplasmic transport at the NE (Lowe et al., 2015). In this study, Lowe et al. 
(2015) demonstrated importin-β accumulates at NPCs and traverses the pore in a Ran-
dependent manner. To be able to study a subpopulation of transporter, a photo-convertible 
fluorescent protein such as mEos2, is used to visualise the protein of interest, importin-β 
(Lowe et al., 2015). Using this approach, the presence of nucleocytoplasmic transport (and so 
presence of NPCs) across the region of the NPC gap can be determined. 
 
To study nucleocytoplasmic transport during chlamydial infection, the mEos2-importin-β assay 
was first reconstituted in cultured HeLa cells. Cells were cultured for 24 hours prior to semi-
permeabilisation with digitonin, incubated with purified mEos2-importin-β and DRAQ-5 to 
stain DNA, and imaged live (Fig 4.6A). As expected (Lowe et al., 2015), mEos2-importin-β 
accumulated at the NE where it shuttles through the NPCs. The system was then transposed to 
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cells infected with C. trachomatis LGV2 for 48 hours (Fig 4.6B). Unexpectedly, mEos2-importin-
β could not be introduced into infected cells, although present in neighbouring non-infected 
cells, indicating the infected cells were apparently not permeabilised by digitonin. Whilst not 
the focus of this thesis, and frustrating for the analysis of nuclear transport in infected cells, 
these data are intriguing. Digitonin permeabilises cell membranes by complexing with and 
precipitating cholesterol (Schulz, 1990), and therefore the resistance of Chlamydia-infected 
cells to digitonin-permeabilisation could indicate the cholesterol content of the plasma 
membrane has been dramatically altered. 
 
As the permeabilisation method was unsuccessful, an alternative approach was adopted. A 
mammalian expression vector was engineered to express an mEos2-importin-β fusion protein 
(Methods 2.4). The vector was first tested by transiently transfecting cultured HeLa cells, fixing 
and staining DNA with DRAQ-5. mEos2-importin-β was distributed around the NE in a punctate 
distribution (Fig 4.7A), similar to distribution of purified mEos2-importin-β in permeabilised 
cells (Fig 4.6A). HeLa cells were then transfected with the mEos2-importin-β vector prior to 
infection with C. trachomatis LGV2 and fixation. At 48 hpi, when NE changes occur, a localised 
and striking depletion of mEos2-importin-β occurs at the inclusion-proximal face of the NE (Fig 
4.7B). The location and size of the zone of mEos2-importin-β depletion is consistent with the 
depletion of NPCs described previously. These data suggest host nucleocytoplasmic transport 
is absent proximal to the inclusion, and further suggests that NPCs are not modified, but 
entirely absent. 
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Figure 4.6 Chlamydia-infected cells are resistant to digitonin-permeabilisation. HeLa cells at 
48 hours post infection (hpi) with C. trachomatis LGV2 were semi-permeabilised with digitonin, 
incubated with mEos2-importin-β (green) and stained with DRAQ-5 to visualise DNA (grey, 
blue) for live imaging. (A) Confocal images of non-infected cells in the xy-plane. (B) Confocal 
images of Chlamydia-infected cells in the xy-plane, with the inclusion (I) periphery indicated by 
the white dashed line (Methods 2.8). 
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Figure 4.7. Transiently expressed importin-β is depleted at the inclusion-proximal face of the 
nuclear envelope during Chlamydia infection. HeLa cells transiently expressing mEos2-
importin-β (green, grey) were infected with C. trachomatis LGV2, fixed and stained with DRAQ-
5 to visualise DNA (blue). Left panels: confocal images of cells in the xy-plane, with the 
inclusion (I) periphery indicated by the white dashed line (Methods 2.8). Right panels: confocal 
xy-sections of the midsection of the nuclei, ascending in the z dimension through the cell (1-6) 
with a step of 0.34 µm. Red borders indicate the sections equivalent to the left panels. White 
arrows highlight areas of importin-β depletion. (A) Non-infected (NI) (B) 48 hours post 
infection (hpi). Scale bars, 10 µm.  
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4.6 Distribution of host nuclear messenger RNA appears 
unaffected during Chlamydia infection 
 
In addition to mediating protein transport between the cytosol and the nucleus, NPCs are the 
conduit for the export of messenger RNA (mRNA) from the nucleus to the cytosol. The export 
of host mRNA is blocked during certain viral infections (Castelló et al., 2009; Kuss et al., 2013). 
For example, expression of poliovirus 2A protease in host cells induces cleavage of a number of 
FG-repeat containing Nups, including Nup62 and Nup98 in the central pore, and Nup153 of the 
nuclear basket. This results in inhibition of nuclear export and subsequent accumulation of 
poly(A) mRNA in the nucleus (Castelló et al., 2009). Moreover, addition of IFN-γ to cells 
infected with poliovirus partially prevented the cleavage of Nup98, thus preventing the 
inhibition of RNA nuclear export (Castelló et al., 2009). Adenoviruses, herpesviruses and 
vesiculoviruses also inhibit mRNA export, but instead target mRNA export factors such as 
nuclear export factor 1 (NXF1) (Kuss et al., 2013). Given that NPCs are entirely removed from 
the NE proximal to the inclusion, mRNA distribution was investigated during infection with  
C. trachomatis. 
 
Fluorescent in-situ hybridisation (FISH) can be used to investigate mRNA distribution. FISH is a 
method developed in the 1980s to study localisation of DNA and chromosomes within the cell 
(Levsky and Singer, 2003). In more recent years, FISH techniques have taken advantage of the 
3’ end polyadenylation of messenger RNA (mRNA) to study mRNA localisation in the host cell 
(Castelló et al., 2009; Wickramasinghe et al., 2010). A 30 base poly-thymine (polyT) probe 
conjugated to a 5’-AlexaFluor 488 dye was used to visualise the pool of cellular polyadenylated 
mRNA. As a negative control, a 30 base poly-adenine (polyA) probe conjugated to a 5’-
AlexaFluor 488 dye was also used. RPE1 cells were cultured and fixed prior to hybridisation of 
either polyT or polyA probes. RPE1 cells were used since they possess a normal karyotype and 
also exhibit lamin A/C patches and NPC gaps during chlamydial infection. In cells labelled with 
the polyT probe, fluorescence is localised predominantly to the nucleus, with the cytosol 
labelled weakly (Fig 4.8). The nuclear staining consists of many small punctate structures, 
similar to the pre-mRNA splicing regions in the nucleus, the nuclear speckles, in agreement 
with examples of poly(A) staining in the literature (Castelló et al., 2009; Wickramasinghe et al., 
2010). As expected, the poly(A) probe exhibited near zero fluorescence. Mixing the probes at a 
1:1 poly(T) to poly(A) ratio in a competitive inhibition assay also abrogated poly(A) mRNA 
143 
 
signal, suggesting the poly(A) probes competes with the poly(A) tail of mRNA by binding to the 
poly(T) probe. The poly(T) probe is therefore specifically detecting poly(A) mRNA. 
 
With the assay optimised, poly(A) mRNA localisation in Chlamydia-infected cells was observed. 
Fixed C. trachomatis LGV2-infected RPE1 cells were hybridised with the poly(T) probe and 
labelled for DNA (Fig 4.9). Cytosolic mRNA levels appear unchanged during chlamydial 
infection. At 24 hpi, nuclear mRNA staining is similar to non-infected cells. However, later in 
infection, at 48 and 72 hpi, nuclear mRNA fluorescence intensity increases and the speckle-like 
localisation becomes more clustered. Polarisation of nuclear poly(A) mRNA to the inclusion-
proximal face of the nucleus was not observed. From this qualitative analysis, the levels of 
nuclear poly(A) mRNA increase, suggesting nuclear export of mRNA is inhibited. However, it is 
also possible that the increase in poly(T) probe fluorescence in the nucleus is due to a 
compaction of nuclear volume as the inclusion expands and distorts nuclear shape. Therefore, 
quantification of nuclear poly(A) mRNA levels during infection is required that takes into 
account the nuclear volume. 
 
RPE1 cells were infected with C. trachomatis LGV2, fixed prior to hybridisation with the poly(T) 
probe and labelled for lamin B. The nuclear periphery was detected using the lamin B 
fluorescence and a mask generated, within which the total intensity of poly(A) mRNA 
fluorescence was measured relative to the area of the nucleus (Fig 4.10A). The resulting 
average pixel intensity corrected for the area was then summed across the z-stack and divided 
by the number of z-sections to give the mean nuclear pixel intensity per unit volume or mean 
voxel intensity (Methods 2.8.4). The mean voxel intensity was averaged across the infected cell 
population and compared relative to non-infected cells at that time point (Fig 4.10B). The 
results show no significant difference between infected and control at any time points post 
infection. These data suggest there is no significant change in nuclear mRNA levels due to the 
removal of NPCs proximal to the IM, and therefore global mRNA export is not inhibited. 
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Figure 4.8. Optimisation of fluorescence in-situ hybridisation to visualise poly(A) mRNA. 
RPE1 cells were cultured and fixed prior to hybridisation with a 5’-AlexaFluor® 488-conjugated 
poly-thymine or poly-adenine probe [green, grey (centre panels)], or a 1:1 mixture of both 
probes. DNA [blue, grey (left panels)] was stained with DRAQ-5. Confocal images of all cells 
were acquired with identical laser power and photomultiplier voltage to ensure an accurate 
comparison of fluorescence intensity. Scale bars, 10 µm. 
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Figure 4.9. Nuclear poly(A) mRNA fluorescence is increased and clustered late during 
chlamydial infection. RPE1 cells were infected with C. trachomatis LGV2 and fixed prior to 
hybridisation with an AlexaFluor® 488-conjugated poly(T) probe (green, grey) to visualise 
poly(A) mRNA, and staining for DNA (blue) with DRAQ-5. Left panels: confocal images of cells 
in the xy-plane, with the inclusion (I) periphery indicated by the white dashed line (Methods 
2.8). Right panels: confocal xy-sections of the midsection of the nuclei, ascending in the z 
dimension through the cell (1-6) with a step of 0.34 µm.  Red borders indicate the sections 
equivalent to the left panels. (A) 24 hours post infection (hpi) (B) 48 hpi (C) 72 hpi. Confocal 
images of all cells were acquired with identical laser power and photomultiplier voltage to 
ensure an accurate comparison of fluorescence intensity. Scale bars, 10 µm. 
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Figure 4.10. Total nuclear poly(A) mRNA levels remain constant during Chlamydia infection. 
RPE1 cells were infected with C. trachomatis LGV2 and fixed prior to hybridisation with an 
AlexaFluor® 488-conjugated poly(T) probe to visualise poly(A) mRNA and staining with anti-
lamin B1 primary antibody and AlexaFluor® 546-conjugated secondary antibody to visualise 
lamin B. z-series were acquired for nuclei in non-infected (NI) or infected (I) cells (n=150) at 24, 
48 or 72 hours post infection. (A) CellProfiler was used to automatically detect and convert the 
nuclear periphery from the lamin B fluorescence into a filled object representing the nuclear 
area. (B) Histogram showing the mean nuclear voxel intensity [measured in arbitrary intensity 
units (AIU)] in non-infected or infected cells (Methods 2.8.4). Error bars show standard 
deviation. 
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4.7 Heterochromatin accumulates on the face of the nucleus 
proximal to the inclusion 
 
The nuclear basket of NPCs regulates chromatin organisation at the nuclear periphery by 
restricting heterochromatin, which is tethered by lamin A/C at the NE through lamina-
associated domains in the genome, from spreading (Guelen et al., 2008; Krull et al., 2010). The 
lamin A/C alterations correlate with the NPC gap at the late stage of Chlamydia infection (Figs 
3.9 and 3.15). Nuclear shape is also modified during chlamydial infection (Fig 3.2), becoming 
progressively lobulated which may influence chromosome positioning (Cremer and Cremer, 
2010). Therefore, the positioning of chromatin in relation to the NPCs and lamin A/C was 
interrogated during infection with Chlamydia.  
 
Histone modifications to individual chromatin domains lead to the condensation or de-
condensation of chromatin structure, and thus restrict or allow access to transcription factors 
to repress or activate gene expression (Bártová et al., 2008). Histone modifications can 
therefore be used as markers for heterochromatin, the tightly packed transcriptionally 
repressed form of chromatin, or euchromatin, the loosely packed transcriptionally active form 
of chromatin (Bártová et al., 2008). Triple methylation of histone H3 lysine 9 (H3K9me3) is 
associated with constitutive heterochromatin (Rea et al., 2000), while triple methylation of 
histone H3 lysine 4 (H3K4me3) is associated with euchromatin (Schneider et al., 2004). 
Therefore, to investigate chromatin distribution during chlamydial infection, the localisation of 
histone markers H3K9me3 and H3K4me3 in non-infected and C. trachomatis LGV2-infected 
HeLa cells was examined.  
 
In non-infected cells, H3K4me3 was distributed across the nuclear lumen (Fig 4.11A), 
consistent with euchromatin being localised distal to the nuclear periphery (Kimura, 2013). 
H3K9me3 was enriched towards the periphery of the nucleus and around the nucleoli (Fig 
4.11B), as expected given the reported localisation of heterochromatin (Poleshko et al., 2013; 
Towbin et al., 2013). At 24 hpi with C. trachomatis LGV2, the distribution of H3K4me3 and 
H3K9me3 within the nucleus was similar to that of non-infected cells (Fig 4.12A and 4.13A). 
The distribution of H3K4me3 at 48 hpi also remained consistent, with no polarisation towards 
or away from the nuclear periphery (Fig 4.12B). However, changes were observed in the 
distribution of H3K9me3 at this time point, with an enriched patch of H3K9me3 appearing at 
the inclusion-proximal face of the NE, and H3K9me3 being depleted around the remainder of 
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the nuclear periphery (Fig 4.13B). These phenotypes are remarkably similar to the changes to 
lamin A/C during infection observed in chapter 3 (section 3.5), when an enrichment of lamin 
A/C is observed in the NE proximal to the inclusion, and lamin A/C is depleted elsewhere 
around the nuclear periphery. Indeed, when lamin A/C and H3K9me3 are co-labelled in cells 
infected with C. trachomatis LGV2 for 48 hours, the lamin A/C patch and H3K9me3 enrichment 
were present in close proximity (Fig 4.14). 
 
The frequency of heterochromatin enrichment was then quantified. Enrichment in H3K9me3 
was defined as a region on one face of the nucleus greater than 1 µm in the xy and z planes 
axis with at least 50% higher fluorescence intensity than the H3K9me3 at the opposing face of 
the nucleus. At 24 hpi just 2.0 ± 0.1% of infected cells had an enrichment of H3K9me3 at the 
luminal face of the nucleus proximal to the IM, whilst at 48 and 72 hpi 22.3 ± 3.2 and 27.8 ± 
5.3% of infected cells showed enrichments respectively (Fig 4.15). These frequencies are very 
similar to the occurrence of the NPC gap, which occurred at 21.3% at 48 hpi and 24.7% at 72 
hpi, rather than the lamin A/C patch, which occurred at 52.9% at 48 hpi and 72.1% at 72 hpi. 
Taken together, these data show heterochromatin localisation is modified late during 
chlamydial infection, with enrichment in heterochromatin observed in the region of the 
nucleus proximal to the inclusion. 
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Figure 4.11. Distribution of euchromatin and heterochromatin in the nuclei of cultured HeLa 
cells. Fixed HeLa cells were stained with (A) anti-H3K4me3 primary antibody and an 
AlexaFluor® 488-conjugated secondary antibody (grey, upper) to visualise euchromatin or (B) 
anti-H3K9me3 primary antibody and an AlexaFluor® 488-conjugated secondary antibody (grey, 
lower) to visualise heterochromatin. Confocal xy-sections of nuclei ascend in the z dimension 
through the cell (1-6) with a step 0.34 µm. Scale bars, 10 µm. 
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Figure 4.12. Euchromatin distribution is not polarised during infection with Chlamydia. HeLa 
cells were infected with C. trachomatis LGV2, fixed and double stained with anti-H3K4me3 
primary antibody and an AlexaFluor® 488-conjugated secondary antibody (cyan, grey) to 
visualise euchromatin and anti-Chlamydia primary antibody and an AlexaFluor® 546-
conjugated secondary antibody (red) to visualise bacteria. Left panels: confocal images of 
infected cells in the xy-plane, with the inclusion (I) periphery indicated by the white dashed 
line (Methods 2.8). Right panels: confocal xy-sections of the nuclei, ascending in the z 
dimension through the cell (1-6) with a step of 0.34 µm. Red borders indicate the sections 
equivalent to the left panels. (A) 24 hours post infection (hpi). (B) 48 hpi. Scale bars, 10 µm. 
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Figure 4.13. Heterochromatin accumulates at the inclusion-proximal face of the nucleus late 
during chlamydial infection. HeLa cells were infected with C. trachomatis LGV2, fixed and 
double stained with anti-H3K9me3 primary antibody and an AlexaFluor® 488-conjugated 
secondary antibody (cyan, grey) to visualise heterochromatin and anti-Chlamydia primary 
antibody and an AlexaFluor® 546-conjugated secondary antibody (red) to visualise bacteria. 
Left panels: confocal images of infected cells in the xy-plane, with the inclusion (I) periphery 
indicated by the white dashed line (Methods 2.8). Right panels: confocal xy-sections of the 
nuclei, ascending in the z dimension through the cell (1-6) with a step of 0.34 µm. Red borders 
indicate the sections equivalent to the left panels. (A) 24 hours post infection (hpi). (B) 48 hpi. 
Scale bars, 10 µm. 
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Figure 4.14. Heterochromatin and lamin A/C are enriched in close proximity at the inclusion-
proximal face of the nuclear periphery late during chlamydial infection. HeLa cells were 
infected with C. trachomatis LGV2, fixed and double stained with anti-H3K9me3 primary 
antibody and an AlexaFluor® 488-conjugated secondary antibody (cyan, grey) to visualise 
heterochromatin and anti-lamin A/C primary antibody and an AlexaFluor® 546-conjugated 
secondary antibody (red) to visualise lamin A/C. Left panels: confocal images of infected cells 
in the xy-plane, with the inclusion (I) periphery indicated by the white dashed line (Methods 
2.8). Right panels: confocal xy-sections of the nuclei, ascending in the z dimension through the 
cell (1-6) with a step of 0.34 µm. Red borders indicate the sections equivalent to the left 
panels. (A) 24 hours post infection (hpi). (B) 48 hpi. Scale bars, 10 µm. 
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Figure 4.15. Enrichment of heterochromatin occurs more frequently late during chlamydial 
infection. Histogram showing the proportion of non-infected (white bars) or C. trachomatis 
LGV2 infected (black bars) HeLa cells (n=100) exhibiting an enrichment of heterochromatin 
scored at each time point. An enrichment of heterochromatin was defined as a region of 
H3K9me3 on one face of the nucleus greater than 1 μm in the xy and z planes with at least 
50% higher fluorescence intensity than the H3K9me3 at the opposing face of the nucleus. Error 
bars show standard deviation (**p<0.05 using Student’s t-test as indicated). 
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4.8 Lamin A/C is required for the depletion of NPCs and 
enrichment of heterochromatin observed during chlamydial 
infection 
 
The nuclear lamina is essential for determining nuclear pore complex positioning within the NE 
(Liu et al., 2000; Guo and Zheng, 2015), and also tethers heterochromatin at the nuclear 
periphery by interacting with nucleotide sequences in the mammalian genome termed lamina-
associated domains (Guelen et al., 2008). Furthermore, the increased lobulation of granulocyte 
nuclei is associated with a depletion of NL proteins (Olins et al., 2001). Given these NL 
functions, and given that the lamin A/C patch occurs in a significantly higher frequency of 
Chlamydia-infected cells than the depletion in NPCs or enrichment of heterochromatin (Figs 
3.9, 3.15, 4.15), it was hypothesised lamin A/C may be at the origin of the NPC, 
heterochromatin and nuclear shape changes described previously (Figs 3.14, 4.13, 3.2). 
 
Lamin A/C knockout fibroblasts were used to investigate this hypothesis. Mouse embryonic 
fibroblasts (MEFs), either WT or knockout for the gene encoding prelamin A/C (LMNA) by 
deletion of a region of LMNA from exon 8 to exon 11 [a generous gift from Professor Brian 
Burke (A*STAR, Singapore), created as described in Sullivan et al. (1999)], were infected with 
C. trachomatis LGV2, fixed and labelled for NPCs and lamin A/C or heterochromatin and lamin 
A/C. The absence of lamin A/C was verified by immunofluorescence, and the distribution of 
NPCs and heterochromatin analysed (Fig 4.16). In non-infected LMNA-/- MEFs, the absence of 
lamin A/C was clear. NPC levels appeared reduced in LMNA-/- MEFs compared to WT MEFs, but 
remained distributed around the entire nuclear periphery (Fig 4.16B). Heterochromatin was 
depleted from the nuclear periphery in LMNA-/- MEFs compared to WT MEFs (Fig 4.16D), as 
expected given the importance of lamin A/C in tethering heterochromatin at the NE (Solovei et 
al., 2013). The depletion of NPCs and enrichment of heterochromatin observed in the nuclei of 
C. trachomatis-infected HeLa cells (Figs 3.14 and 4.13) were present in C. trachomatis-infected 
WT MEFs (Figs 4.17A, 4.18A, 4.19A), confirming NE alterations occur independently of host cell 
line. However, neither the depletion of NPCs nor the enrichment of heterochromatin was 
observed in the LMNA-/- MEFs (Figs 4.17B, 4.18B, 4.19B), suggesting lamin A/C is required for 
these changes. The lobulation of nuclei in C. trachomatis-infected cells was also investigated in 
infected LMNA-/- MEFs, but no significant differences were observed compared to WT MEFs 
(Fig 4.20). These data support the conclusion that depletion of lamin A/C increases lobulation 
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of nuclei in infected cells, as lobulation of the nuclei of WT infected cells occurs in the NE distal 
to the inclusion where lamin A/C is depleted, and the nuclei of LMNA-/- MEFs are similarly 
lobulated in this region. 
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Figure 4.16. Distribution of nuclear pore complexes and heterochromatin in wildtype (WT) 
and LMNA-/- mouse embryonic fibroblasts (MEFs). Fixed (A, C) WT and (B, D) LMNA-/- MEFs 
were double stained with anti-lamin A/C primary antibody and an AlexaFluor® 546-conjugated 
secondary antibody [grey (left panels), red] to visualise lamin A/C, and either mAb414 primary 
antibody and an AlexaFluor® 488-conjugated secondary antibody [grey (A, B, centre panels), 
green] to visualise phenylalanine glycine-repeat containing nucleoporins (FG-Nups) or anti-
H3K9me3 primary antibody and an AlexaFluor® 488-conjugated secondary antibody [grey (C, 
D, centre panels), cyan] to visualise heterochromatin. Scale bars, 10 µm.  
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Figure 4.17. Lamin A/C is required for the Chlamydia-induced depletion of NPCs proximal to 
the inclusion. (A) WT or (B) LMNA-/- mouse embryonic fibroblasts (MEFs) were infected with  
C. trachomatis LGV2 for 48 hours, fixed and triple stained with mAb414 primary antibody and 
an AlexaFluor® 488-conjugated secondary antibody (green) to visualise phenylalanine glycine-
repeat containing nucleoporins (FG-Nups), anti-lamin A/C primary antibody and an AlexaFluor® 
546-conjugated secondary antibody (red) to visualise lamin A/C, and DRAQ-5 (grey) to visualise 
DNA. The inclusion (I) is indicated by a white-dashed line (Methods 2.8). A white arrow 
indicates an area of FG-Nup depletion and lamin A/C enrichment. Scale bars, 10 µm. 
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Figure 4.18. Lamin A/C is required for Chlamydia-induced enrichment of heterochromatin 
proximal to the inclusion. (A) WT or (B) LMNA-/- mouse embryonic fibroblasts (MEFs) were 
infected with C. trachomatis LGV2 for 48 hours, fixed and double stained with anti-H3K9me3 
primary antibody and an AlexaFluor® 488-conjugated secondary antibody (grey, cyan) to 
visualise heterochromatin and anti-lamin A/C primary antibody and an AlexaFluor® 546-
conjugated secondary antibody (red) to visualise lamin A/C. The inclusion (I) is indicated by a 
white-dashed line (Methods 2.8). A white arrow indicates an area enriched in heterochromatin 
and lamin A/C. Scale bars, 10 µm. 
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Figure 4.19. Quantification confirms lamin A/C is required for Chlamydia-induced nuclear 
envelope changes. WT (white bars) or LMNA-/- (black bars) mouse embryonic fibroblasts were 
infected with C. trachomatis LGV2, fixed at the indicated time post infection and stained with 
mAb414 primary antibody and an AlexaFluor® 488-conjugated secondary antibody to visualise 
phenylalanine glycine-repeat containing nucleoporins (FG-Nups) or anti-H3K9me3 primary 
antibody and an AlexaFluor® 488-conjugated secondary antibody to visualise 
heterochromatin. The proportion of cells (n=100) with (A) FG-Nup depletion or (B) H3K9me3 
enrichment was scored according to previously defined parameters (Methods 2.8.4). Error 
bars show standard deviation (**p<0.05 using Student’s t-test as indicated). 
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Figure 4.20. Lobulation of nuclei in Chlamydia-infected WT mouse embryonic fibroblasts 
(MEFs) is similar to LMNA-/- MEFs. (A) WT or (B) LMNA-/- MEFs were infected with C. 
trachomatis LGV2, fixed at the indicated time post infection and stained with mAb414 primary 
antibody and an AlexaFluor® 488-conjugated secondary antibody to visualise the nuclear 
envelope. Maximum projections of nuclei (n=100) at each time point were scored for the 
number of lobes according to previously defined parameters (Methods 2.8.1). White bars: 
single lobed, grey bars: bi-lobed, black bars: multi-lobed. Error bars show standard deviation. 
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4.9 Chlamydia trachomatis replicates faster in cells lacking 
lamin A/C 
 
The experiments shown previously have demonstrated that lamin A/C is required for the 
enrichment of heterochromatin and depletion of NPCs observed during infection with  
C. trachomatis at the inclusion-proximal face of the nucleus (Figs 4.17-4.19). From scoring the 
frequency of NE modifications following penicillin G-killing of the bacteria, it was concluded 
that C. trachomatis specifically induces the enrichment of lamin A/C in a patch of the NE 
adjacent to the inclusion, likely through translocated effectors (Fig 4.4). Indeed, the lamin A/C 
patch occurs in 72.1 ± 11.5% of cells infected with C. trachomatis for 72 hours (Fig 3.9). Thus, 
formation of the lamin A/C patch and the subsequent effects on the NPCs and 
heterochromatin may be important for the chlamydial lifecycle. To investigate this, the size 
and shape of inclusions was measured in WT or LMNA-/- MEFs infected with C. trachomatis 
LGV2. 
 
Maximum projections of C. trachomatis-infected cells were used to measure the roundness of 
inclusions or contour ratio. The data showed the contour ratio of inclusions in  
LMNA-/- MEFs was not significantly different than that of WT MEFs (Fig 4.21A), indicating 
inclusion shape does not change. Inclusion size was measured by automated reconstruction of 
the inclusion volume using the entire z-stack (Methods 2.8.5). Measurements of inclusion size 
were unsuccessful at 72 hpi, as it was not possible for the macro to differentiate between 
fluorescence at the inclusion periphery and fluorescence of EBs released from lysed cells. 
Nevertheless, the data showed inclusions in LMNA-/- MEFs were significantly larger than those 
of WT MEFs, with the difference being greatest at 48 hpi (Fig 4.21B). Taken together, these 
data suggest that inclusions are larger in cells lacking lamin A/C. 
 
The increase in inclusion size in LMNA-/- MEFs may result in an increase in the number of 
infectious progeny produced during C. trachomatis infection. To investigate this, the number 
of EBs in Chlamydia-infected WT and LMNA-/- MEFs can be quantified by collecting bacteria at 
the time point of interest, infecting a second monolayer of cells and scoring the number of 
inclusions. The proportion of inclusions observed is then used to calculate the number of 
inclusion forming units (Methods 2.3.2). First, inclusion formation of C. trachomatis in WT and 
LMNA-/- MEFs was assessed to ensure any alterations in IFUs measured are not due to 
differences during chlamydial entry and early development up to 24 hpi (Fig 4.22A). No 
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significant difference occurred, and so bacteria infect both the WT and LMNA-/- MEFs equally. 
Subsequently, IFUs were recovered from the cell layer and growth media of Chlamydia-
infected WT and LMNA-/- MEFs and quantified (Fig 4.22B and C). At 48 and 72 hpi, significantly 
more inclusions were formed from both the cell layer and the growth media collected from the 
LMNA-/- MEFs compared to the WT MEFs. Thus, ~7 fold at 48 hpi and ~6 fold at 72 hpi more 
bacterial progeny are produced when Chlamydia infects LMNA-/- cells. These data suggest  
C. trachomatis replicates faster in cells lacking lamin A/C. 
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Figure 4.21. Inclusion size, but not shape, is significantly altered in LMNA-/- mouse 
embryonic fibroblasts (MEFs). WT (white) or LMNA-/- (black) MEFs were infected with  
C. trachomatis LGV2, fixed at the indicated time post infection and double stained with anti-
Chlamydia primary antibody and an AlexaFluor® 488-conjugated secondary antibody to 
visualise infected cells and DRAQ-5 to visualise DNA. (A) Inclusion roundness (or contour ratio, 
4π x area/perimeter2) was measured from maximum projections of inclusions (n=40). (B) 
Inclusion size was measured by automated reconstruction of the inclusion volume using the 
entire z-stack (Methods 2.8.5). Error bars show standard deviation (***p<0.01 using Student’s 
t-test as indicated). 
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Figure 4.22. Increased bacterial progeny are produced from LMNA-/- mouse embryonic 
fibroblasts (MEFs) compared to WT MEFs. (A) WT (white) or LMNA-/- (black) MEFs were 
infected with C. trachomatis LGV2, fixed at 24 hours post infection (hpi) and double stained 
with anti-Chlamydia primary antibody and an AlexaFluor® 488-conjugated secondary antibody 
to visualise infected cells and DRAQ-5 to visualise DNA. The number of inclusions was scored 
across 6 fields of view (n=300 cells) in duplicate and compared to the number of nuclei to 
determine the proportion of infected cells. (B) Cell layers or (C) growth medium collected at 48 
or 72 hpi were lysed and diluted in fresh medium to infect a new layer of HeLa cells (Methods 
2.9). After 24 hours, cells were fixed and labelled for Chlamydia and DNA. Inclusion-forming 
units (IFUs) were then quantified (IFU/ml). Error bars show standard deviation (***p<0.01 
using Student’s t-test as indicated). 
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4.10 Discussion 
 
The data presented in this chapter establish that infection by C. trachomatis drives increased 
lobulation of nuclei, NPC depletion and heterochromatin reorganisation (Figs 4.13, 4.14 and 
4.20) in a lamin A/C dependent manner (Figs 4.17-4.19). Although nuclear mRNA levels do not 
change during infection with Chlamydia (Figs 4.9 and 4.10), nuclear transport is absent 
proximal to the inclusion (Fig 4.7). The dimensions of the lamin A/C patch and NPC gap are 
independent of physical pressure on the nucleus (Fig 4.1), and the NE modifications are 
induced by bacterial factors (Figs 4.2, 4.3 and 4.4) and are repaired following inclusion 
clearance (Fig 4.5). Finally, the Chlamydia inclusion is larger and more progeny are produced 
when lamin A/C is depleted (Figs 4.21 and 4.22). 
 
The mechanism by which Chlamydia simultaneously induces the lamin A/C patch whilst 
depleting lamin A/C from the remainder of the NL remains unknown, but the dual nature of 
these effects suggest multiple pathways or bacterial effectors will be necessary. The frequency 
of NE modifications was reduced to levels similar to that of non-infected cells following 
penicillin G-killing of the bacteria at 3 and 24 hpi (Fig 4.4), suggesting a bacterial effector is 
released after 24 hpi. Notably, expression of NUE, a Chlamydia effector targeted to the 
nucleus with histone methyltransferase activity, peaks at 24-40 hpi (Belland et al., 2003). 
Viable bacteria are required to maintain the NE changes, as there is an immediate reduction in 
the frequency of lamin A/C patches and NPC gaps following bacterial killing at 48 hpi (Fig 4.4), 
and NPC gap frequency returns to levels observed in control cells within 24 hours of inclusion 
clearance (Fig 4.5). This time frame correlates with the time taken for HeLa cells to complete 
the cell cycle, indicating the NE may be being repaired following reassembly after mitosis. 
Immunoprecipitation experiments were attempted to determine whether any Chlamydia 
effector or effectors could be detected interacting with lamin A/C, and also to determine 
whether lamin A/C interacts with additional host proteins during infection. However, 
extraction of lamin A from the cell lysate was unsuccessful, and so modifications to the 
immunoprecipitation protocol may be required before these experiments can be completed. 
 
Following confirmation that the phenotypes observed during Chlamydia infection are 
bacterially driven, the major focus of this chapter was to determine the functional implications 
of the NE changes during Chlamydia infection. Host nucleocytoplasmic transport does not 
occur proximal to the inclusion (Fig 4.7), agreeing with previous observations that suggested 
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NPCs are entirely removed from this region. The lack of importin-β in regions where there are 
no NPCs indicates that the NTR must ‘sense’ NPCs through which it can traverse, rather than 
aggregate across the entire nuclear periphery. mEos2-importinβ can be photo-converted using 
a 405 nm laser to emit red fluorescence rather than green, and therefore could be used to 
study whether NPC transport is affected elsewhere in the NE by monitoring the half-life of red 
molecules at the NE. If transport is faster, the time taken for red molecules to be imported into 
the nucleus and replaced at the NE by green molecules will be reduced (Lowe et al., 2015). 
Using this experimental model, it can therefore be determined whether the cell compensates 
for a significant region of the NE becoming impermeable during chlamydial infection. From the 
FISH experiments, one can conclude that the cell can compensate, as there were no detectable 
changes to the global cellular nuclear poly(A) mRNA levels during infection (Fig 4.10). This 
suggests the local abrogation of nucleocytoplasmic transport proximal to the inclusion does 
not affect the overall distribution of mRNA, and that there is no block in mRNA export such as 
that reported during poliovirus infection (Castelló et al., 2009). 
 
Following these experiments into the impact of depletion of NPCs, the potential consequences 
of the lamin A/C patch were investigated. H3K9me3, a marker for heterochromatin, was 
observed enriched towards the inclusion-proximal face of the nucleus, in close proximity to the 
lamin A/C patch, and depleted around the remainder of the nuclear periphery (Figs 4.13 and 
4.14). At this stage, it is unknown whether this enrichment represents a redistribution of 
existing heterochromatin, or whether chromatin is being condensed proximal to the inclusion 
to the heterochromatin state and de-condensed elsewhere around the nuclear periphery. If 
the former, this would necessitate a reorganisation of chromosome territories within the 
nucleus which would not necessarily indicate a change in gene expression. However, if the 
latter, then the accessibility of transcription factors to genes proximal to the inclusion would 
be limited, which would reduce expression of genes in this region. Given that lamin A/C is 
required for these changes (Fig 4.18), it is more likely that Chlamydia utilises the chromatin 
tethering functions of lamin A/C as a means to reorganise chromatin distribution close to its 
intracellular niche. Indeed, as the nuclear basket proteins of NPCs are important in preventing 
the spread of heterochromatin (Shinkura and Forrester, 2002), one might hypothesise NPCs 
must be removed in this region for heterochromatin to be so highly enriched, as is observed. 
The accumulation of heterochromatin further distinguishes the Chlamydia-induced nuclear 
envelope changes from those observed in HGPS cells, where the increased thickness of the NL 
due to incorporation of LAΔ50 results in a loss of a peripheral heterochromatin (Goldman et 
al., 2004). 
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One of the most interesting avenues of research arising out of these observations of 
heterochromatin distribution during infection is to identify genes residing in this 
transcriptionally repressive region of chromatin. FISH could be used to investigate this, 
possibly by studying the positioning of chromosome territories to determine whether specific 
chromosomes are redistributed into this region. Further questions exist in the increased size of 
the inclusion and increased production of infectious progeny in cells lacking lamin A/C (Fig 
4.22). Firstly, why does Chlamydia construct or stabilise this patch of lamin A/C with 
subsequent alterations to NPC and heterochromatin distribution, when simply depleting lamin 
A/C entirely allows the bacteria to replicate in much greater numbers? Chlamydia is clearly 
capable of depleting lamin A/C, as both immunofluorescence and immunoblotting 
experiments presented in chapter 3 show total levels of lamin A/C are reduced late in 
infection. It could therefore be concluded that Chlamydia may be sacrificing increased 
replication to control other factors, for example, genes related to the immune response may 
be located in the heterochromatin enriched region. Secondly, how does the lack of lamin A/C 
lead to a larger inclusion and so increase bacterial replication? Lamin A/C contributes to the 
shape and stiffness of the nucleus, therefore nuclei lacking lamin A/C may be more flexible. 
This could allow the inclusion to expand into and displace the nucleus to a greater degree, and 
so increase the space available within the inclusion for the bacteria to replicate. It would be 
interesting to study the effect of the opposite phenotype, enrichment of lamin A/C, on 
Chlamydia infection and whether this results in reduced inclusion size and bacterial 
replication.  
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Chapter 5 – Identification of chlamydial proteins that are 
targeted to and interact with the host nucleus 
 
5.1 Introduction 
 
The experiments presented thus far have focused on identifying changes to the host nucleus 
following Chlamydia infection. However, the bacterial proteins responsible for the changes 
described in chapters 3 and 4 remain unknown. NUE, a SET-domain containing protein with 
histone methyltransferase activity targeted to the nucleus (Pennini et al., 2010), is a candidate 
for interacting with heterochromatin, but further effectors are likely required to mediate other 
changes such as the simultaneous enrichment and depletion of lamin A/C from different 
regions of the NE. Major advances have been made over the course of this work in tools for 
the genetic modification of Chlamydia (Wang et al., 2011; Ding et al., 2013; Agaisse and Derré, 
2014; Bauler and Hackstadt, 2014). However, as these tools are only now becoming widely 
available, it is particularly important to first gather as much information as possible about 
potential effector proteins to guide future experiments. Therefore, a computational approach 
was adopted to narrow the list of potential Chlamydia effector proteins that may be 
interacting with components of the host nucleus.  
 
Many pathogens, including Chlamydia, utilise molecular mimicry to host proteins to interfere 
with and subvert host biological processes. This mimicry can occur on a predominantly 
functional level, whereby bacterial effectors develop distinct folds with no sequence similarity 
to eukaryotic proteins, yet have molecular surfaces that mirror host protein surfaces and so 
functionally mimic host processes (Stebbins and Galan, 2001). For example, Salmonella SptP 
induces hydrolysis of GTP to inhibit Rac1 and Cdc42 signalling, mimicking the function of host 
GTPase activating proteins to restore normal cytoskeletal architecture following bacterial 
internalisation (Fu and Galán, 1999; Stebbins and Galán, 2000). Alternatively, pathogen 
molecular mimicry can occur on a more structural level, whereby bacterial effectors adopt 
eukaryotic folds. For example, the chlamydial protein IncA is proposed to use structural 
mimicry to the SNARE motif, a eukaryotic motif involved in vesicle fusion, to aid in the fusion 
of C. trachomatis-containing vesicles in cells infected with multiple EBs (Delevoye et al., 2008). 
Furthermore, NUE contains a SET domain, a 130-residue domain found in eukaryotic histone 
methyltransferases (Pennini et al., 2010). In this chapter, the hypothesis that structural 
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mimicry of eukaryotic folds by pathogens could be exploited to identify new Chlamydia 
effectors that may be structural homologues of host nuclear proteins was explored. 
 
Remote protein homology detection servers such as HHpred predict homologous structures 
from proteins that share less than 20% primary sequence similarity with the target (Söding et 
al., 2005). This is particularly important for C. trachomatis, since at the time of publication of 
the genome sequence it was reported 28% of predicted proteins have no similarity to any 
other sequences deposited in GenBank (Stephens et al., 1998), probably due to the 
evolutionary distance of the Chlamydiaceae from other pathogens (Stephens et al., 1998; 
Clarke, 2011). HHpred can detect such remote homologues by creating and comparing hidden 
Markov models (HMM) of sequence profiles (Söding, 2005). HMMs are statistical models that 
consider all possible combinations of matches, mismatches and gaps to generate an alignment 
of a set of sequences (Mount, 2004). Thus information, such as amino acid frequencies at 
certain positions and position-specific probabilities for insertions and deletions can be 
incorporated into the prediction (Söding, 2004; Söding et al., 2005). Additionally, HHpred 
incorporates the prediction of secondary structure elements (SSEs) into the alignment 
algorithms, allowing the detection of structural homologues from even more remote 
sequences.  
 
It is also important when considering potential Chlamydia effectors to identify whether the 
proteins are translocated into the host cell and are therefore capable of acting as effectors. 
Chlamydia utilise both type II and type III secretion systems to translocate effectors into the 
host cell. Computational prediction can be used as a first step to determine whether proteins 
are likely to be secreted by either of these systems.  T2S substrates of Gram negative bacteria 
contain an N-terminal signal peptide for delivery to the general secretory pathway or twin-
arginine translocation (Tat) system machinery to allow translocation across the cytoplasmic 
membrane into the periplasmic space (Voulhoux et al., 2001; Filloux, 2004). However, the 
exact signal by which these substrates are then targeted to the T2S system is unknown, 
although protein folding is required suggesting the signal may be conformation dependent 
(Voulhoux et al., 2000; Korotkov et al., 2012). For the prediction of T3S substrates, numerous 
features are taken into account in addition to the N-terminal sequence, including position-
specific amino acid composition profiles and the C-terminal sequence, which is required for 
secretion of some T3S effectors such as Salmonella SipC (Chang et al., 2005; Arnold et al., 
2009; Wang et al., 2011; Dong et al., 2015). 
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The aim of this chapter is to use remote protein homology detection and structure prediction 
approaches in combination with available secretion prediction algorithms to identify 
Chlamydia effector proteins that may be targeted to or interact with the host nucleus, and so 
may be candidates for contributing to the nuclear reorganisation reported in the previous 
chapters. 
 
5.2 Remote sequence homology and fold recognition reveals 
Chlamydia encodes proteins that are possible structural mimics 
of host nucleoporins and nuclear transport receptors 
 
Whilst the Chlamydia effector protein NUE is targeted to the nucleus, the nuclear localisation 
signal is atypical (Pennini et al., 2010), and so exactly how NUE enters the host nucleus 
remains unknown. One possibility is that Chlamydia secretes proteins capable of mimicking the 
nuclear transport receptors (NTRs) such as importin-β, which transport cargo into the nucleus 
(Pemberton and Paschal, 2005). NTRs share a common fold, an α-solenoid, which consists of 
many repeats of α-helices packed together to form an elongated super-helix or ‘solenoid’ 
(Kobe and Kajava, 2000). Various repeat motifs in α-solenoids have been defined, including 
Armadillo (ARM), HEAT and ankyrin repeats, which differ subtly in their helical arrangement 
(Andrade et al., 2001; Mosavi et al., 2004). For example, the ARM repeat consists of three 
helices, whilst the ankyrin repeat consists of two α-helices separated by long loop regions 
(Kobe and Kajava, 2000). In NTRs, the α-solenoid fold provides a large surface area for protein-
protein interactions (Andrade et al., 2001). However, the α-solenoid fold is not unique to NTRs. 
For example, the scaffold A subunit of protein phosphatase 2A, a serine/threonine 
phosphatase which regulates the function of many proteins including Akt, p53 and c-Myc, is a 
HEAT repeat-containing α-solenoid (Seshacharyulu et al., 2013). Furthermore, structural NPC 
components share the α-solenoid fold, in this case conferring flexibility to the pore to allow 
expansion during transport of large cargo (Andrade et al., 2001; Devos et al., 2006). Given that 
NPCs are depleted in the NE proximal to the inclusion, it could be speculated that Chlamydia 
could encode α-solenoid effectors that mimic the NPCs to form ‘chlamydial’ pores in this 
region of the NE, allowing efficient transport of chlamydial effectors into the nucleus. 
Remarkably, a predicted α-solenoid protein is targeted to the host nucleus during infection 
with the obligate intracellular bacteria Anaplasma phagocytophilum, which infects neutrophils 
(Caturegli et al., 2000). The AnkA protein contains 11 ankyrin repeat domains which is 
predicted to confer an α-solenoid fold, and can bind DNA and nuclear proteins with likely 
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effects on host gene expression (Park et al., 2004). Thus, attempts were made to identify 
Chlamydia proteins containing an α-solenoid fold. 
 
HHblits is a prediction software for the identification of remote sequence homology (Remmert 
et al., 2011). In brief, HHblits first converts the query sequence, or multiple sequence 
alignment (MSA), to an HMM profile sequence (as described in section 5.1). It then searches 
an HMM database, created by clustering all homologous sequences from the UniProt database 
with a minimum pairwise sequence identity of 20% (Hauser et al., 2013), for other HMMs 
below a threshold expect value (E-value), the number of hits one can expect to detect by 
chance for a given database size. These HMMs are then added to and merged with the query 
HMM sequence and this new HMM profile is used for the next iteration. Iterations repeat until 
the specified number of cycles or until no new hits are found, at which point the resulting 
identified proteins are displayed. However, when α-solenoid containing Nups such as Nup85 
and Nup107, or NTRs such as importin-β and importin-α are input into HHblits, no Chlamydia 
proteins were identified despite identification of 10,000 homologous sequences. 
 
Given this initial result, an alternative approach was undertaken. Members of the 
Planctomycetes-Verrucomicrobia-Chlamydiae (PVC) superphylum (excluding the Chlamydiae) 
express ‘membrane coat-like’ (MC) proteins which consist of an α-solenoid followed by a β-
propeller fold (Santarella-Mellwig et al., 2010). These MC proteins are found in all eukaryotes, 
and two Nups adopt this fold, Nup133 and Nup160 (Devos et al., 2004). In bacteria of the PVC 
superphylum, MC proteins are controversially proposed to allow a compartmentalised cell 
plan, and as such these bacteria have been suggested to reflect an intermediary in 
eukaryogenesis (Santarella-Mellwig et al., 2010; McInerney et al., 2011; Devos, 2012). 
Importantly, as these are prokaryotic proteins, they may have closer sequence homology to 
Chlamydia proteins than the eukaryotic α-solenoids searched such as Nup85 and importin-β, 
and so may reveal Chlamydia proteins with similar folds. Thus, amino acid sequences of all MC 
proteins of PVC superphylum species detected by Santarella-Mellwig et al. (2010) (Appendix 
5.1) were input into HHblits to detect Chlamydia proteins. A subset of these proteins is listed 
in Table 5.1.  
 
From the 47 MC proteins input into HHblits, six proteins from C. trachomatis were identified 
(Table 5.2). Of these hits, three proteins were identified multiple times, CT234, CT350 and 
CT384. The highest probability identification (90.91%) of CT234 was from a hypothetical 
Planctomyces maris protein. The probability score of an identified protein represents the 
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probability to be a true positive, defined to be either globally homologous or locally similar in 
structure to the query protein. The highest probability identifications of CT350 (98.40%) and 
CT384 (96.57%) were from a hypothetical Blastopirellula marina protein. The remaining 
proteins, CT198, CT599 and CT780 were identified with homology to just one of the query 
sequences, the Rhodopirellula baltica protein probable L-sorbosone dehydrogenase, with 
probabilities of 28.15%, 27.51% and 59.99% respectively. As these probability scores were 
significantly lower than the other proteins, CT198, CT599 and CT780 were excluded at this 
stage. 
 
To confirm whether CT234, CT350 and CT384 have α-solenoid folds, amino acid sequences 
were submitted to the HHpred homology detection and structure prediction server (Table 5.3) 
(Söding, 2005). HHpred calculates the probability of a template to be a true positive using the 
same parameters as for HHblits. Both CT350 and CT384 were predicted with 99.8% and 99.91% 
probability respectively to be structurally homologous to protein phosphatase 2A regulatory 
subunit A, an α-solenoid protein. CT234 was predicted to have two domains, the N-terminal 
domain matching a transmembrane protein, the multidrug transporter MDFA, and the C-
terminal domain matching an artificial α-solenoid GFP binding protein, bGFP-A. Homology was 
also detected between the three chlamydial proteins and other α-solenoid proteins, including 
importin-β, transportin-1 and β-catenin. Additionally, InterPro domain assignments predict 
CT350, CT384 and the C-terminal domain of CT234 to have an ARM-like helical domain, which 
occur in α-solenoid structures (Andrade et al., 2001). These data therefore suggest  
C. trachomatis encodes at least three proteins that adopt an α-solenoid fold. 
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Species Gene Identifier (IMG database)  Encoded protein name 
Verrucomicrobium spinosum 642333382 hypothetical protein 
Rhodopirellula baltica 637434028 similar to glucose 
dehydrogenase-B 
Pedosphaera parvula 642472080 hypothetical protein 
Planctomyces maris 641112091 hypothetical protein 
Lentisphaera araneosa 641131688 hypothetical protein 
Gemmata obscuriglobus 642225569 hypothetical protein 
Chthoniobacter flavus 642911643 heme-binding protein 
Blastopirellula marina 638979470 hypothetical protein 
 
 
 
Table 5.1. Subset of membrane coat-like (MC) proteins of the Planctomycetes-
Verrucomicrobia-Chlamydiae (PVC) superphylum used for remote homology detection. Gene 
identifiers of genes encoding for MC proteins detected by Santarella-Mellwig et al. (2010) 
correspond to entries in the Integrated Microbial Genomes & Microbiome Samples (IMG) 
database, available at https://img.jgi.doe.gov. A full list of MC proteins used for remote 
homology detection is available in Appendix 5.1.  
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Table 5.2. Chlamydia proteins identified by remote sequence homology to bacterial 
membrane-coat like (MC) proteins. MC proteins identified in Santarella-Mellwig et al. (2010) 
were input into HHblits. Instances identified refer to the number of times the chlamydial 
protein was detected as homologous to an MC protein. Gene identifiers correspond to entries 
in the Integrated Microbial Genomes & Microbiome Samples (IMG) database, available at 
https://img.jgi.doe.gov. The probability, expect value (E-value) and sequence identity are listed 
for the best match. The probability of an identified protein to be a true positive (globally 
homologous or locally similar in structure to the query protein) was calculated by comparing 
the amino acid distributions between columns from the query protein alignment and columns 
from the identified protein template alignment together with probabilities for insertions and 
deletions at each position, position specific gap penalties and secondary structure information. 
The expect value (E-value) is the expected number of false positives with a higher probability 
than the identified protein when scanning the database. The sequence identity is the 
percentage of characters which match exactly between the query and the identified protein. 
  
Protein Instances 
identified 
IMG gene identifier of 
best match 
Probability 
(%) 
E-value Sequence 
identity 
CT198 1 637438335 28.15 88 23% 
CT234 22 641112478 90.91 0.027 26% 
CT350 73 638979470 98.40 1e-09 18% 
CT384 62 638979470 96.57 9.3e-05 18% 
CT599 1 637438335 27.51 96 23% 
CT780 1 637438335 59.99 13 29% 
179 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5.3. Structural predictions of identified chlamydial proteins. Amino acid sequences of 
CT234, CT350 and CT384 were submitted to HHpred and InterPro. CT234, predicted to contain 
two domains, was submitted separately for the N-terminal domain (NTD) and C-terminal 
domain (CTD). The top predicted structures with over 50% coverage of the input sequence are 
shown. The probability, expect value (E-value) and sequence identity are listed for the best 
match. The probability of an identified protein to be a true positive (globally homologous or 
locally similar in structure to the query protein) was calculated by comparing the amino acid 
distributions between columns from the query protein alignment and columns from the 
identified protein template alignment together with probabilities for insertions and deletions 
at each position, position specific gap penalties and secondary structure information. The 
expect value (E-value) is the expected number of false positives with a higher probability than 
the identified protein when scanning the database. The sequence identity is the percentage of 
characters which match exactly between the query and the identified protein. For each 
sequence, InterPro predicted a single domain. 
 
 
  
Protein Top predicted structure Probability 
(%) 
E-value Sequence 
identity 
InterPro Domain 
assignment 
CT234  
NTD 
Multidrug transporter 
MdfA 
99.85 3.6E-18 11% Major facilitator 
superfamily domain 
CT234 
CTD 
bGFP-A/EGFP complex 99.90 1.4E-21 16% Armadillo-like 
helical domain 
CT350 Protein phosphatase 
2A regulatory subunit A 
99.80 8.4E-18 14% Armadillo-like 
helical domain 
CT384 Protein phosphatase 
2A regulatory subunit A 
99.91 1.9E-21 11% Armadillo-like 
helical domain 
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5.3 Proteome-wide identification of α-solenoid folds using 
secondary structure prediction 
 
The previous method, although successful in identifying three predicted α-solenoid proteins 
encoded by Chlamydia, is dependent on a degree of sequence homology between the MC 
proteins and chlamydial proteins. Given this requirement, it is unknown as to whether 
Chlamydia encodes further α-solenoid proteins that are not sufficiently homologous at the 
level of primary sequence to be detected. Thus, an alternative, broader approach was adopted 
to determine the entire repertoire of chlamydial α-solenoid proteins. With just 894 coding 
genes, C. trachomatis has a relatively small genome compared to other prokaryotes, more 
readily allowing whole proteome approaches to catalogue specific protein folds. α-solenoid 
proteins have a distinct secondary structure sequence, consisting of repeats of ~10-20 α-
helical residues separated by ~3-8 coil residues. This repeating pattern can be exploited to 
identify proteins likely to have this fold in Chlamydia. 
 
First, a tool for calculating and visualising the consensus secondary structure prediction 
sequences of proteins was written using the Python programming language (for code, see 
Appendix 5.2). The tool creates a consensus SSE sequence from the SSE predictions and 
confidence values of three available SSE prediction algorithms: Jpred, Psipred and RaptorX 
(Cuff et al., 1998; McGuffin et al., 2000; Källberg et al., 2012). For each amino acid residue of 
the protein sequence of interest, the SSE type (helix, strand or coil) and corresponding 
confidence value (scored from 0-9, with 9 being high confidence) are recorded and summed. 
The SSE type with the highest confidence value is then selected as the consensus SSE for this 
position, and the confidence value of this consensus SSE is recalculated by dividing the sum of 
the confidence values for the SSE type by the maximum confidence value possible, which is 27 
(3*9). For example, if Psipred and RaptorX predict an α-helix at a certain position with 
confidence values of 8 and 7 respectively, whilst Jpred predicts a β-strand with confidence 
value of 5, the consensus SSE will be an α-helix with a confidence of 15/27. The consensus 
sequence is then output using the PostScript language to a visual format, where residue type is 
indicated by colour and confidence is indicated by bar height. 
 
By visualising the consensus SSE sequences of a group of proteins with similar structures, 
parameters can be devised from the recurring SSE features to filter the chlamydial proteome 
to identify proteins with similar SSE sequences, such as α-solenoids. The consensus sequence 
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of the SSE predictions of structural Nups and NTRs are depicted in Figure 5.1. The results 
showed two distinct SSE patterns corresponding to the domains of human structural NPC 
proteins described previously (Devos et al., 2006), with proteins forming either a β-propeller 
fold (Nup37, Nup43, Sec13, Seh1), an α-solenoid fold (Nup85, Nup107), or a combination of 
both (Nup133, Nup160). Additionally, the NTR importin-β also formed an α-solenoid fold. The 
α-solenoid fold in the Nups and NTRs was minimally 450 amino acids in length, was comprised 
of over 90% α-helix or loop SSEs and over 40% α-helix SSEs, and had a minimal uninterrupted 
sequence of α-helix and/or loop residues of 200 (Fig 5.1). These observations were therefore 
used as parameters to filter the chlamydial proteome to identify NPC- or NTR-like α-solenoid 
proteins.  
 
First, each protein sequence of the predicted C. trachomatis D/UW-3/CX proteome were 
analysed by PsiPred, Jpred and RaptorX to acquire SSE predictions (Fig 5.2). The secondary 
structure consensus tool was then run to determine an SSE consensus for each protein. Using 
the parameters for the identification of α-solenoids defined previously, the proteome was 
then filtered to identify all potential α-solenoids proteins. In total, 55 proteins remained from 
the 894 sequences examined (Appendix 5.3). The SSE predictions of these proteins were then 
manually curated to remove proteins unable to adopt an α-solenoid that had been detected 
despite filtering (Fig 5.3). For example, whilst the SSE sequence of CT641 is of sufficient length 
and composition to meets the previously defined parameters, it is comprised of extensive α-
helical regions rather than alternating α-helical and coil repeats characteristic of α-solenoids, 
and so was excluded (Fig 5.3A). Conversely, the SSE sequence of CT350 consists of alternating 
α-helical and coil repeats and so was accepted (Fig 5.3B). After curation, just 12 potential α-
solenoid proteins remained (Fig 5.3C). These 12 proteins were then submitted to HHpred and 
InterPro, and only three proteins, CT234, CT350 and CT384, were predicted to contain an α-
solenoid fold by both algorithms. The consensus SSE prediction of these proteins is shown in 
Figure 5.4. All three of these proteins were identified using the previous method, supporting 
the prediction that they adopt an α-solenoid fold, and suggesting no further α-solenoid 
proteins are present in the predicted Chlamydia proteome.   
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Figure 5.1. Graphical representation of consensus secondary structure sequences of a subset 
of structural Nups and importin-β. The consensus secondary structure sequence and 
confidence (bar height) was determined from three prediction algorithms, PsiPred, Jpred and 
RaptorX. β-sheets are represented in blue, α-helices in pink, whilst coil residues are not shown. 
Vertical scale bar, confidence (Conf) scored from 0-9. Horizontal scale bar, residue number.  
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Figure 5.2. Workflow used to identify chlamydial proteins with α-solenoid fold. Parameters 
for filtering the chlamydial proteome were determined based on the secondary structure 
sequence of α-solenoids from NPC proteins and NTRs.  
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Figure 5.3. Consensus secondary structure sequences of the predicted α-solenoid proteins in 
the C. trachomatis proteome. The consensus secondary structure element (SSE) sequence was 
determined for each protein in the C. trachomatis proteome from three prediction algorithms, 
PsiPred, Jpred and RaptorX. The SSE sequences were then filtered for proteins with an α-
solenoid fold using parameters (as defined in Figure 5.2) devised from analysis of the 
secondary structure sequence of structural Nups and importin-β. Following filtering, 55 
proteins remained (Appendix 5.3). Sequences were then manually curated to remove incorrect 
hits such as (A) CT641, which is comprised of extensive α-helical regions rather than 
alternating α-helical and coiled coil repeats characteristic of α-solenoids as in (B) CT350. 
Following curation, 12 SSE sequences remained, corresponding to the chlamydial proteins in 
(C). β-sheets are represented in blue, α-helices in pink, whilst coil residues are not shown. 
Vertical scale bar, confidence (Conf) scored from 0-9. Horizontal scale bar, residue number. 
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Table 5.4. Structural predictions of predicted chlamydial α-solenoid proteins. Amino acid 
sequences of chlamydial α-solenoid proteins (Fig 5.3C) were submitted to HHpred and 
InterPro. CT234, predicted to contain two domains, was submitted separately for the N-
terminal domain (NTD) and C-terminal domain (CTD). The top predicted structures with over 
50% coverage of the input sequence are shown. The probability, expect value (E-value) and 
sequence identity are listed for the best match. The probability of an identified protein to be a 
true positive (globally homologous or locally similar in structure to the query protein) was 
calculated by comparing the amino acid distributions between columns from the query protein 
alignment and columns from the identified protein template alignment together with 
probabilities for insertions and deletions at each position, position specific gap penalties and 
secondary structure information. The expect value (E-value) is the expected number of false 
positives with a higher probability than the identified protein when scanning the database. The 
sequence identity is the percentage of characters which match exactly between the query and 
the identified protein. The InterPro domains with the great sequence coverage are shown. 
Protein Top predicted structure 
(>50% sequence coverage) 
Probability 
(%) 
E-value Sequence 
identity (%) 
InterPro Domain 
assignment 
CT114 No detected structures - - - C-terminal 
tetratricopeptide-
like helical domain 
CT204 NADC family transporter 100.00 7.7E-39 20 Sodium/sulphate 
symporter 
CT234 
NTD 
Multidrug transporter 
MdfA 
99.85 3.6E-18 11 Major facilitator 
superfamily 
domain 
CT234 
CTD 
bGFP-A/EGFP complex 99.90 1.4E-21 16 Armadillo-like 
helical domain 
CT250 Chromosomal replication 
initiator protein DNAA 
100.00 8.3E-52 25 P-loop containing 
nucleoside 
triphosphate 
hydrolase 
CT275 Chromosomal replication 
initiator protein DNAA 
100.00 3.1E-50 32 P-loop containing 
nucleoside 
triphosphate 
hydrolase 
CT350 Protein phosphatase 2A 
regulatory subunit A 
99.80 8.4E-18 14 Armadillo-like 
helical domain 
CT384 Protein phosphatase 2A 
regulatory subunit A 
99.91 1.9E-21 11 Armadillo-like 
helical domain 
CT409 Arginine/agmatine 
antiporter 
99.96 2.4E-27 14 Sodium/alanine 
symporter 
CT608 DNA helicase II 100.00 2.4E-73 38 P-loop containing 
nucleoside 
triphosphate 
hydrolase 
CT636 No detected structures - - - No detected 
domains 
CT651 Cell division cycle protein 
16 homolog 
100.00 7.9E-30 10 No detected 
domains 
CT744 Pre-mRNA-processing 
factor 6 
99.97 1.7E-25 11 No detected 
domains 
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Figure 5.4. Graphical representation of consensus secondary structure sequences of 
identified chlamydial proteins. The consensus secondary structure sequence and confidence 
(bar height) was determined from three prediction algorithms, PsiPred, Jpred and RaptorX. β-
sheets are represented in blue, α-helices in pink, whilst coil residues are not shown. Nup85 
and importin-β are shown for comparison. Vertical scale bar, confidence (Conf) scored from 0-
9. Horizontal scale bar, residue number.  
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5.4 Prediction of bacterial protein secretion 
 
In order for a Chlamydia protein to be a bacterial effector, it must first be secreted by the 
pathogen. Chlamydia has two known secretion pathways involved in the translocation of 
virulence effectors, the type II secretion pathway and the type III secretion pathway. 
 
For T2S, effectors possess an N-terminal signal peptide for translocation across the bacterial 
cytoplasmic membrane into the periplasmic space via the Sec or Tat pathways, and are 
subsequently exported by the double-membrane-spanning T2S system (Voulhoux et al., 2001; 
Filloux, 2004; Costa et al., 2015). SignalP is an algorithm that uses a neural-network based 
method trained and tested separately on eukaryotes, Gram-positive and Gram-negative 
bacteria for the prediction of signal peptides from amino acid sequences for translocation into 
the periplasmic space (Petersen et al., 2011). SignalP can therefore be used to predict 
chlamydial proteins targeted for secretion via T2S, and is the highest performing N-terminal 
signal peptide prediction method according to two independent assessments (Choo et al., 
2009; Petersen et al., 2011; Sperschneider et al., 2015). SignalP outputs a score between 0 and 
1.0, with the authors recommending scores above 0.45 as indicating sufficient selectivity and 
sensitivity for a positive prediction (Petersen et al., 2011). 
 
For type III secretion, five algorithms exist for the prediction of secretion, EffectiveT3 (Arnold 
et al., 2009), ANN (Löwer and Schneider, 2009), BPBAac (Wang et al., 2011), T3_MM (Wang et 
al., 2013) and BEAN 2.0 (Dong et al., 2015). EffectiveT3, ANN and BPBAac use machine learning 
approaches that take into account N-terminal sequence features such as amino acid 
composition (Aac), frequency of SSEs and G+C content of the primary DNA sequence (Arnold et 
al., 2009; Löwer and Schneider, 2009; Wang et al., 2011). EffectiveT3 and ANN apply a sliding 
window approach, varying the start and length of the sequence during the learning and testing 
procedure, in order to determine the region of the N-terminus to analyse (Arnold et al., 2009; 
Löwer and Schneider, 2009). EffectiveT3 outputs a probability score from 0 to 1, with 0.95 
considered to be the minimum for a positive prediction. ANN uses a threshold as the decision 
boundary for classification of output as positive or negative for T3S, with values above 0.4 
indicating a sufficient true positive to false positive ratio to be predicted as T3S. BPBAac adopts 
a different approach, identifying distinct position-specific Aac profiles using the first 100 amino 
acids of the N-terminus (Wang et al., 2011). BPBAac is scored from 0 to 1.0, with the authors 
suggesting a score of 0.5 as minimal for a positive prediction with selectivity of over 95% 
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(Wang et al., 2011). T3_MM calculates and compares the absolute composition of each species 
of amino acid across a 100 amino acid N-terminal region between T3S and non-T3S proteins, 
and also sequentially calculates and compares the probability of each amino acid at the 
current position based on the amino acid at the preceding position between T3S and non-T3S 
proteins (Wang et al., 2013). From these values, a likelihood ratio (R) of a sequence being a T3S 
or a non T3S protein is determined. A minimal R value of 0 is suggested as a cut-off, at which 
point proteins are predicted as effectors with 89.6% selectivity and 90.9% sensitivity (Wang et 
al., 2013). Finally, BEAN 2.0 combines a sequence alignment-based predictor, which searches 
the training dataset for the most similar sequence to the query, a domain based-predictor, 
which scans and compares the Pfam domains of the query protein to the Pfam domains of the 
training dataset, and a machine-learning predictor, which analyses the Aac separately for the 
N-terminal 2-51 amino acids, 52-121 amino acids and C-terminal 50 amino acids and compares 
to the training dataset (Dong et al., 2015). Bean 2.0 also recommends a minimal score of 0 as a 
cut-off for positive prediction of T3S, although the significance of this value was not described 
(Dong et al., 2015). Independent studies to determine which of these algorithms performs the 
best with regards to sensitivity and selectivity have not been conducted, therefore all five 
algorithms were used in parallel. 
 
To determine which of the identified α-solenoid proteins are predicted to possess a signal 
peptide for translocation through the Sec or Tat pathways, or are likely to be exported by a 
type III secretion system, amino acid sequences of CT234, CT350 and CT384 (see Appendix 5.4) 
were analysed using the six prediction algorithms described previously (Table 5.5). CT234 was 
not predicted by any of the algorithms to be secreted. CT350 was predicted to have a signal 
peptide for translocation to the bacterial periplasm using SignalP 4.0, and predicted by ANN 
and BEAN 2.0 to be secreted by T3S. It is unknown whether a protein can be secreted by both 
the Sec/Tat machinery and T3S systems, but as this has never been reported it is unlikely. 
CT384 was predicted by EffectiveT3 and ANN to be secreted by T3S. ANN was the only 
algorithm that predicted both of these proteins to be T3S, with CT384 scoring 0.920 and CT350 
scoring 0.430. Whilst neither of these two proteins were predicted to be secreted using 
BPBAac, both scores were close to the author-suggested cut-off of 0.5 at 0.401 for CT350 and 
0.455 for CT384. Additionally, both proteins scored close to the cut-off of 0 when analysed by 
T3_MM, with CT384 scoring -0.101 and CT350 scoring -0.187. Taken together, these data 
suggest that CT234 is unlikely to be secreted by Chlamydia, whilst both CT350 and CT384 could 
be chlamydial effector proteins.  
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Protein Type II secretion Type III secretion 
SignalP 4.0 EffectiveT3 
1.0.1 
BPBAac ANN T3_MM Bean 2.0 
CT234 0.130 0 -0.963 0.040 -0.564 -0.303 
CT350 0.676 0 0.401 0.430 -0.187 0.00651 
CT384 0.147 0.998 0.455 0.920 -0.101 -0.346 
 
 
 
 
Table 5.5. Prediction of secretion of C. trachomatis α-solenoid containing proteins. Cells 
shaded yellow scored above the author-suggested cut-offs for the algorithm (for a detailed 
explanation of the scoring method of each algorithm, refer to section 5.4). SignalP 4.0 cut-off = 
0.570, EffectiveT3 1.0.1 cut-off = 0.95, BPBAac cut-off = 0.5, ANN cut-off = 0.4, T3_MM cut-off 
= 0.0, Bean 2.0 cut-off = 0.0. 
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5.5 CT384-GFP is enriched in the nucleus when expressed in 
host cells 
 
To determine the localisation of potential effector proteins in bacterial pathogens, antibodies 
can be raised against the protein of interest to observe protein localisation at endogenous 
levels. Alternatively, tagged constructs can be used to transform the bacteria and the 
localisation of the protein observed by immunofluorescence labelling. However, chlamydial 
proteins typically have poor antigenicity, and genetic tools to transform Chlamydia are not yet 
widely available. To circumvent these issues, the protein of interest can be ectopically 
expressed as a fusion protein with GFP in the host cell. Although this is more artificial than 
expression by the bacteria, it is frequently used in the field as an alternative approach for 
determining initial localisation, and so allowing further functional studies to be conducted. 
 
Mammalian expression vectors encoding for CT350-GFP and CT384-GFP were used to transfect 
HeLa cells, with vector encoding for GFP alone used as a control. GFP alone was distributed 
across the cell, with enrichment at the nucleus in some cells, whilst other cells had no nuclear 
enrichment (Fig 5.5A). Both CT350-GFP and CT384-GFP appeared enriched in the nucleus of 
transfected cells, and the nucleus in these cells appeared more lobulated and the nucleoli 
distorted (Fig 5.5B and C). To confirm nuclear enrichment of CT350-GFP and CT384-GFP in 
transfected cells, fluorescence intensity was quantified in the nucleus and in the cytosol, and 
the mean nuclear fluorescence intensity relative to cytosolic fluorescence intensity plotted as a 
histogram (Fig 5.6). For GFP, the ratio of mean nuclear fluorescence to mean cytosolic 
fluorescence was 1.37 ± 0.41. For CT350-GFP and CT384-GFP, the ratio of mean nuclear 
fluorescence to mean cytosolic fluorescence was 1.70 ± 0.42 and 2.39 ± 0.54 respectively. The 
difference in the relative nuclear fluorescence between GFP and CT350-GFP was not 
statistically significant (p>0.05) when the datasets were compared using the Student’s t-test, 
whilst the difference in the relative nuclear fluorescence between GFP and CT384-GFP was 
statistically significant (p<0.05). 
 
Taken together, these data suggest that the remote sequence homology, SSE prediction and 
fold recognition approaches were successful in identifying chlamydial proteins capable of 
localisation to the nucleus when expressed in eukaryotic cells. Further experiments to identify 
which host proteins are interacting with these chlamydial proteins and the localisation of these 
chlamydial proteins during infection will shed further light on their function.  
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Figure 5.5. Preliminary data suggests chlamydial α-solenoid proteins localise to the nucleus 
when ectopically expressed in HeLa cells. HeLa cells transiently expressing mammalian 
expression vector encoding for (A) GFP, (B) CT350-GFP or (C) CT384-GFP were fixed and 
viewed by confocal microscopy. Scale bars, 10 μm.  
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Figure 5.6. CT384-GFP is significantly enriched at the nucleus when ectopically expressed in 
HeLa cells. HeLa cells transiently expressing GFP, CT350-GFP or CT384-GFP were fixed and 
viewed by confocal microscopy. Fluorescence intensity of maximum intensity projections of 
confocal xy-sections was measured in the nucleus and in the cytosol (n=10) of transfected 
cells, and the mean ratio of nuclear to cytosolic fluorescence signal plotted as a histogram. 
Error bars show standard deviation (**p<0.05 using Student’s t-test between GFP and CT350-
GFP/CT384-GFP). 
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5.6 Discussion 
 
In this chapter, computational methods have been used to identify chlamydial proteins 
structurally similar to structural NPC or NTR proteins that localise to the nucleus when 
ectopically expressed in host cells. The first of these methods used remote sequence 
homology and fold recognition (Tables 5.1-5.3), whilst the second used a proteome-wide 
approach, taking advantage of the common SSE features of structural NPC proteins and NTRs 
to identify similar folds in proteins encoded by C. trachomatis (Figs 5.2-5.4 and Table 5.4). Both 
methods identified three proteins: CT234, CT350 and CT384. Of these, CT350 and CT384 are 
predicted to be secreted by the bacteria according to secretion prediction algorithms (Table 
5.5).  
 
To confirm whether the prediction of secretion of CT350 and CT384 is correct, and so whether 
these chlamydial proteins are capable of being effectors, antibodies could be raised against 
CT350 and CT384 to detect their presence in the host cell during infection. For this approach, 
purified protein should be produced to immunise a host, serum should be collected and 
antibodies should be tested. However, as demonstrated by efforts in the Hayward laboratory 
(Dumoux et al., 2015; McMahon, In preparation), production of purified chlamydial proteins is 
not a trivial process and requires a significant time investment, therefore an alternative 
method was adopted. Historically, the secretion of Chlamydia effectors has been 
demonstrated by expressing proteins of interest in Yersinia enterocolitica, which encodes a 
heterologous type III secretion system (Fields and Hackstadt, 2000; Clifton et al., 2004). 
However, during the course of this work attempts were made to transform C. trachomatis 
using the new genetic tools that became available, as this additionally allows the study of 
endogenous localisation of target proteins (Wang et al., 2011). These methods were 
successfully used by Bauler and Hackstadt (2014) to demonstrate the secretion of IncD, an 
inclusion membrane effector. Other effectors genetically tagged with a FLAG sequence have 
also been expressed and properly translocated into the host cell (Agaisse and Derré, 2014). In 
brief, the pTrl2 vector (a kind gift from Professor. Scott Hefty), derived from the endogenous C. 
trachomatis plasmid, was introduced into C. trachomatis EBs by transformation in a CaCl2 
buffer (Wickstrum et al., 2013). pTrl2 encodes beta-lactamase conferring bacterial resistance 
to penicillin G. Rounds of antibiotic selection were then performed using increasing 
concentrations of penicillin G. Successful transformants constitutively express red fluorescent 
protein, and so are visible by fluorescence microscopy. Expression of the tagged protein of 
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interest is controlled by a tetracycline repressor, and is inducible by the addition of 
anhydrotetracycline (Wickstrum et al., 2013). Although C. trachomatis LGV2 was successfully 
transformed in the Hayward laboratory using the original pTRL2 cloning vector, transformation 
experiments using vector with CT384-3xFLAG inserted at the multiple cloning site were to date 
unsuccessful. Modifications to the transformation protocol, for example by using lower 
concentrations of antibiotic during initial rounds of selection, may be used in the future to 
confirm secretion of the identified proteins. 
 
Whilst localisation of CT384 during chlamydial infection remains to be confirmed, preliminary 
data suggests CT384-GFP is enriched in the nucleus when ectopically expressed in HeLa cells, 
and that there is an apparent induction of aberrant nuclear architecture reminiscent of nuclei 
in Chlamydia-infected cells as shown in chapter 3 (Figs 5.5 and 5.6). Further experiments are 
necessary to examine the impact of expression levels on this nuclear localisation, and 
quantification of the frequency of aberrant nuclear architecture is required. Nevertheless, 
experiments to observe the different compartments of the nucleus such as the NE, the 
nucleoli, the nuclear speckles and heterochromatin in these transfected cells may reveal 
further insights into CT384 function, and might be linked to the previous investigations in 
chapters 3 and 4. Should transformation of Chlamydia with pTRL2 vector encoding for CT384-
3xFLAG be successful, coimmunoprecipitation and mass spectrometry studies could be 
conducted with Chlamydia-infected lysates using antibodies to the FLAG tag to identify which 
protein or proteins are interacting with CT384. As CT384 is predicted to have an α-solenoid 
fold that may be mimicking the NTRs, it would be interesting to determine if CT384 interacts 
with NUE, as the mechanism by which NUE traffics to the nucleus is unknown (Pennini et al., 
2010). Similarly, these approaches could be used for other potential effectors such as CT350. 
 
Finally, it would be interesting to apply the bioinformatics approach developed here to 
determine whether other chlamydial proteins have eukaryotic domains. The remote sequence 
homology and fold recognition approach used in this work is specific, requiring an 
intermediate protein to be present in another prokaryote, and so may not be as suitable for 
such searches. The proteomic approach based on SSE prediction may be more transferable, as 
it does not require any sequence homology between the query protein and chlamydial 
proteins for identification. Indeed, during the course of this work a proteomic approach was 
also used by Fournier et al. (2013) to identify α-solenoid proteins from a broad range of 
eukaryotic, archaeal and prokaryotic proteomes. In their approach, a neural network was 
trained on known α-solenoid protein sequences to identify the linker between two α-helices of 
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a repeat unit, and three such identifications were required to predict a protein sequence as 
containing an α-solenoid (Fournier et al., 2013). For the Chlamydiae, 155 α-solenoids were 
identified from 103375 protein sequences, a frequency of 0.15% (Fournier et al., 2013). When 
compared to the 894 ORFs of the C. trachomatis genome, a frequency of 0.15% predicts 1.34 
α-solenoid-containing proteins, less than the three proteins found in this work predicted to 
have an α-solenoid fold. These data indicate that C. trachomatis may encode a higher than 
average number of α-solenoid proteins than other members of the Chlamydiae. Nevertheless, 
the analysis by Fournier et al. (2013) supports the predictions of α-solenoid-containing 
Chlamydia proteins presented in this chapter, and validates the use of a broad, proteome-
based method. It would be interesting to use the proteomic approach to search for other 
chlamydial proteins that may mimic eukaryotic folds, such as, for example, the SUN or KASH 
domains of the LINC proteins in the NE, which are involved in the regulation of nuclear 
positioning and movement (Burke and Roux, 2009).   
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Chapter 6 – Discussion 
 
The results presented in this thesis demonstrate a novel and unique interaction between  
Chlamydia trachomatis and the host nucleus. During infection, the nucleus appears polarised 
with the formation of a specific domain proximal to the inclusion, leading to gross architectural 
changes to the entire nucleus, whereby the shape of the nuclear envelope (NE) becomes 
increasingly lobulated (Fig 6.1). Indeed, the NE proximal to the inclusion exhibits an 
enrichment of lamin A/C, termed a ‘lamin A/C patch’, whereas the region of the NE distal to 
the inclusion exhibits depletion of lamin A/C (Figs 3.7-3.10). This lamin A/C patch is coincident 
with a reduction in lamin B (Figs 3.11 and 3.12) and corresponding depletion of NPCs (termed 
an ‘NPC gap’) (Figs 3.14 and 3.15), which is only observed at the inclusion-proximal face of the 
NE with no additional disruption occurring around the remainder of the NE. These Chlamydia-
induced NE modifications are distinct from endogenous cellular pore-free islands, as the ER is 
not excluded from the region closely surrounding them, and no characteristic enrichment in 
emerin is present (Figs 3.24-3.26) (Maeshima et al., 2006). C. trachomatis drives the 
enrichment of lamin A/C (Figs 4.2-4.4), and the lamin A/C patch was demonstrated to be 
necessary for the depletion of NPCs by using a LMNA-/- cell line (Figs 4.17 and 4.19). 
Furthermore, these changes in lamin A/C induced a specific enrichment of heterochromatin at 
the inclusion-proximal face of the nucleus (Figs 4.13-4.15 and 4.18-4.19). This nuclear 
reorganisation led to an absence of transport at the nuclear-proximal face of the inclusion but 
failed to discernibly redistribute global cellular mRNA (Figs 4.7 and 4.9-4.10). Finally, 
chlamydial infection in the absence of lamin A/C permitted increased bacterial replication (Fig 
4.22). 
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Figure 6.1. Summary of the Chlamydia-induced modifications to nuclear architecture in 
infected wild-type and LMNA-/- cells. (A) In wild-type (WT) cells infected with C. trachomatis 
LGV2 or C. trachomatis A a specific domain is formed proximal to the inclusion, characterised 
by enriched lamin A/C (red), depletion of NPCs (green) and enrichment of heterochromatin 
(blue). The inclusion-distal face of the nuclear envelope (black) becomes lobulated. (B) In 
LMNA-/- cells infected with C. trachomatis LGV2 a domain of depleted NPCs and enriched 
heterochromatin is not formed, although the inclusion-distal face of the nuclear envelope 
remains lobulated. However, the inclusion is larger and more bacterial progeny are produced. 
EBs: elementary bodies. RBs: reticulate bodies. 
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The Chlamydia-induced alterations involve the depletion of lamin A/C from the inclusion-distal 
region of the NE, and simultaneous stabilisation or enrichment at the inclusion-proximal face 
(Figs 3.7-3.10). It is unlikely that a single bacterial effector mediates both depletion and 
stabilisation of lamin A/C, and so two distinct pathways likely account for these alterations. 
Lamin A/C is removed from the NE via two cellular processes. Firstly, cyclin dependent kinase 1 
(Cdk1) phosphorylates both serine 22 in the head domain and serine 392 in the tail domain of 
lamin A/C to induce depolymerisation and the consequent disassembly of the NL during 
mitosis (Heald and McKeon, 1990; Peter et al., 1990). Secondly, caspase-6 is activated during 
apoptosis and can cleave lamin A/C (Orth et al., 1996; Takahashi et al., 1996). Immunoblotting 
experiments demonstrated that lamin A and lamin C levels are reduced during infection (Fig 
3.10), suggesting lamin A/C is depleted rather than disassembled and rearranged. Caspase-6 is 
therefore one candidate capable of mediating the depletion of lamin A/C during infection. 
Caspase-6 can be activated by caspases 1, 3, 7 and 9 (Guo et al., 2006; Inoue et al., 2009; 
Akpan et al., 2011), or by self-activation upon over-expression (Klaiman et al., 2009). 
Conversely, caspase-6 activity is reduced by interaction with the transcription factor Sox11 
(Waldron-Roby et al., 2015). Chlamydial subversion of caspase-6 regulation is therefore a 
possible pathway by which lamin A/C levels are depleted during infection. Alternatively, 
Chlamydia also secretes proteases, including CT441 and HtrA, to degrade substrates such as 
the p65/RelA subunit of the heterodimeric NF-κB complex (CT441) (Lad et al., 2007a; Wu et al., 
2011). It is therefore possible that Chlamydia encodes an effector that targets lamin A/C 
directly. Type II secretion can be blocked using arylomycin C16, an inhibitor of the Sec-
dependent pathway peptidase I, and so whether the likely T2S protease HtrA may be involved 
in degradation of lamin A/C could be determined (Wu et al., 2011). Should neither capsase-6 
nor chlamydial proteases be involved in the lamin A/C degradation, a broader approach may 
be required to identify Chlamydia effectors required for lamin A/C depletion, such as screening 
of a library of C. trachomatis mutants to identify a strain that does not induce depletion of 
lamin A/C (Kokes et al., 2015). 
 
Analysis of lamin A/C fluorescence around the nuclear periphery demonstrated that lamin A/C 
levels are equal to or greater at the inclusion-proximal face of the NE than lamin A/C levels in 
non-infected cells (Fig 3.9). It could be argued that these changes represent a stabilisation of 
pre-existing lamin A/C. Indeed, in Hutchinson-Gilford progeria syndrome (HGPS) cells the 
thickening of the lamin A/C network at the nuclear periphery is attributed solely to the 
accumulation of a truncated form of lamin A, LAΔ50, as the normal processing and turnover of 
this truncate is disrupted (Goldman et al., 2004). Alternatively, lamin A/C could be re-localised 
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from elsewhere in the nucleus into this inclusion-proximal region of the NE. Such a 
rearrangement occurs during human cytomegalovirus (HCMV) infection (Camozzi et al., 2008). 
This viral pathogen redirects both lamin A/C and lamin B into regions of HCMV protein UL53 
accumulation at late stages of infection, resulting in a ruffled staining pattern of lamins at the 
nuclear rim. This rearrangement was also dependent on the viral protein UL50, but no 
variations in the total amount of nuclear lamins were detected during HCMV infection 
(Camozzi et al., 2008). Thus, C. trachomatis likely secretes an effector or effectors that direct 
the specific stabilisation or enrichment of lamin A/C on the inclusion-proximal face of the NE. 
The C. psittaci SINC effector localises to the inner face of the NE adjacent to the inclusion, and 
localises in close proximity to NL proteins including lamin A/C. However these authors could 
not identify a homologue of SINC encoded by C. trachomatis (Mojica et al., 2015). 
Immunoprecipitation experiments may yet reveal the identity of Chlamydia effectors in 
complex with lamin A/C. 
 
A key feature of the lamin A/C patch was its location in close proximity to the inclusion 
membrane. Analysis of electron micrographs of infected cells revealed the IM closely follows 
the contours of the NE (Fig 3.4), and across this region there is an increase in electron density 
in the IM suggesting the IM may be modified, for example, with specific Inc proteins. 
Furthermore, the distance between the IM and NE is consistent, hinting at the presence of 
complexes between these membranes which maintain the separation. Cryo-electron 
tomography techniques such as those used by Nans and colleagues (2014) may yet reveal 
electron densities between the IM and NE. Nevertheless, the lamin A/C patch may represent a 
novel junction between the nucleus and the inclusion mediated by chlamydial proteins. 
Precedent exists for such junctions between the inclusion and host organelles, as membrane 
contact sites (MCSs) between the C. psittaci RB envelope, the IM and mitochondria, and 
between the C. trachomatis RB envelope, the IM and the ER have previously been reported 
(Matsumoto, 1981; Dumoux et al., 2012). However, in both of these examples RBs are 
frequently located in the inclusion lumen at the contact site, which was not observed where 
the IM and the NE are adjacent. Furthermore, the distance between the IM and the 
mitochondria, or the IM and the ER at these MCSs is approximately 10-30 nm, significantly less 
than the 163 nm distance observed between the IM and the NE. These data therefore suggest 
if a junction does exist between the IM and NE where lamin A/C is enriched, it is likely 
structurally distinct from MCSs observed previously, and warrants further investigation. 
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NPCs are also depleted and lamin B is reduced in the region of the NE where the lamin A/C 
patch is located (Figs 3.11-3.15). A similar phenotype is observed in cellular pore-free islands, 
which are present on the nuclear surface of proliferating cells and are also characterised by an 
enrichment in lamin A/C, and the depletion of lamin B and NPCs (Maeshima et al., 2006). As 
discussed previously, the nuclei of HGPS cells also exhibit a thickening of lamin A/C, resulting in 
abnormal pore distribution and depletion of lamin B in regions of increased lobulation 
(Goldman et al., 2004). It is therefore likely that the NPC gap and lamin B reduction are a 
cellular response to the enrichment of lamin A/C, rather than being specifically induced by 
Chlamydia. Heterochromatin was also enriched proximal to the inclusion and is dependent on 
the presence of lamin A/C (Figs 4.13-4.15, 4.18 and 4.19). Maeshima and colleagues (2006) did 
not investigate heterochromatin with respect to PFIs, but Goldman and co-workers (2004) 
observed a complete loss of peripheral heterochromatin in HGPS nuclei, a phenotype counter 
to that evident in Chlamydia-infected cells. There may therefore be another Chlamydia 
effector that drives the lamin A/C-associated redistribution of heterochromatin. NUE exhibits 
in vitro histone methyltransferase activity via a SET domain, and localises to the nucleus when 
ectopically expressed in mammalian cells (Pennini et al., 2010). Methylation of histone H3 
lysine 9 has a role in targeting and anchoring chromatin to the NE, and so NUE could 
potentially function in the reorganisation of heterochromatin (Towbin et al., 2013). The 
endogenous localisation of NUE is yet to be determined in infected cells, but with recent 
advances in the genetic manipulation of Chlamydia, it is now feasible to generate a strain 
expressing epitope-tagged NUE to study this (Weber et al., 2015). Parallel experiments 
conducted in the Hayward laboratory by Dr. Maud Dumoux have shown that nucleoplasmic 
lamin A/C is depleted during late (48-72 hpi) C. trachomatis infection in addition to the 
depletion from the NE presented in this thesis (Dumoux and Hayward, unpublished data). A 
recent study by Gesson and co-workers (2016) demonstrated that nucleoplasmic lamin A/C 
interacts with euchromatic regions bound by LAP2α in addition to heterochromatic lamina-
associated domains, and so depletion of nucleoplasmic lamin A/C may have consequences for 
the epigenetic regulation of both gene activation and gene repression in infected cells (Gesson 
et al., 2016). 
 
In chapter 4 experiments were conducted to determine the functional impact of  
C. trachomatis induced NE alterations. As NPCs were depleted, host nucleocytoplasmic 
transport was assessed. The NTR importin-β was excluded from a region of the nuclear 
periphery proximal to the inclusion (Fig 4.7), suggesting transport of proteins is blocked in this 
area as observed at pore-free islands (Appendix 6.1). This correlates with the absence of NPCs 
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at the inclusion-proximal face of the NE, demonstrating that host nucleocytoplasmic transport 
does not occur in regions of the NE lacking NPCs. However, given that the NPC gap is likely an 
indirect consequence of the formation of the lamin A/C patch, it is difficult to speculate as to 
how the local absence of host nucleocytoplasmic transport is advantageous to the chlamydial 
lifecycle. Changes to total nuclear mRNA levels were not detected during infection, suggesting 
global mRNA export is not significantly impaired, and so the functional consequences of NPC 
gap formation remain unclear (Fig 4.10). The speckle-like pattern of nuclear mRNA 
fluorescence did however appear more clustered in infected cells (Fig 4.9). Compaction of the 
nuclear area in the xy-plane due to the distortion of nuclear shape may account for these 
changes, but nevertheless it would be interesting to investigate the behaviour of the nuclear 
speckles, the mRNA splicing compartments of the nucleus, in infected cells. Nuclear speckles 
become enlarged and rounded during inhibitor induced, or heat-shock induced, transcriptional 
inhibition, and speckles compact when transcription levels are high such as during viral 
infection (Lamond and Spector, 2003). Thus, the morphology of nuclear speckles during 
chlamydial infection may be an indicator of host transcription levels, the study of which could 
reveal novel mechanisms by which Chlamydia targets the host nucleus. 
 
In addition to the nuclear speckles, the host nucleus contains many other structures that 
mediate specialised nuclear functions from transcription to DNA repair. Given the architectural 
and compositional changes in the NE and the associated reorganisation of heterochromatin, 
studying these other major compartments and structures of the nucleus such as the 
chromosome territories and the nucleoli could determine the extent to which Chlamydia is 
hijacking this major organelle. Chromosome territories describe the non-random distribution 
of chromosomes within the nucleus, in which both highly transcribed and poorly transcribed 
regions are segregated, allowing for co-regulation of the activation or repression of expression 
of specific genes (Cremer and Cremer, 2010). Changes in the distribution of chromosome 
territories have been described during viral infection. Epstein-Barr virus infection induced 
alterations in the radial position of chromosome 17, whereas the localisation of chromosome 
18 remained stable (Li et al., 2010). However, the consequences of positional changes in 
chromosome 17 were not determined. In the context of the results presented in this thesis, 
the chromosome territories would be interesting to study to identify whether any clusters of 
genes are specifically relocated to the enriched region of heterochromatin on the inclusion-
proximal face of the nucleus, and so explain why it is advantageous for the bacteria to 
reorganise the heterochromatin to this location. 
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The impact of the changes in lamin A/C on nuclear shape, stability and stiffness should also be 
considered. A-type lamins are the main proponents in providing mechanical support to the 
nucleus from lamin A/C located in both the nucleoplasm and the nuclear periphery (Dahl et al., 
2004). Additionally, A-type lamins allow the cell to modulate gene expression in response to 
extracellular or cytoskeletal forces in a process termed mechanotransduction (Crisp et al., 
2006; Dahl et al., 2008). Inclusion-distal depletion of lamin A/C likely results in the increased 
lobulation of nuclei during Chlamydia infection (Fig 4.2), as the nuclei of infected cells lacking 
lamin A/C were similarly lobulated (Fig 4.20). These observations correlate with increased 
lobulation of nuclei in granulocytes, a phenotype also linked to the depletion of lamins (Olins 
et al., 2001), but contrast with progeria cells, in which accumulation of truncated lamin AΔ50 
also induces nuclear lobulation (Goldman et al., 2004). Nevertheless, the inclusion-distal 
depletion and inclusion-proximal stabilisation of lamin A/C likely differentially impact the 
flexibility of nuclei. Lamin A/C is enriched on the inclusion-proximal face of the nucleus, and 
thus the stiffness of this region of the NE is likely increased. One could hypothesise that this 
reinforced region of the NE would provide a platform for the inclusion to support its expansion 
and maintain its shape. However, inclusions within infected LMNA-/- mouse embryonic 
fibroblasts (MEFs) were similarly shaped and were also larger than those formed within WT 
MEFs (Fig 4.21). The functional consequences of the stabilisation of lamin A/C proximal to the 
inclusion are therefore unlikely to be related to the flexibility of the NE in this region. 
 
Conversely, the NE distal to the inclusion is likely more flexible, as cells lacking lamin A/C 
exhibit reduced nuclear stiffness, but also misshapen nuclei and increased nuclear and cellular 
fragility due to a loss of connectivity between the nucleus and the cytoskeleton (Broers et al., 
2004; Lammerding et al., 2004). The reduction in lamin A/C may therefore increase cellular 
sensitivity to mechanical stress caused by, for example, the expanding inclusion, which could 
contribute to the lytic pathway of Chlamydia exit from the host cell. One could also consider 
the in vivo scenario, in which pressure would be applied on the Chlamydia-infected cell by the 
surrounding cells of the epithelium, promoting lysis once the inclusion expands to a critical 
point. As a starting point to investigating these possibilities, the propensity for bacterial exit via 
the lytic pathway in cells lacking lamin A/C could be analysed. Furthermore, it would also be 
intriguing to consider whether the infection model typically used for studying Chlamydia 
infection may also have an impact on the architectural changes to the nucleus and nuclear 
envelope. In vivo, C. trachomatis preferentially infects the columnar epithelium, an organised 
layer of polarised rectangular epithelial cells. In comparison to infection of HeLa or MEF cell 
lines, numerous infection characteristics are altered during infection of these polarised 
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epithelial cells, including entry and exit mechanisms, infectious progeny, infection kinetics and 
a number of innate immune pathways (Wyrick and Bavoil, 2006). As an initial avenue to 
investigating whether characteristics such as cell shape or orientation impact on the observed 
changes to lamin A/C and nuclear shape, infection of polarised epithelial cells such as the A2EN 
human endocervical epithelial cell line could therefore be studied (Buckner et al., 2013). 
 
Finally, LMNA-/- MEFs were utilised in experiments presented in this thesis in the context of 
examining the effects on the Chlamydia lifecycle. As previously described, in infected cells 
lacking lamin A/C inclusions are significantly larger and more infectious progeny are produced 
(Figs 4.21 and 4.22). This challenged the understanding of the functionality of the lamin A/C 
patch. Ongoing work in the laboratory has shown that inclusion size and infectious progeny are 
also increased in HGPS cells infected with C. trachomatis (Dumoux and Hayward, unpublished 
data). While LMNA-/- cells and HGPS cells exhibit an absence and stabilisation of lamin A/C at 
the NE respectively, a clear decrease in nucleoplasmic lamin A/C can be observed in both. This 
highlights the potential importance for nucleoplasmic lamin A/C-mediated reorganisation of 
heterochromatin and the potential effects on gene expression. It would be interesting to study 
the effect on the Chlamydia lifecycle when the degradation of inclusion-distal lamin A/C is 
prevented. If the reverse phenotype occurs, then a smaller inclusion and less infectious 
progeny may be expected. 
  
In conclusion, the data presented in this thesis have demonstrated a novel mechanism by 
which a pathogenic intracellular bacterium interacts with and manipulates the host nucleus. 
C. trachomatis polarises the nucleus towards the inclusion by inducing major architectural 
changes to the nuclear envelope. The polarisation of heterochromatin likely generates an 
environment whereby C. trachomatis can better manipulate host gene expression in order to 
enhance aspects of infection not related to inclusion enlargement and bacterial replication, for 
example, the inhibition of host responses to infection such as immune signalling or apoptosis. 
These observations are distinct from the known interactions of intracellular pathogenic 
bacteria with the nucleus, that can be broadly categorised into three groups (Bierne and 
Cossart, 2012): bacterial proteins that manipulate chromatin structure, including  
C. trachomatis NUE, which can methylate histones H2B, H3 and H4 in vitro (Pennini et al., 
2010), and the L. pneumophila protein RomA, which methylates H3K14 to repress host gene 
expression (Rolando et al., 2013); bacterial proteins that target nuclear regulators of gene 
expression such as the Shigella flexneri effector OspF, which inhibits MAPK signalling to block 
activation of pro-inflammatory genes (Arbibe et al., 2007; Brennan and Barford, 2009); and 
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bacterial proteins that manipulate the cell cycle, for example E. coli CifEc which induces arrest 
at G1/S or G2/M by stabilising cyclin-dependent kinase inhibitors (Samba-Louaka et al., 2008). 
The work presented here demonstrates that in addition to manipulating nuclear function with 
effectors such as NUE, C. trachomatis targets the nucleus on a more global level than is known 
for other bacterial pathogens, inducing a major reorganisation of nuclear architecture with 
potential impact on gene expression, chromosome organisation and mechanotransduction. 
These findings reveal exciting avenues for further research into the relationship between 
Chlamydia trachomatis and nuclear architecture and function.  
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Appendix 3.1. Full z-stack of the nucleus of the cell shown in figure 3.11A infected with C. 
trachomatis for 24 hours. HeLa cells were infected with C. trachomatis LGV2, fixed at 24 hours 
post infection (hpi) and stained with anti-lamin B1 primary antibody and an AlexaFluor® 546-
conjugated secondary antibody (grey) to visualise lamin B. Panels show confocal xy-sections of 
the nucleus, ascending in the z dimension through the cell (1-24) with a step of 0.34 µm. Scale 
bars, 10 µm. 
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Appendix 3.2. Full z-stacks of the nuclei of the cell shown in figure 3.11B infected with C. 
trachomatis for 48 hours. HeLa cells were infected with C. trachomatis LGV2, fixed at 48 hours 
post infection (hpi) and stained with anti-lamin B1 primary antibody and an AlexaFluor® 546-
conjugated secondary antibody (grey) to visualise lamin B. Panels show confocal xy-sections of 
the nuclei, ascending in the z dimension through the cell (1-16) with a step of 0.34 µm. (A) 
Nucleus equivalent to the upper panel in figure 3.11B. (B) Nucleus equivalent to the lower 
panel in figure 3.11B. Scale bars, 10 µm. 
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Appendix 3.3. Full z-stack of the nucleus of the cell shown in the upper panel of figure 3.11C 
infected with C. trachomatis for 72 hours. HeLa cells were infected with C. trachomatis LGV2, 
fixed at 72 hours post infection (hpi) and stained with anti-lamin B1 primary antibody and an 
AlexaFluor® 546-conjugated secondary antibody (grey) to visualise lamin B. Panels show 
confocal xy-sections of the nuclei, ascending in the z dimension through the cell (1-21) with a 
step of 0.34 µm. Scale bars, 10 µm. 
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Appendix 3.4. Full z-stack of the nucleus of the cell shown in the lower panel of figure 3.11C 
infected with C. trachomatis for 72 hours. HeLa cells were infected with C. trachomatis LGV2, 
fixed at 72 hours post infection (hpi) and stained with anti-lamin B1 primary antibody and an 
AlexaFluor® 546-conjugated secondary antibody (grey) to visualise lamin B. Panels show 
confocal xy-sections of the nuclei, ascending in the z dimension through the cell (1-21) with a 
step of 0.34 µm. Scale bars, 10 µm. 
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Appendix 3.5. Full z-stack of the nucleus of the cell shown in figure 3.14A infected with C. 
trachomatis for 24 hours. HeLa cells were infected with C. trachomatis LGV2, fixed at 24 hours 
post infection (hpi) and stained with mAb414 primary antibody and an AlexaFluor® 488-
conjugated secondary antibody (grey) to visualise phenylalanine glycine-containing 
nucleoporins (FG-Nups). Panels show confocal xy-sections of the nuclei, ascending in the z 
dimension through the cell (1-24) with a step of 0.34 µm. Scale bars, 10 µm. 
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Appendix 3.6. Full z-stack of the nucleus of the cell shown in the upper panel of figure 3.14B 
infected with C. trachomatis for 48 hours. HeLa cells were infected with C. trachomatis LGV2, 
fixed at 48 hours post infection (hpi) and stained with mAb414 primary antibody and an 
AlexaFluor® 488-conjugated secondary antibody (grey) to visualise phenylalanine glycine-
containing nucleoporins (FG-Nups). Panels show confocal xy-sections of the nuclei, ascending 
in the z dimension through the cell (1-24) with a step of 0.34 µm. Scale bars, 10 µm. 
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Appendix 3.7. Full z-stack of the nucleus of the cell shown in the lower panel of figure 3.14B 
infected with C. trachomatis for 48 hours. HeLa cells were infected with C. trachomatis LGV2, 
fixed at 48 hours post infection (hpi) and stained with mAb414 primary antibody and an 
AlexaFluor® 488-conjugated secondary antibody (grey) to visualise phenylalanine glycine-
containing nucleoporins (FG-Nups). Panels show confocal xy-sections of the nuclei, ascending 
in the z dimension through the cell (1-24) with a step of 0.34 µm. Scale bars, 10 µm. 
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Appendix 3.8. Full z-stacks of the nuclei of the cell shown in figure 3.14C infected with C. 
trachomatis for 72 hours. HeLa cells were infected with C. trachomatis LGV2, fixed at 72 hours 
post infection (hpi) and stained with mAb414 primary antibody and an AlexaFluor® 488-
conjugated secondary antibody (grey) to visualise phenylalanine glycine-containing 
nucleoporins (FG-Nups). Panels show confocal xy-sections of the nuclei, ascending in the z 
dimension through the cell (1-24) with a step of 0.34 µm. (A) Nucleus equivalent to the upper 
panel in figure 3.14C. (B) Nucleus equivalent to the lower panel in figure 3.14C .Scale bars, 10 
µm. 
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Species Gene Identifier 
(IMG database)  
Encoded protein name 
Blastopirellula 
marina 
638976093 probable L-sorbosone dehydrogenase 
638976556 glucose dehydrogenase-B [pyrroloquinoline-quinone] 
precursor-like protein 
638978984 hypothetical protein 
638979435 Cytochrome c-like protein 
638979470 hypothetical protein 
638980220 hypothetical protein 
638980641 hypothetical protein 
638980874 hypothetical protein 
638980886 L-sorbosone dehydrogenase-like protein 
638981029 hypothetical protein 
638981356 hypothetical protein 
638981358 glucose dehydrogenase-B [pyrroloquinoline-quinone] 
precursor-like protein 
Chthoniobacter 
flavus 
642908240 heme-binding protein 
642910918 membrane-bound dehydrogenase domain protein 
642911202 glucose dehydrogenase-B (pyrroloquinoline-quinone) 
(precursor)-like protein 
642911438 membrane-bound dehydrogenase domain protein 
642911451 heme-binding protein 
642911540 membrane-bound dehydrogenase domain protein 
642911638 coagulation factor 5/8 type domain protein 
642911643 heme-binding protein 
642913322 membrane-bound dehydrogenase domain protein 
642913358 heme-binding protein 
642913419 membrane-bound dehydrogenase domain protein 
642913493 heme-binding protein 
642913495 membrane-bound dehydrogenase domain protein 
642913861 heme-binding protein 
Gemmata 
obscuriglobus 
642220721 hypothetical protein 
642221071 hypothetical protein 
642225323 hypothetical protein 
642225569 hypothetical protein 
642225867 hypothetical protein 
642226015 hypothetical protein 
642226674 hypothetical protein 
642227083 probable L-sorbosone dehydrogenase 
Lentisphaera 
araneosa 
641128129 hypothetical protein 
641128534 probable cytochrome c precursor 
641128545 hypothetical protein 
641129208 hypothetical protein 
641131688 hypothetical protein 
641131908 hypothetical protein 
641132248 hypothetical protein 
641132354 hypothetical protein 
641132994 hypothetical protein 
Pedosphaera 
parvula 
642468634 heme-binding protein 
642469007 heme-binding protein 
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642469316 membrane-bound dehydrogenase domain protein 
642472080 heme-binding protein 
642472266 membrane-bound dehydrogenase domain protein 
642472454 membrane-bound dehydrogenase domain protein 
642473041 membrane-bound dehydrogenase domain protein 
642474024 membrane-bound dehydrogenase domain protein 
642474746 membrane-bound dehydrogenase domain protein 
Planctomyces 
maris 
641107130 hypothetical protein 
641108038 hypothetical protein 
641110955 hypothetical protein 
641110980 probable L-sorbosone dehydrogenase 
641111294 hypothetical protein 
641111761 hypothetical protein 
641112091 hypothetical protein 
641112369 hypothetical protein 
641112478 hypothetical protein 
641112544 hypothetical protein 
641112798 quinoprotein glucose dehydrogenase 
Rhodopirellula 
baltica 
637433005 similar to L-sorbosone dehydrogenase 
637433385 conserved hypothetical protein-putative cytochrome c 
637434028 similar to glucose dehydrogenase-B 
637438096 conserved hypothetical protein-possibly contains 
sugar binding site 
637438335 probable L-sorbosone dehydrogenase 
Verrucomicrobium 
spinosum 
642329454 hypothetical protein 
642329771 hypothetical protein 
642329814 hypothetical protein 
642332150 hypothetical protein 
642332272 hypothetical protein 
642332458 hypothetical protein 
642333361 hypothetical protein 
642333382 hypothetical protein 
642333400 probable L-sorbosone dehydrogenase 
642333437 probable secreted glycosyl hydrolase 
642333450 hypothetical protein 
642333699 hypothetical protein 
642333971 hypothetical protein 
642334466 hypothetical protein 
642334781 hypothetical protein 
642334798 hypothetical protein 
 
 
Appendix 5.1. Membrane coat-like (MC) proteins of the Planctomycetes-Verrucomicrobia-
Chlamydiae (PVC) superphylum used for remote homology detection. Gene identifiers of 
genes encoding for MC proteins detected by Santarella-Mellwig et al. (2010) correspond to 
entries in the Integrated Microbial Genomes & Microbiome Samples (IMG) database, available 
at https://img.jgi.doe.gov.  
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Appendix 5.2. Python code for the secondary structure element (SSE) consensus and visual 
output tool. To run, navigate to the directory where the predicted SSE sequences are located 
(in text format with Psipred syntax) using the Unix command-line interpreter and execute the 
script using Python. The tool will output the consensus SSE sequence as a .txt file and in a 
visual format (for an example, refer to Figure 5.1) which can be read using a PostScript viewing 
software. 
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Appendix 5.3. Python code for filtering consensus secondary structure element (SSE) 
sequences to identify α-solenoid proteins. To run, replace the object self.path with the 
location of the directory where the consensus SSE sequences generated from the SSE 
consensus tool are located in .txt format, and execute the script using Python. The tool will 
generate a list of the input proteins whose SSE sequences conform to the parameters defined 
in Figure 5.2. 
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Appendix 5.4. Consensus secondary structure sequences of predicted α-solenoid proteins 
following filtering of the C. trachomatis proteome. The consensus secondary structure 
element (SSE) sequence was determined for each protein in the C. trachomatis proteome from 
three prediction algorithms, PsiPred, Jpred and RaptorX. The SSE sequences were then filtered 
for proteins with an α-solenoid fold using parameters (as defined in figure 5.2) devised from 
analysis of the secondary structure sequence of structural Nups and importin-β. The SSE 
sequences of the 55 remaining proteins are shown. Accession identifiers correspond to entries 
in the UniParc database. β-sheets are represented in blue, α-helixes in pink, whilst coil 
residues are not shown. Vertical scale bar, confidence (Conf) scored from 0-9. Horizontal scale 
bar, residue number.  
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>CT234 (O84237)  
MLLFYKGSGSLRALRFLLSLRRGEEKRALLFLLLGLIWSVACYGSLALGESLFLEEIGAE 
KLPFAYLGASFFLCFISCLILYNLSRKRVSPKALFLSFISCVLICNLYLFWHLAIHKGVS 
GTPTFLYRILIWGLTILCYANFWGFIDQFFNIQDAKRHFCIFNAITFCGDFLGARIVNQI 
QYLGAELILLAFIVVITFIFPLVHYISSSLKELSEDHNLFLDTGYPPSTKQTLKLCLKDK 
YTFYLVSFYFLMQLLVVFTEFNYLKIFDAQFGNAETCELTENFTKYSSWISLGNMFFALF 
AYSRVITRFGINNIILFAPICFFSLFCCWSIKTSVFIATMGMIAREGLAYALDDNNLQLL 
IYGIPNKIRNQVRIAIESFVEPAGMFICALLCLFIPHQYVLCIIISAVCILLAILLRTHY 
SKAILRNLSLESIHRRRSIREWFADMNDTEKRQAEILLLTHLKNPQERNQMFAFQHLLNL 
KNRAVLPNLLLHMNKLGLSGKLKTLNMLKNSVWAKDFLTLELLKRWSSLPQHPTIAAALH 
LYFVEHDLLHVSDIADDLYDQSGDRLFAAVLIVRKHKPSGEYQALAEKHLSEILESEDPE 
LIIKGLSILALERSPSNFPIILPFLTHPNEQVFLQACLSLETCADKQYAQYGRTVLNTLK 
KTKDTQAAQALLNTLAALLDASLVYEFVLASVQLKNVLRKLAETILASLPKECIPILIEM 
VADHSLHNSCRIMAAKALSHIDSRQLKRLALKILKSKAAKTLFYDYHKNFIQKRYPRYDL 
HLLIESLEANYQAEVNFMLAFLAIVGSSDYADVLIRSLTGKNLKARAQALESLEKDCENH 
LFTLVTPFVYRDKHTSDEKYYMKKGVEPLAIEELLNRLEQTPFLFSKLIAQQLKEELSLC 
DAEFSSALQSFAKKQKTSILSREYITSS 
 
 
>CT350 (O84354) 
MGLSRLAFISFLSFTLSASCDFPSSVSQRILFSCRKSVPQALEAYLEASATYQQHDFSVL 
RVIAESYLQQSFLSEDTYIRKSAIIGAGLSGSSEALELLSEAIETQDLYEQLLILNAATS 
QLSKTSDKLLFKGLTASHPVIRLEAAYRLACMKNSKVSDYLYSFIYKLPEEIQNLAATIF 
LQLETEEADAYIHHLLSSPNNLTRNYVAYLIGEYKQKRFLPTLRSLLTSASPLDQEGALY 
ALGKLEDSGSYPRIKALSSRSNPEVVLAAAQTLLFLEKEEEALPILTNLCQQKLLRALYT 
ARFLSQEKGEELLLPIFYNATQEEIRLNTALALVHQGCTDPQVLHYLTEILESKVLHRIF 
LPTHSTGKAIQFWKECTTFPLMSQEDKMRTLAMYRVAEDTILSALLKLPNDAYLPYLERI 
LASQKTILAAKAIAFLSVTAHPQALSLVSKAALTPGDPIIRAYANLALYTMTKDPEKKAV 
LYRYAEQLIEDTILFTDAENPLPSPSSSYLRYQVSPETRTQLMLAILETLVSSKTDEDIR 
VFLSLMKKTHYKNIPILSGLLMRIVE 
 
 
>CT384 (O84389) 
MCCVDGSNSIQQRMRFCEYRTAAQEAKTSLSSDCSLLEARLALRALAKHHEYSAWREAFL 
RSQERFPSLEADRDIHEDLAASLLQKNIRHSSLTVRVITILAVGMARDYRLVPIVLQALS 
DDSDTVREIAVQVAVMYGSSCLLRAVGDLAKNDSSIQVRITAYRAAAVLEIQDLVPHLRV 
VVQNTQLDGTERREAWRSLCVLTRPHSGVLTGIDQALMTCEMLKEYPEKCTEEQIRTLLA 
ADHPEVQVATLQIILRGGRVFRSSSIMESVQKLACNSLSARVQMQAAAILYLEGDPFGED 
KLTEGLSATSSILCEAASEAVCSLGIHGVHLAGRFLSKVQGMRSRVNLAFALLVSREKVE 
EAGDVVASFIHRIEPCRAIEQFLCEDQKIFVASSPLQVEIMKRDLAKKIIRLLVAAQYSK 
AKMVVAQYLAGQQVGWSFCSEVFWEEGDSEDFVEPLQEESFAFALEKALSFLQREGGEAG 
LHAVISLYPHSRWQDKLTILEAIAYSENRIATCFLRERCLQEAASLQSAAAGAVFALFK 
 
 
Appendix 5.5. Amino acid sequences and UniProt database accession numbers of identified 
C. trachomatis α-solenoid proteins in FASTA format. 
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Appendix 6.1. Regions lacking mEos2-importin-β equivalent to pore-free islands are present 
at the nuclear surface in Chlamydia-infected cells. HeLa cells transiently expressing mEos2-
importin-β (grey) were infected with C. trachomatis LGV2 and fixed at 48 hours post infection. 
Panels at the base and midsection of the nuclei are shown, ascending in the z dimension 
through the cell (1-3) with a step of 0.34 µm. (A) Nucleus equivalent to the upper panels in 
figure 4.7B. (B) Nucleus equivalent to the lower panels in figure 4.7B. Pore-free islands in the 
nuclei are indicated by yellow arrowheads, areas of importin-β depletion are highlighted by 
white arrowheads. Scale bars, 10 µm. 
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